data_1b28_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1b28 _Structure_validation_residue.Date_analyzed 2017-03-24 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.72 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 15.5 tpt . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.72 ' HB3' ' O ' ' A' ' 1' ' ' MET . 40.4 ttmt 84.22 112.26 0.06 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.19 0.519 . . . . 0.0 109.957 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 94.3 95.26 1.6 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.194 -1.003 . . . . 0.0 110.915 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.5 mtt -135.8 -52.75 0.75 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.4 m -146.51 -56.04 0.27 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.057 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.991 ' HA ' ' HB3' ' B' ' 113' ' ' ARG . 98.6 mttt -85.85 56.72 4.1 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.45 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 44.8 mtt -137.26 -60.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 171.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 7' ' ' MET . 31.5 Cg_exo -61.11 103.96 0.26 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.511 2.141 . . . . 0.0 111.493 170.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 82.6 mt-30 -94.7 143.66 26.26 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.656 1.217 . . . . 0.0 111.573 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -116.25 96.95 5.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.727 -1.579 . . . . 0.0 106.945 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -99.24 131.92 44.92 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.807 0.813 . . . . 0.0 111.044 -175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.53 -173.93 3.56 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.242 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -137.63 118.41 14.12 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.162 -0.962 . . . . 0.0 111.646 -175.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -125.36 146.68 55.08 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.389 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -47.12 143.37 10.32 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 121.875 1.717 . . . . 0.0 111.506 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -58.35 -36.91 74.17 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -172.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.53 -36.59 84.28 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.719 -0.613 . . . . 0.0 112.518 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.3 t -62.98 -44.01 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.878 -0.514 . . . . 0.0 111.582 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 56.5 mt -58.22 -49.55 76.7 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.43 -0.508 . . . . 0.0 112.254 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -56.44 -25.86 51.84 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 tt -78.11 -39.29 41.8 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.577 173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.7 t -60.69 -38.34 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 121.452 -0.78 . . . . 0.0 110.989 170.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 95.8 mtt180 -72.06 -30.84 65.54 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.492 175.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -66.5 -54.08 27.92 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.26 174.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.8 t -59.89 -34.86 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.09 -32.97 74.72 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -72.47 -41.21 66.29 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.85 -48.82 80.06 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.729 0.641 . . . . 0.0 112.729 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -75.35 -13.77 60.43 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.524 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.45 58.3 11.89 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.031 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.47 ' HE1' ' CB ' ' A' ' 35' ' ' SER . 25.9 ttt -145.33 147.63 32.53 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.93 0.871 . . . . 0.0 108.898 -176.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.5 t -67.19 143.72 56.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.9 0.857 . . . . 0.0 110.368 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -61.46 -37.7 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -55.58 -53.73 52.77 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.274 -0.891 . . . . 0.0 111.84 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.47 ' CB ' ' HE1' ' A' ' 31' ' ' MET . 60.4 m -71.46 -22.1 61.87 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -71.21 -57.17 4.75 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.5 -0.75 . . . . 0.0 112.163 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.2 mp -66.38 -28.37 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -56.73 -41.09 76.9 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.642 169.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -74.92 -16.31 60.66 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.44 -36.15 20.82 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.078 1.308 . . . . 0.0 111.748 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.6 m -73.83 -7.95 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.954 172.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.651 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -108.97 -25.13 10.88 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.978 0.808 . . . . 0.0 112.208 174.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -83.56 -16.01 47.05 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.968 172.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.1 t -108.15 -50.52 3.03 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.427 ' O ' ' CG ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -103.4 69.09 0.98 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 123.143 1.449 . . . . 0.0 107.623 175.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 1.01 ' HB2' ' NH2' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -84.89 -43.46 14.07 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 120.98 -1.075 . . . . 0.0 111.291 -176.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.675 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 27.5 mmmt 118.44 33.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.127 0.965 . . . . 0.0 110.438 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -94.47 -30.32 14.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.744 167.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.56 65.29 0.1 OUTLIER Glycine 0 N--CA 1.467 0.739 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 1.01 ' NH2' ' HB2' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -112.38 -87.81 0.54 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -177.126 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.6 tp -60.8 -37.88 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.6 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.16 -88.34 0.75 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.26 -0.971 . . . . 0.0 110.919 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.149 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 16.0 tpt . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' B' ' 102' ' ' LYS . 22.9 pttp -171.88 109.44 0.26 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.139 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.11 62.22 0.01 OUTLIER Glycine 0 N--CA 1.466 0.684 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 16.4 tpt -101.25 -64.32 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 27.3 t -85.5 -71.81 0.51 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . 0.42 ' H ' ' HD3' ' B' ' 108' ' ' PRO . 58.2 mtmt -145.11 -86.96 0.11 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 174.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' MET . . . . . . . . . . . . . 65.3 mtt -143.08 63.28 12.86 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 169.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.42 ' HD3' ' H ' ' B' ' 106' ' ' LYS . 54.4 Cg_endo -93.11 79.3 0.26 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 121.797 1.665 . . . . 0.0 110.39 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -86.98 144.66 26.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 122.53 1.157 . . . . 0.0 111.571 -173.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -140.68 110.06 6.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.307 -174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -93.84 130.61 39.81 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.811 0.815 . . . . 0.0 111.135 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 34.8 mt -104.7 171.4 7.35 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.991 ' HB3' ' HA ' ' A' ' 6' ' ' LYS . 97.2 mtt180 -134.09 94.1 3.19 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.812 0.815 . . . . 0.0 109.596 -176.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' TRP . . . . . 0.439 ' CZ2' HD11 ' B' ' 112' ' ' LEU . 54.7 m0 -121.29 151.1 55.49 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.87 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -55.61 144.06 76.5 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 121.673 1.582 . . . . 0.0 110.586 170.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.91 -30.29 67.71 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.96 -38.54 82.89 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.63 -0.669 . . . . 0.0 112.092 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.59 -44.44 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.204 0.526 . . . . 0.0 111.015 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 58.4 tp -67.7 -34.01 76.03 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . 0.715 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 68.0 m-20 -70.61 -25.85 63.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.564 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 15.2 tp -78.17 -32.59 50.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.228 172.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.78 -39.19 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 167.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . 0.715 ' HB2' ' O ' ' B' ' 120' ' ' ASP . 2.9 mmp_? -54.34 -48.91 70.86 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.108 0.48 . . . . 0.0 111.797 169.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -56.92 -57.51 12.19 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.277 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.93 -39.04 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.82 -30.97 72.0 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -73.19 -44.77 59.29 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.795 -0.565 . . . . 0.0 112.192 174.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.93 -51.83 67.99 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -79.36 -12.75 59.91 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.467 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.96 59.85 8.97 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.268 -0.967 . . . . 0.0 111.932 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 59.2 tpp -141.38 146.18 36.29 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 65.2 m -67.66 142.0 56.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.038 0.923 . . . . 0.0 110.982 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 14.0 m -64.82 -33.38 63.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -58.8 -53.34 59.53 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.807 -0.558 . . . . 0.0 111.43 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 59.0 m -71.98 -19.5 61.87 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -71.83 -57.29 4.46 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.743 -0.598 . . . . 0.0 111.756 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 2.6 mp -69.7 -25.85 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -58.59 -37.71 76.37 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.882 0.849 . . . . 0.0 109.694 168.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' GLN . . . . . 0.487 HE21 ' HA ' ' B' ' 139' ' ' GLN . 2.4 tp60 -78.61 -21.4 48.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.111 177.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 84.9 mt -81.57 -31.67 32.5 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.562 1.074 . . . . 0.0 112.189 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.21 -25.61 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.926 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.492 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 30.6 mmt -84.48 -28.81 26.51 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.383 -0.823 . . . . 0.0 112.539 175.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -74.08 -24.79 59.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.654 171.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 67.3 m -84.83 -43.32 14.28 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.154 -0.341 . . . . 0.0 110.301 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.791 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 18.1 m-30 -77.27 95.92 4.46 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.791 ' HG3' ' O ' ' B' ' 145' ' ' PHE . 10.9 mtpt 165.69 -36.94 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.817 -166.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' B' ' 148' ' ' GLU . 13.6 tptm -81.16 63.63 5.58 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 123.201 1.477 . . . . 0.0 109.797 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' B' ' 147' ' ' LYS . 26.6 tt0 169.7 -32.85 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 112.804 -1.998 . . . . 0.0 108.786 -174.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 89.01 68.28 1.26 Allowed Glycine 0 N--CA 1.466 0.691 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . 0.507 ' HB2' ' H ' ' B' ' 151' ' ' ILE . 48.1 mtt180 -105.49 -84.21 0.5 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.277 1.037 . . . . 0.0 108.821 -169.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.507 ' H ' ' HB2' ' B' ' 150' ' ' ARG . 6.9 tp -58.93 -43.34 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 114.11 -1.405 . . . . 0.0 112.769 174.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -90.59 -112.16 1.57 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.726 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.491 -179.409 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.679 ' HG3' ' HE3' ' A' ' 4' ' ' MET . 27.9 ttt . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -169.37 103.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.76 78.38 1.41 Allowed Glycine 0 N--CA 1.468 0.804 0 C-N-CA 120.245 -0.978 . . . . 0.0 111.025 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.679 ' HE3' ' HG3' ' A' ' 1' ' ' MET . 26.4 mmt -93.73 -50.36 5.42 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.426 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.452 ' HB2' HE21 ' A' ' 9' ' ' GLN . 33.5 t -77.59 -95.17 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -126.83 -54.33 1.41 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 168.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.4 mmt -90.58 149.68 41.18 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 165.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 1.009 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 69.4 Cg_exo -46.4 128.9 12.91 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 122.659 2.239 . . . . 0.0 115.739 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.452 HE21 ' HB2' ' A' ' 5' ' ' SER . 24.2 tt0 -83.19 149.43 26.84 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.628 -176.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -133.44 113.12 12.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.369 -172.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -96.6 142.29 28.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.813 0.816 . . . . 0.0 111.987 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.477 HD11 ' CZ2' ' A' ' 14' ' ' TRP . 41.2 mt -122.52 171.58 9.0 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.573 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' HB3' ' HA ' ' B' ' 106' ' ' LYS . 97.7 mtt180 -137.28 93.15 2.78 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.504 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.477 ' CZ2' HD11 ' A' ' 12' ' ' LEU . 53.7 m0 -119.2 153.75 53.38 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.476 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.77 142.05 74.9 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 121.55 1.5 . . . . 0.0 110.479 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -58.79 -33.32 70.19 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.39 -39.75 89.23 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.65 -0.656 . . . . 0.0 112.167 175.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.9 t -64.46 -46.65 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.92 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 56.2 tp -61.66 -40.78 96.14 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 91.7 m-20 -68.94 -26.81 65.26 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.876 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.3 tp -75.68 -31.48 59.76 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.175 171.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -64.21 -36.06 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.523 -0.736 . . . . 0.0 109.74 168.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 21.5 mmt180 -64.15 -38.72 92.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.875 0.369 . . . . 0.0 111.746 170.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 20' ' ' ASP . 68.5 mmtt -61.35 -54.35 44.91 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.2 t -58.21 -38.03 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.11 -32.5 73.9 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.93 -41.76 67.47 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.98 -50.27 74.41 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -76.69 -13.08 60.07 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.513 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.63 59.63 8.99 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.668 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.2 tpt -140.41 147.16 39.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.004 0.907 . . . . 0.0 108.75 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 63.0 m -66.77 144.94 56.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.118 0.961 . . . . 0.0 110.999 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -62.88 -36.76 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -60.59 -52.96 62.95 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.838 -0.539 . . . . 0.0 112.081 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.1 m -71.44 -20.66 62.07 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -69.8 -59.69 2.78 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.785 -0.572 . . . . 0.0 111.74 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.1 mp -70.19 -25.84 28.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.264 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -59.26 -38.72 80.76 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 122.102 0.953 . . . . 0.0 109.441 169.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.523 HE21 ' HA ' ' A' ' 39' ' ' GLN . 1.2 tp60 -77.89 -17.13 57.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.267 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.1 mt -83.83 -35.54 24.15 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.756 1.162 . . . . 0.0 111.828 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.8 m -71.68 -11.97 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.31 169.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.869 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -97.29 -28.87 13.86 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.375 0.989 . . . . 0.0 112.352 172.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.55 -15.47 59.24 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.417 -0.802 . . . . 0.0 112.332 172.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.4 m -118.87 -9.05 10.19 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.431 ' O ' ' CG ' ' A' ' 45' ' ' PHE . 1.6 t80 -152.26 67.35 0.84 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.869 ' HB2' ' O ' ' A' ' 42' ' ' MET . 0.1 OUTLIER -91.02 -45.43 8.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.505 -174.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.697 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 6.0 mmmm 126.67 33.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.766 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -95.93 -28.55 14.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.143 166.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.78 78.94 0.45 Allowed Glycine 0 N--CA 1.467 0.708 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.721 HH21 ' HB3' ' A' ' 46' ' ' LYS . 74.9 mtt-85 -123.71 -85.78 0.65 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.632 1.206 . . . . 0.0 109.052 -171.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 tp -62.81 -45.55 98.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 113.542 -1.663 . . . . 0.0 112.912 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.95 99.09 0.15 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.091 -179.554 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.891 ' O ' ' HB2' ' B' ' 102' ' ' LYS . 15.6 tpt . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.891 ' HB2' ' O ' ' B' ' 101' ' ' MET . 88.3 tttt 133.5 108.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.382 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.96 87.46 1.23 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.115 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 26.2 mmt -139.02 -50.92 0.53 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 89.7 p -160.55 -33.89 0.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.972 175.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 97.7 mttt -87.02 35.66 0.7 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' MET . . . . . 0.447 ' HB2' ' HD3' ' B' ' 108' ' ' PRO . 25.6 mmt -132.57 -49.47 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.663 173.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' B' ' 107' ' ' MET . 18.5 Cg_exo -68.98 103.18 0.99 Allowed 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.521 2.147 . . . . 0.0 110.582 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -99.06 147.7 24.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.93 0.871 . . . . 0.0 110.548 -174.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -133.61 108.57 8.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.849 -174.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -91.4 141.65 28.52 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.962 0.887 . . . . 0.0 112.003 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.441 HD11 ' CZ2' ' B' ' 114' ' ' TRP . 53.0 mt -125.87 168.82 13.34 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.261 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -127.26 85.53 2.38 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.829 0.823 . . . . 0.0 109.67 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' TRP . . . . . 0.441 ' CZ2' HD11 ' B' ' 112' ' ' LEU . 44.7 m0 -119.32 142.49 32.52 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.628 -171.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.94 145.15 53.17 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 121.972 1.781 . . . . 0.0 111.661 172.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 1.009 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . 11.9 ttp180 -61.37 -34.96 76.19 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.87 -35.9 81.53 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.2 -42.76 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.982 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.922 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 80.7 mt -67.37 -32.06 72.72 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 75.7 m-20 -65.31 -33.49 76.1 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.502 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 19.2 tp -77.72 -32.33 52.82 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.077 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.1 -36.34 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . 0.922 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 25.5 mmm-85 -65.24 -35.3 80.61 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.984 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.64 -55.77 20.96 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.723 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 93.0 t -57.99 -36.18 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.77 73.09 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -72.06 -44.61 63.05 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.847 -0.533 . . . . 0.0 112.186 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -57.48 -51.77 68.11 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -80.46 -13.13 59.38 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.499 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.79 61.11 7.09 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.922 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 58.8 tpp -142.77 143.52 32.24 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.866 0.841 . . . . 0.0 109.011 -176.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 64.8 m -68.63 148.48 50.39 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 122.07 0.938 . . . . 0.0 110.929 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 16.5 m -64.04 -35.53 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -59.87 -53.55 56.56 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.62 -0.675 . . . . 0.0 111.681 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 60.0 m -70.73 -23.98 62.54 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -68.46 -57.77 5.34 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.528 -0.733 . . . . 0.0 112.286 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 3.9 mp -68.82 -26.42 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.211 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -56.29 -39.82 73.31 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.496 168.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -76.03 -22.98 55.13 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.821 -0.751 . . . . 0.0 112.917 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 58.9 mt -82.8 -34.38 26.99 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.124 1.329 . . . . 0.0 112.471 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 18.4 m -70.56 -24.86 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.964 172.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.64 -31.77 18.39 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.315 -0.866 . . . . 0.0 112.6 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -77.58 -23.62 49.94 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.418 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' SER . . . . . 0.856 ' C ' ' HB3' ' B' ' 150' ' ' ARG . 35.5 t -97.57 -66.67 0.89 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 1.17 ' HA ' ' CG ' ' B' ' 150' ' ' ARG . 0.1 OUTLIER -75.24 98.99 3.9 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 122.927 1.346 . . . . 0.0 107.892 174.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 1.107 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 27.9 ttpp -138.15 -42.52 0.51 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.535 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 1.107 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 2.5 tmtt? 138.64 48.18 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.889 0.852 . . . . 0.0 109.2 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -151.54 -30.63 0.17 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.276 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 157.05 64.24 0.01 OUTLIER Glycine 0 N--CA 1.466 0.66 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -173.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . 1.17 ' CG ' ' HA ' ' B' ' 145' ' ' PHE . 0.0 OUTLIER -90.52 -55.07 3.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.19 0.995 . . . . 0.0 111.249 -172.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 3.6 tp -120.65 -53.64 3.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.602 -168.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -178.64 98.01 0.11 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 119.884 -1.15 . . . . 0.0 110.25 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.569 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.971 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 61.5 tpp . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.971 ' HB2' ' O ' ' A' ' 1' ' ' MET . 88.6 tttt 143.87 99.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.203 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.3 98.17 0.12 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.1 mtt -140.26 -39.3 0.44 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.866 ' O ' ' HB3' ' B' ' 113' ' ' ARG . 90.0 p -159.92 -40.59 0.05 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.568 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -86.38 30.06 0.73 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.452 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 55.4 tpp -149.68 -48.64 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 118.736 -0.65 . . . . 0.0 112.534 173.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 7' ' ' MET . 15.9 Cg_exo -73.03 96.13 0.85 Allowed 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.248 1.965 . . . . 0.0 111.053 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 78.0 mt-30 -99.91 144.81 28.53 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.541 1.162 . . . . 0.0 111.126 -176.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -120.77 105.66 10.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.148 -1.387 . . . . 0.0 107.689 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -90.26 135.1 33.88 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.872 0.844 . . . . 0.0 111.279 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.91 171.08 14.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.33 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -129.91 106.54 8.73 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.093 -170.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 53.7 m0 -118.62 152.82 51.76 Favored Pre-proline 0 N--CA 1.474 0.755 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.228 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.26 146.23 32.38 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 121.776 1.651 . . . . 0.0 110.758 171.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.55 -33.48 72.73 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -174.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.75 -32.03 73.06 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.625 -0.672 . . . . 0.0 112.314 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.84 -43.38 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.13 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.908 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 59.6 mt -62.39 -40.49 96.66 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -69.81 -24.16 63.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.52 -0.472 . . . . 0.0 112.171 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.7 tp -80.17 -35.09 36.97 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.889 -0.507 . . . . 0.0 111.291 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.86 -33.74 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 170.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.908 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 29.5 mmm-85 -67.61 -40.04 84.72 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 122.18 -0.325 . . . . 0.0 111.255 171.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -63.67 -52.79 59.12 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.798 HG22 ' HG2' ' B' ' 150' ' ' ARG . 0.5 OUTLIER -60.03 -40.11 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.97 -34.34 77.31 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.4 -40.2 81.4 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -60.29 -49.19 78.58 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -76.38 -13.34 60.13 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.625 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.14 61.99 5.3 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.718 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.8 ttt -137.85 148.57 45.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.993 0.901 . . . . 0.0 109.118 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -67.91 135.79 53.0 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.021 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.85 -39.69 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -174.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -59.7 -48.76 80.39 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.435 -0.791 . . . . 0.0 112.039 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.8 m -72.16 -15.75 61.97 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -73.9 -55.77 5.77 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.683 -0.635 . . . . 0.0 111.849 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mp -65.82 -30.67 50.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -57.0 -37.83 72.22 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.125 170.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.502 HE21 ' HA ' ' A' ' 39' ' ' GLN . 2.2 tp60 -77.04 -23.09 52.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.201 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.39 -37.22 37.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.773 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.32 -13.89 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.281 171.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.53 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 29.4 mmt -97.44 -14.79 20.95 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.531 -1.356 . . . . 0.0 112.869 175.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -94.64 -25.55 16.72 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 119.539 -0.865 . . . . 0.0 112.313 171.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 1.153 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 74.4 m -93.72 -71.94 0.63 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 175.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.973 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 14.7 t80 -71.07 178.35 3.29 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 164.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.973 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER 169.61 -58.83 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 O-C-N 119.923 -1.735 . . . . 0.0 108.8 177.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.89 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 4.5 tmtp? -132.5 23.23 4.37 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.23 169.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 73.86 9.2 4.8 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.43 46.73 1.08 Allowed Glycine 0 N--CA 1.47 0.964 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 171.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 1.153 ' HB3' ' O ' ' A' ' 44' ' ' SER . 1.9 mpp_? -131.57 -84.95 0.5 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -169.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.2 tp -66.66 -42.91 90.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.903 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.71 124.01 1.02 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.273 -179.642 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.883 ' O ' ' CB ' ' B' ' 102' ' ' LYS . 66.0 mtt . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.883 ' CB ' ' O ' ' B' ' 101' ' ' MET . 88.4 tttt 115.96 106.93 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.384 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.62 43.89 0.02 OUTLIER Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.237 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -173.71 36.56 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 88.7 p 48.57 69.03 0.6 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -77.89 -58.17 3.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 167.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' MET . . . . . 0.713 ' H ' ' HD3' ' B' ' 108' ' ' PRO . 24.5 ttt -162.07 46.05 0.17 Allowed Pre-proline 0 CA--C 1.552 1.046 0 CA-C-O 117.898 -1.049 . . . . 0.0 112.926 168.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.713 ' HD3' ' H ' ' B' ' 107' ' ' MET . 17.2 Cg_exo -74.43 102.59 1.57 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 124.274 2.562 . . . . 0.0 109.646 174.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -95.51 154.19 17.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.083 0.944 . . . . 0.0 111.174 -172.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -148.76 115.13 5.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -92.1 126.91 37.37 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.38 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 31.4 mt -97.76 173.65 7.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.965 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.866 ' HB3' ' O ' ' A' ' 5' ' ' SER . 98.7 mtt180 -134.07 85.57 2.21 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.705 -175.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' TRP . . . . . 0.433 ' CZ2' HD11 ' B' ' 112' ' ' LEU . 45.2 m0 -119.45 150.6 50.06 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.125 -172.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.02 145.35 64.02 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 121.747 1.631 . . . . 0.0 111.009 172.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -60.86 -36.58 79.52 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 119.776 -0.769 . . . . 0.0 112.849 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.9 -33.72 76.69 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.38 -42.13 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.904 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.92 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 64.4 mt -65.2 -34.74 79.09 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 75.6 m-20 -65.76 -34.72 78.84 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.516 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 28.2 tp -80.16 -29.46 38.77 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 120.394 -0.523 . . . . 0.0 112.176 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 67.8 t -64.94 -33.25 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 166.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . 0.92 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 30.2 mmm-85 -62.98 -41.34 99.54 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 122.14 -0.35 . . . . 0.0 111.514 171.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.98 -48.69 51.9 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.272 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.84 -43.42 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.88 -42.57 81.03 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.4 -33.35 72.88 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -68.46 -41.13 80.65 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.047 -0.408 . . . . 0.0 111.749 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -72.04 -8.33 53.95 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.389 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.54 63.67 3.28 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.782 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 18.7 ttt -153.58 145.55 23.63 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.729 0.776 . . . . 0.0 109.281 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 66.4 m -73.35 144.81 46.35 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.61 0.719 . . . . 0.0 109.837 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 14.0 m -65.18 -38.04 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -64.0 -45.52 88.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.306 -0.871 . . . . 0.0 111.416 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 57.0 m -71.94 -19.24 61.93 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -73.15 -55.42 6.49 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.695 -0.628 . . . . 0.0 111.619 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 3.7 mp -68.16 -27.44 37.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.996 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -57.79 -40.38 79.73 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 122.071 0.939 . . . . 0.0 109.63 169.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' GLN . . . . . 0.45 HE21 ' HA ' ' B' ' 139' ' ' GLN . 3.6 tp60 -73.98 -21.27 60.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.163 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.88 -32.21 31.13 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.087 -1.008 . . . . 0.0 111.777 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 31.2 m -80.21 1.21 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.192 170.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.705 ' O ' ' HG2' ' B' ' 146' ' ' LYS . 2.1 mmt -113.73 -18.84 11.76 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.086 -1.009 . . . . 0.0 111.873 170.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -84.28 -24.01 30.1 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.307 169.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 38.5 t -84.65 -54.04 4.98 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.489 ' O ' ' HG2' ' B' ' 146' ' ' LYS . 6.1 m-85 -70.62 102.94 2.38 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 172.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.801 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 7.0 mmmt -166.82 -59.62 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 118.949 -1.1 . . . . 0.0 108.597 -163.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.801 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 0.0 OUTLIER 163.59 23.71 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.558 172.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 1.011 ' HB2' ' NH2' ' B' ' 150' ' ' ARG . 44.8 mt-10 -81.25 -34.64 31.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 168.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 174.35 47.63 0.05 OUTLIER Glycine 0 CA--C 1.53 0.986 0 C-N-CA 119.342 -1.409 . . . . 0.0 114.348 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . 1.011 ' NH2' ' HB2' ' B' ' 148' ' ' GLU . 0.5 OUTLIER -137.92 -97.26 0.19 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.175 0.987 . . . . 0.0 109.713 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 8.9 tp -60.86 -36.84 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . 0.517 ' HA3' ' HD3' ' B' ' 147' ' ' LYS . . . -80.21 -84.82 0.65 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.873 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.185 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.593 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.963 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 26.4 mmt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.963 ' HB2' ' O ' ' A' ' 1' ' ' MET . 54.6 tptt 132.29 -76.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.636 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.28 114.02 0.57 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -162.66 43.81 0.13 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.538 ' O ' ' HB3' ' B' ' 113' ' ' ARG . 6.9 p 78.0 -37.38 0.23 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -177.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -88.81 28.27 1.19 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.63 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.408 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 26.4 ttt -151.5 -47.85 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 176.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 7' ' ' MET . 22.2 Cg_exo -69.52 102.17 0.96 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.341 2.027 . . . . 0.0 111.664 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 18.0 tt0 -97.88 146.43 25.45 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.954 0.883 . . . . 0.0 110.324 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -135.92 105.67 6.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.915 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -92.36 141.65 28.31 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.04 0.924 . . . . 0.0 111.49 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 29.9 mt -119.41 -176.03 3.06 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.518 HH12 ' HA ' ' B' ' 101' ' ' MET . 90.3 mtt180 -142.12 94.03 2.61 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.283 -0.886 . . . . 0.0 109.555 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.468 ' CZ2' HD11 ' A' ' 12' ' ' LEU . 48.2 m0 -119.55 141.58 31.17 Favored Pre-proline 0 N--CA 1.473 0.722 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.592 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -48.32 142.67 16.49 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 121.862 1.708 . . . . 0.0 111.599 173.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -59.0 -33.9 71.23 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.89 -34.64 78.61 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.687 -0.633 . . . . 0.0 112.35 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.54 -42.71 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.864 -0.522 . . . . 0.0 111.15 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.933 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 56.7 mt -65.34 -36.21 83.33 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -66.27 -29.59 69.85 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.747 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.3 tp -81.55 -31.5 32.66 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.856 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.44 -35.3 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 167.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.933 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 29.7 mmm-85 -64.99 -36.52 84.67 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.781 172.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -63.07 -55.58 24.29 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.114 -0.366 . . . . 0.0 110.814 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.1 t -55.56 -37.95 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 -33.06 74.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.77 -44.88 63.27 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.943 -0.473 . . . . 0.0 112.226 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -58.86 -51.63 69.2 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -79.31 -11.15 59.94 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.568 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.6 58.49 12.03 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.426 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 58.4 tpp -147.08 142.27 27.23 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.6 m -66.28 147.97 52.53 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.108 0.956 . . . . 0.0 111.157 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 m -64.29 -34.53 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -58.45 -52.02 67.37 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.762 -0.586 . . . . 0.0 111.453 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -72.08 -19.28 61.84 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -71.86 -58.58 3.33 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.714 -0.616 . . . . 0.0 111.869 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mp -68.49 -27.85 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.9 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -59.2 -35.38 73.5 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.182 169.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.524 HE21 ' HA ' ' A' ' 39' ' ' GLN . 2.5 tp60 -77.99 -22.78 48.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.991 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.2 mt -81.22 -30.18 34.31 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.359 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.9 m -71.68 -28.28 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.646 169.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.431 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 11.4 mmt -82.02 -25.58 34.55 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.385 -0.822 . . . . 0.0 112.653 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -77.7 -24.54 49.22 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.335 -0.853 . . . . 0.0 111.338 170.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.9 t -80.03 -51.15 9.39 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.82 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 21.7 m-85 -69.18 99.59 1.16 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 171.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.82 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 11.0 mtpt 161.21 -41.66 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.111 -167.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 48' ' ' GLU . 2.5 tmtp? -79.89 67.17 5.6 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.934 1.35 . . . . 0.0 109.91 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 47' ' ' LYS . 12.5 tt0 161.07 -35.41 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.364 -175.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 111.43 62.42 0.48 Allowed Glycine 0 N--CA 1.467 0.709 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.09 -84.08 0.34 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 tp -61.13 -37.22 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.405 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.69 105.03 0.27 Allowed Glycine 0 N--CA 1.466 0.677 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.121 -179.846 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.914 ' O ' ' CB ' ' B' ' 102' ' ' LYS . 27.4 ttt . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.914 ' CB ' ' O ' ' B' ' 101' ' ' MET . 88.3 tttt 118.59 105.05 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.45 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.64 -65.98 0.2 Allowed Glycine 0 N--CA 1.467 0.74 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 59.8 mtt -131.32 -45.02 1.0 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.601 ' HG ' ' H ' ' B' ' 106' ' ' LYS . 28.8 p -89.11 -106.76 0.08 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . 0.601 ' H ' ' HG ' ' B' ' 105' ' ' SER . 96.2 mttt -135.05 -79.76 0.44 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 174.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' MET . . . . . 0.44 ' N ' ' HD3' ' B' ' 108' ' ' PRO . 28.1 ttt -158.8 65.6 2.93 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.079 168.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' B' ' 107' ' ' MET . 5.7 Cg_exo -95.87 92.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 121.81 1.674 . . . . 0.0 107.813 -176.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 39.8 mt-30 -82.35 133.55 35.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 122.486 1.136 . . . . 0.0 113.112 -168.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -118.25 100.43 7.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.979 -1.464 . . . . 0.0 107.436 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -86.17 138.66 31.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.919 0.866 . . . . 0.0 112.044 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.472 HD11 ' CZ2' ' B' ' 114' ' ' TRP . 38.9 mt -122.23 173.8 7.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.459 -177.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.538 ' HB3' ' O ' ' A' ' 5' ' ' SER . 98.7 mtt180 -139.7 89.91 2.36 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.413 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' TRP . . . . . 0.472 ' CZ2' HD11 ' B' ' 112' ' ' LEU . 52.8 m0 -117.84 149.08 44.61 Favored Pre-proline 0 N--CA 1.472 0.669 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.764 -174.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.96 143.03 51.14 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 121.706 1.604 . . . . 0.0 110.756 170.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -59.07 -32.29 69.66 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.6 -40.02 92.19 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.545 -0.722 . . . . 0.0 112.227 175.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 66.5 t -66.61 -42.0 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.816 -0.552 . . . . 0.0 111.32 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.881 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 63.2 tp -67.91 -33.74 75.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -70.64 -23.03 62.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.611 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 45.9 tp -80.03 -32.27 39.56 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.916 -0.49 . . . . 0.0 111.293 172.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 91.4 t -68.87 -30.52 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.612 -0.68 . . . . 0.0 109.827 169.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . 0.881 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 6.8 mmm180 -69.7 -39.49 76.88 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 122.114 -0.366 . . . . 0.0 111.161 171.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -66.54 -55.52 15.12 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.437 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 p -55.13 -40.92 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.42 83.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.83 -39.07 83.94 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -61.27 -47.97 83.54 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -75.1 -13.44 60.48 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.622 175.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.93 60.41 6.9 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.78 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 25.3 ttt -142.4 145.09 33.47 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.849 0.833 . . . . 0.0 109.153 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 89.6 p -68.62 142.11 55.21 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.776 0.798 . . . . 0.0 110.521 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 17.4 m -62.66 -37.45 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -58.1 -51.74 68.42 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.159 -0.963 . . . . 0.0 112.376 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 55.7 m -72.97 -18.69 61.34 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -72.81 -57.02 4.39 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.797 -0.564 . . . . 0.0 112.154 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 4.6 mp -68.95 -27.45 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -58.12 -37.91 75.5 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.107 0.956 . . . . 0.0 109.68 168.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' GLN . . . . . 0.449 HE21 ' HA ' ' B' ' 139' ' ' GLN . 3.1 tp60 -79.37 -17.01 55.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.39 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 80.9 mt -82.59 -35.87 26.7 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.949 1.249 . . . . 0.0 111.595 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 23.5 m -71.15 -14.59 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.528 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.605 ' O ' ' HG2' ' B' ' 146' ' ' LYS . 0.2 OUTLIER -101.16 -25.43 14.02 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.292 0.951 . . . . 0.0 112.719 175.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.83 -25.62 44.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.916 172.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' SER . . . . . 1.236 ' O ' ' HB3' ' B' ' 150' ' ' ARG . 75.4 m -98.19 -61.12 1.43 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 1.039 ' HA ' ' HG2' ' B' ' 150' ' ' ARG . 0.9 OUTLIER -90.78 70.2 6.58 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 123.332 1.539 . . . . 0.0 108.518 175.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 1.022 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 0.1 OUTLIER -90.2 -48.74 6.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.108 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 1.022 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 0.0 OUTLIER 134.26 58.09 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.659 1.218 . . . . 0.0 108.219 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -152.94 -27.7 0.15 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.74 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 144.77 69.96 0.02 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 106.434 -2.666 . . . . 0.0 106.434 -171.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . 1.236 ' HB3' ' O ' ' B' ' 144' ' ' SER . 0.0 OUTLIER -100.15 -61.06 1.42 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 122.426 1.108 . . . . 0.0 111.167 -167.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 4.5 tp -110.11 -53.83 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.057 -169.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.0 94.53 0.09 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.907 -179.845 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.911 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 26.2 mmt . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.911 ' HB2' ' O ' ' A' ' 1' ' ' MET . 87.9 tttt 150.7 96.55 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.116 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 139.05 82.11 0.09 OUTLIER Glycine 0 N--CA 1.468 0.778 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.123 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.9 mtt -139.32 -69.33 0.42 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.1 t -89.49 -85.23 0.21 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HB2' ' H ' ' A' ' 7' ' ' MET . 96.7 mttt -133.22 -90.86 0.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 173.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.418 ' H ' ' HB2' ' A' ' 6' ' ' LYS . 64.6 mtt -148.02 68.16 10.37 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 168.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -101.08 82.95 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 121.556 1.504 . . . . 0.0 109.16 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -91.37 151.62 20.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 122.368 1.08 . . . . 0.0 111.005 -174.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -146.69 116.84 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -97.92 119.2 36.11 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.136 -173.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.432 HD12 ' CZ2' ' A' ' 14' ' ' TRP . 44.9 mt -93.62 169.72 10.12 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.419 0.628 . . . . 0.0 109.734 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 1.156 ' HB3' ' CB ' ' B' ' 105' ' ' SER . 96.1 mtt180 -129.55 86.95 2.47 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.79 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.432 ' CZ2' HD12 ' A' ' 12' ' ' LEU . 45.3 m0 -120.39 141.6 32.27 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.931 -172.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.27 145.09 36.71 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 121.889 1.726 . . . . 0.0 111.659 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -60.0 -34.68 73.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.93 -37.11 85.73 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.719 -0.613 . . . . 0.0 112.501 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.7 t -63.17 -41.38 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.853 -0.53 . . . . 0.0 111.125 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.922 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 76.6 mt -66.84 -32.69 74.13 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -64.84 -33.03 75.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.488 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.3 tp -77.03 -33.68 57.34 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.261 -0.575 . . . . 0.0 112.16 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.23 -35.94 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 169.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.922 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 27.2 mmm-85 -63.73 -37.02 85.79 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.812 172.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -64.1 -54.98 25.41 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.044 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.7 t -58.99 -35.87 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.49 -31.09 72.16 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -71.61 -45.96 60.61 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.89 -0.506 . . . . 0.0 112.098 173.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.32 -52.59 64.74 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -78.89 -14.36 59.27 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.513 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.82 59.64 9.83 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.264 -0.969 . . . . 0.0 111.764 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 57.7 tpp -138.16 148.13 44.56 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.069 0.938 . . . . 0.0 109.154 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.6 t -65.86 141.98 58.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.825 0.822 . . . . 0.0 110.698 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.5 m -66.44 -40.03 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -64.62 -41.8 95.93 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.279 -0.888 . . . . 0.0 112.495 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.6 m -72.35 -25.93 61.72 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 175.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -69.69 -54.5 13.57 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.825 -0.547 . . . . 0.0 111.886 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 mp -69.45 -25.25 28.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.356 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -57.34 -40.49 78.1 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.101 167.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -75.05 -20.27 59.64 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.868 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.5 mt -84.27 -33.84 23.93 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.95 1.25 . . . . 0.0 112.279 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.5 m -74.2 -13.7 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.244 170.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.696 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 28.4 mmt -99.72 -14.2 18.99 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.758 -1.214 . . . . 0.0 112.944 175.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -98.2 -18.21 18.57 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 119.871 -0.732 . . . . 0.0 112.757 172.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 1.255 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 36.2 t -100.15 -71.5 0.7 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 174.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.768 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 8.1 t80 -70.49 170.98 10.93 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 162.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.768 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -179.84 -55.13 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 O-C-N 119.521 -1.987 . . . . 0.0 109.063 177.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 1.474 ' HB2' ' NH2' ' A' ' 50' ' ' ARG . 73.5 mttt -119.28 -61.1 1.67 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 168.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.499 ' H ' HH21 ' A' ' 50' ' ' ARG . 8.2 pt-20 168.89 -11.68 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.243 -1.799 . . . . 0.0 110.859 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.51 37.84 3.3 Favored Glycine 0 N--CA 1.473 1.114 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.358 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 1.474 ' NH2' ' HB2' ' A' ' 47' ' ' LYS . 1.2 mpp_? -122.39 -79.21 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -173.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.6 tp -67.78 -48.35 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.417 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.92 119.07 0.54 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.601 -0.714 . . . . 0.0 109.962 179.826 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.575 ' HD2' ' HE1' ' B' ' 104' ' ' MET . 40.9 ttmt -163.95 -81.99 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.97 117.98 3.64 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.575 ' HE1' ' HD2' ' B' ' 102' ' ' LYS . 65.2 mtt -133.6 -42.54 0.84 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 1.156 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 68.5 m -141.26 -48.79 0.41 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.662 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -82.08 42.21 0.71 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.227 -0.589 . . . . 0.0 112.469 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' MET . . . . . . . . . . . . . 25.6 ttt -157.51 -65.24 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.27 79.54 3.23 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.568 2.179 . . . . 0.0 110.585 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 85.8 mt-30 -95.4 141.4 29.0 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 122.267 1.032 . . . . 0.0 110.116 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -113.11 103.99 11.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.042 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -93.67 132.59 37.86 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.802 0.811 . . . . 0.0 110.956 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.57 171.16 14.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.461 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.58 ' NH1' ' HG3' ' A' ' 2' ' ' LYS . 92.5 mtt180 -132.67 120.31 21.56 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.9 0.857 . . . . 0.0 111.518 -174.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' TRP . . . . . . . . . . . . . 49.0 m0 -126.22 147.99 61.83 Favored Pre-proline 0 N--CA 1.475 0.805 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.602 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -46.65 140.08 12.8 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 121.727 1.618 . . . . 0.0 111.182 171.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -58.43 -30.66 67.07 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -173.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.91 -42.28 97.45 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.557 -0.715 . . . . 0.0 111.7 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -64.06 -50.18 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.381 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.49 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 62.2 tp -60.31 -43.03 96.72 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 20.9 m-20 -69.13 -26.11 64.72 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.793 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 19.3 tp -77.56 -30.62 52.76 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.173 172.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 88.7 t -64.16 -32.76 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.503 -0.748 . . . . 0.0 109.768 167.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 21.3 mmt180 -66.74 -43.93 82.84 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.99 -0.444 . . . . 0.0 111.545 172.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -67.44 -52.21 42.35 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.811 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 1.8 p -57.88 -39.76 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.57 -38.04 86.05 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.62 -38.78 84.38 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.82 -45.9 90.48 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.93 -9.94 59.15 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 119.764 -0.775 . . . . 0.0 111.694 175.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 66.72 61.83 5.0 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.766 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 59.5 tpp -145.28 140.11 27.57 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.771 0.796 . . . . 0.0 109.039 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 67.9 m -68.84 140.82 55.23 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.606 0.717 . . . . 0.0 109.575 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 25.1 m -58.83 -37.52 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -173.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -61.27 -52.51 64.41 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.169 -0.957 . . . . 0.0 111.757 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 61.4 m -71.61 -18.24 62.23 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -72.47 -57.35 4.24 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.758 -0.589 . . . . 0.0 111.825 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 4.5 mp -68.59 -27.87 37.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.902 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -57.31 -37.82 73.08 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.79 169.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' GLN . . . . . 0.463 HE21 ' HA ' ' B' ' 139' ' ' GLN . 2.8 tp60 -79.78 -22.92 42.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.283 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.06 -37.04 39.91 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.919 1.236 . . . . 0.0 111.848 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 15.5 m -70.72 -22.14 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.836 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.541 ' O ' ' HB2' ' B' ' 146' ' ' LYS . 0.3 OUTLIER -89.51 -25.0 21.65 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.904 -1.123 . . . . 0.0 112.908 176.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.35 -32.36 60.83 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.712 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' SER . . . . . 0.746 ' O ' ' CB ' ' B' ' 150' ' ' ARG . 35.3 t -94.82 -64.92 1.02 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.961 ' HA ' ' CB ' ' B' ' 150' ' ' ARG . 2.7 t80 -81.56 74.67 8.55 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.855 1.312 . . . . 0.0 108.699 174.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.997 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 86.8 tttt -96.06 -38.17 10.31 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.257 -0.902 . . . . 0.0 112.035 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.997 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 4.0 tmtt? 124.02 20.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.839 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -123.87 -12.1 7.58 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 136.68 59.28 0.06 OUTLIER Glycine 0 N--CA 1.466 0.662 0 N-CA-C 106.296 -2.722 . . . . 0.0 106.296 -172.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . 0.961 ' CB ' ' HA ' ' B' ' 145' ' ' PHE . 0.0 OUTLIER -81.16 -116.85 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.523 1.154 . . . . 0.0 111.339 -169.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.632 HG21 ' HG3' ' B' ' 150' ' ' ARG . 6.5 tp -40.21 -44.43 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.566 -1.652 . . . . 0.0 114.868 171.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -88.29 -126.94 2.65 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.23 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.799 -178.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -173.59 178.92 2.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 122.092 0.949 . . . . 0.0 110.762 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.06 70.38 1.28 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.117 -1.04 . . . . 0.0 111.207 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.3 mtt -90.78 -60.67 1.85 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.6 t -85.2 -80.06 0.22 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HB2' ' H ' ' A' ' 7' ' ' MET . 96.3 mttt -133.93 -88.89 0.39 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 174.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.426 ' H ' ' HB2' ' A' ' 6' ' ' LYS . 63.3 mtt -143.49 61.81 10.37 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.022 169.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -91.2 78.63 0.51 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 121.797 1.665 . . . . 0.0 110.433 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -87.42 144.51 26.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.612 1.196 . . . . 0.0 111.165 -175.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -138.09 117.56 12.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.36 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -94.33 135.21 35.99 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.842 0.83 . . . . 0.0 110.642 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 40.0 mt -111.25 163.85 13.5 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.707 ' HD3' ' HG ' ' B' ' 105' ' ' SER . 98.1 mtt180 -121.94 88.15 2.88 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.981 -173.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.433 ' CZ2' HD12 ' A' ' 12' ' ' LEU . 49.0 m0 -122.64 146.96 49.23 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.57 -170.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HG3' ' SD ' ' B' ' 107' ' ' MET . 41.6 Cg_exo -55.86 144.5 77.25 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 121.967 1.778 . . . . 0.0 110.871 169.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.699 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 12.3 ttp180 -58.75 -35.32 72.56 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.591 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.37 -38.29 89.61 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.07 -42.82 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.952 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.949 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 60.2 tp -64.71 -33.92 77.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.684 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 78.5 m-20 -67.8 -29.92 69.22 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.435 175.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.2 tp -77.75 -31.81 52.33 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.024 -0.423 . . . . 0.0 111.933 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.31 -30.96 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.505 -0.747 . . . . 0.0 109.428 169.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.949 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 27.9 mmm-85 -67.56 -41.95 83.41 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.046 0.451 . . . . 0.0 111.188 170.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.684 ' HG3' ' O ' ' A' ' 20' ' ' ASP . 58.5 mtpt -64.11 -55.52 21.41 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.586 HG22 ' HG3' ' B' ' 150' ' ' ARG . 2.2 p -55.42 -40.61 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.7 82.97 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.8 -38.52 83.42 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.39 -47.43 85.83 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -75.16 -11.88 60.18 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.74 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.96 60.57 6.33 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.771 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.8 ttt -147.44 148.26 31.09 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.863 0.84 . . . . 0.0 108.952 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.8 p -70.46 144.88 51.31 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.809 0.814 . . . . 0.0 110.575 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.34 -36.61 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -57.85 -53.23 60.54 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.271 -0.893 . . . . 0.0 111.548 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.5 m -72.02 -17.33 62.04 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -73.81 -55.52 6.11 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.639 -0.663 . . . . 0.0 111.979 -177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.1 mp -67.44 -28.77 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -57.52 -38.83 75.31 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.219 1.009 . . . . 0.0 109.742 168.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.491 HE21 ' HA ' ' A' ' 39' ' ' GLN . 3.2 tp60 -76.78 -18.08 58.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.546 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.7 mt -83.46 -32.5 25.99 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.602 1.092 . . . . 0.0 111.95 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 m -74.65 -9.29 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.9 169.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.77 -18.83 13.83 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.043 0.838 . . . . 0.0 113.208 174.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -94.99 -22.72 17.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.656 173.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.885 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 32.1 t -94.88 -71.85 0.65 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 176.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.595 ' HA ' ' CG ' ' A' ' 50' ' ' ARG . 0.6 OUTLIER -71.74 140.4 49.51 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 166.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 1.047 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 26.7 ttpp -167.17 -47.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.362 -172.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 1.047 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 2.3 tmtt? 137.28 54.22 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.136 0.969 . . . . 0.0 108.774 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -148.53 -36.51 0.19 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.202 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.74 84.76 0.6 Allowed Glycine 0 N--CA 1.468 0.795 0 N-CA-C 104.866 -3.293 . . . . 0.0 104.866 -169.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.885 ' HB3' ' O ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -115.95 -98.74 0.44 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.536 1.16 . . . . 0.0 109.503 -162.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.521 ' H ' ' HB2' ' A' ' 50' ' ' ARG . 7.0 tp -46.59 -48.12 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 113.562 -1.654 . . . . 0.0 113.728 170.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.84 80.46 0.05 OUTLIER Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.602 -0.714 . . . . 0.0 109.156 -179.583 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.719 ' O ' ' HB2' ' B' ' 102' ' ' LYS . 2.0 mpt? . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.719 ' HB2' ' O ' ' B' ' 101' ' ' MET . 31.6 mmmt 85.73 -76.63 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.291 0.567 . . . . 0.0 109.92 -178.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 179.71 80.06 0.06 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 66.0 mtt -79.44 -58.41 3.22 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.178 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.707 ' HG ' ' HD3' ' A' ' 13' ' ' ARG . 35.9 t -75.67 -76.57 0.15 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 173.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -140.78 -44.89 0.39 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 169.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' MET . . . . . 0.462 ' SD ' ' HG3' ' A' ' 15' ' ' PRO . 67.4 mtt -106.85 159.26 30.54 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 168.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.699 ' HG2' ' HB2' ' A' ' 16' ' ' ARG . 76.3 Cg_exo -48.07 129.46 18.49 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.64 2.227 . . . . 0.0 116.18 -176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.618 HE21 ' HB2' ' B' ' 105' ' ' SER . 81.3 mt-30 -80.54 164.25 23.1 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.582 1.182 . . . . 0.0 111.125 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -137.55 111.51 8.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -103.04 130.41 50.15 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.687 0.756 . . . . 0.0 111.065 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.98 177.88 7.54 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.282 175.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -135.54 121.03 19.29 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.32 -0.862 . . . . 0.0 111.813 -174.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -126.58 141.67 40.86 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.809 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -45.26 139.76 8.65 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 121.907 1.738 . . . . 0.0 111.859 173.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -25.2 63.85 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -173.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -65.04 -44.79 87.94 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.386 -0.821 . . . . 0.0 111.017 173.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 81.4 t -66.14 -49.29 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.688 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.499 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 63.9 tp -62.11 -43.82 98.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 71.5 m-20 -70.2 -24.84 63.18 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.881 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 25.2 tp -77.04 -32.04 56.66 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.009 170.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.83 -34.31 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 O-C-N 121.494 -0.753 . . . . 0.0 109.848 167.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 21.7 mmt180 -65.2 -39.22 92.54 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.119 -0.363 . . . . 0.0 111.791 171.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -66.32 -49.0 68.48 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.987 -0.446 . . . . 0.0 111.615 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 89.0 t -56.17 -39.05 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.17 74.91 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.65 -42.12 74.68 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 174.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.99 -49.41 77.56 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -75.23 -12.1 60.21 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 119.699 -0.801 . . . . 0.0 111.589 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 63.65 57.27 15.11 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.436 -0.887 . . . . 0.0 112.186 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 15.2 tpt -147.46 148.53 31.34 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 90.2 p -65.34 149.6 49.71 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 122.169 0.985 . . . . 0.0 111.647 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.55 -37.73 79.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.62 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -60.46 -45.15 94.76 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.521 -0.737 . . . . 0.0 112.271 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 59.6 m -71.11 -26.83 63.2 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -66.68 -60.46 2.68 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.652 -0.655 . . . . 0.0 112.103 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.59 -27.4 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.126 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -58.63 -37.23 75.47 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.957 169.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -77.3 -18.12 57.79 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.481 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . 0.54 HD21 ' HG ' ' A' ' 44' ' ' SER . 65.2 mt -81.86 -29.01 32.69 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.765 1.166 . . . . 0.0 112.666 176.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.43 -28.92 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.709 169.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.704 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 0.9 OUTLIER -75.65 -28.27 58.7 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.627 -0.671 . . . . 0.0 112.23 172.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -72.03 -26.15 62.08 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.143 -0.973 . . . . 0.0 111.581 170.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 58.7 m -76.91 -56.63 4.42 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.561 ' HD1' ' HB3' ' B' ' 150' ' ' ARG . 15.0 m-85 -64.55 103.08 0.62 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 175.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.704 ' HG3' ' O ' ' B' ' 142' ' ' MET . 2.1 mtpt 173.09 -58.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 117.08 -1.848 . . . . 0.0 112.702 -160.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 1.287 ' HB3' ' NH2' ' B' ' 150' ' ' ARG . 4.4 tmtp? -73.66 1.99 9.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.093 175.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' B' ' 146' ' ' LYS . 20.5 tt0 66.97 13.26 9.4 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -92.05 17.37 57.1 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 119.088 -1.529 . . . . 0.0 111.311 169.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . 1.287 ' NH2' ' HB3' ' B' ' 147' ' ' LYS . 0.7 OUTLIER -128.31 -81.27 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -168.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 7.6 tp -63.67 -46.87 93.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.823 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -112.31 -137.47 7.05 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.917 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.692 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 6' ' ' LYS . 97.8 mttt -105.05 115.6 30.55 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.04 -77.4 1.35 Allowed Glycine 0 N--CA 1.467 0.757 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.1 mtt -85.86 -58.39 2.67 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.7 t -113.61 -102.48 0.41 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.482 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 96.8 mttt -120.7 -88.64 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.417 ' H ' ' HB2' ' A' ' 6' ' ' LYS . 63.0 mtt -146.17 62.91 8.54 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.923 168.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 7' ' ' MET . 13.3 Cg_exo -77.91 99.1 1.25 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 CA-C-N 122.114 1.791 . . . . 0.0 107.953 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 14.5 tt0 -89.66 142.92 27.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 122.409 1.1 . . . . 0.0 112.331 -168.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -131.85 101.72 5.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.043 -175.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -88.15 121.11 30.17 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.877 0.846 . . . . 0.0 110.879 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 30.3 mt -101.42 169.84 8.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 176.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.86 ' HB3' ' O ' ' B' ' 105' ' ' SER . 93.5 mtt180 -129.95 90.8 3.02 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.903 -176.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.457 ' CZ2' HD11 ' A' ' 12' ' ' LEU . 49.1 m0 -119.48 146.77 41.96 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.948 -173.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.59 145.34 48.33 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 121.802 1.668 . . . . 0.0 111.122 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -59.63 -33.41 71.47 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.99 -34.04 75.77 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.627 -0.671 . . . . 0.0 112.332 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.3 t -63.99 -40.5 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.828 -0.545 . . . . 0.0 110.945 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.908 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 69.1 mt -66.2 -33.99 77.01 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -65.56 -29.23 69.82 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.638 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tt -80.24 -33.49 37.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.382 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.66 -33.48 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 168.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.908 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 28.7 mmm-85 -67.93 -40.49 83.32 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.36 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.14 -57.47 7.57 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.085 -0.384 . . . . 0.0 111.372 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.2 p -53.97 -39.66 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.73 -37.06 85.95 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.15 -40.69 82.33 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.98 -49.56 77.18 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -78.32 -12.35 60.0 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.598 175.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.7 61.88 5.52 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.051 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.5 ttt -143.56 146.44 33.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.77 0.795 . . . . 0.0 109.033 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.5 p -70.66 143.69 51.32 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.824 0.821 . . . . 0.0 110.648 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -65.05 -37.14 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -61.84 -47.17 86.26 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.358 -0.839 . . . . 0.0 112.572 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.7 m -73.87 -18.6 60.9 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -73.23 -55.58 6.25 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.805 -0.559 . . . . 0.0 111.961 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -69.76 -27.13 32.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -58.26 -38.67 77.37 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.052 0.929 . . . . 0.0 109.5 168.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.418 HE21 ' HA ' ' A' ' 39' ' ' GLN . 3.7 tp60 -77.83 -16.48 58.28 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.405 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.4 mt -80.83 -37.56 29.81 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.837 1.199 . . . . 0.0 111.566 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.4 m -73.67 -9.52 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.145 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -107.64 -15.81 14.5 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.12 -19.69 17.06 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.483 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.985 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 34.6 t -96.51 -70.3 0.72 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.66 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.6 OUTLIER -73.71 141.79 46.37 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 166.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 1.122 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 37.2 ttpt -167.9 -47.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 120.962 -1.086 . . . . 0.0 111.228 -172.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 1.122 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 2.3 tmtt? 135.85 54.48 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.048 0.928 . . . . 0.0 108.535 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -149.97 -35.72 0.16 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.463 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.0 84.76 0.59 Allowed Glycine 0 N--CA 1.468 0.789 0 N-CA-C 104.996 -3.241 . . . . 0.0 104.996 -169.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.985 ' HB3' ' O ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -115.58 -97.46 0.45 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.63 1.205 . . . . 0.0 109.765 -161.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.493 ' H ' ' HB2' ' A' ' 50' ' ' ARG . 6.8 tp -46.51 -49.12 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 113.376 -1.738 . . . . 0.0 113.992 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 170.79 94.09 0.09 OUTLIER Glycine 0 CA--C 1.524 0.645 0 C-N-CA 119.859 -1.163 . . . . 0.0 110.216 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.736 179.795 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.905 ' O ' ' CB ' ' B' ' 102' ' ' LYS . 66.4 mtt . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.905 ' CB ' ' O ' ' B' ' 101' ' ' MET . 88.5 tttt 119.83 98.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.229 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.88 101.29 1.22 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 67.0 mtt -145.1 108.52 4.62 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.86 ' O ' ' HB3' ' A' ' 13' ' ' ARG . 43.9 m 78.49 -63.35 0.3 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.364 -175.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . 0.439 ' HG3' ' HG2' ' B' ' 107' ' ' MET . 63.2 pttt -61.94 -39.51 92.34 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -176.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' MET . . . . . 0.439 ' HG2' ' HG3' ' B' ' 106' ' ' LYS . 26.4 mmt -95.69 -45.9 0.26 Allowed Pre-proline 0 N--CA 1.474 0.735 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' B' ' 107' ' ' MET . 33.9 Cg_exo -65.46 98.6 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.594 2.196 . . . . 0.0 112.6 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 78.9 mt-30 -99.86 160.5 14.26 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 122.468 1.127 . . . . 0.0 111.565 -176.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -131.13 101.77 5.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -90.52 120.96 32.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.245 -170.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 37.6 mt -111.68 175.17 5.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.825 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -142.14 96.58 2.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.65 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' TRP . . . . . 0.443 ' CZ2' HD11 ' B' ' 112' ' ' LEU . 51.0 m0 -120.62 143.74 37.02 Favored Pre-proline 0 N--CA 1.474 0.76 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.028 -174.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -49.19 139.81 26.65 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 121.778 1.652 . . . . 0.0 111.396 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.02 -29.56 67.35 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.24 -43.54 91.08 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.626 -0.672 . . . . 0.0 111.623 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.14 -47.93 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.598 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.468 ' O ' ' HG3' ' B' ' 123' ' ' ARG . 59.1 tp -61.27 -46.08 91.81 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -69.4 -24.07 63.8 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 25.5 tp -74.89 -32.06 61.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.531 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.44 -28.88 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.64 -0.662 . . . . 0.0 110.41 167.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' B' ' 119' ' ' LEU . 94.3 mtt180 -74.04 -34.97 64.27 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.919 -0.488 . . . . 0.0 111.99 172.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -63.27 -52.85 60.38 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.046 -0.409 . . . . 0.0 110.629 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 97.9 t -55.88 -38.65 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.32 -34.79 77.3 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.34 -40.41 70.74 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.62 -47.63 84.55 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -75.99 -8.58 57.28 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.745 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.51 59.5 8.2 Favored Glycine 0 N--CA 1.47 0.935 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.951 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' MET . . . . . 0.542 ' HE1' ' HB3' ' B' ' 135' ' ' SER . 24.7 ttt -151.74 149.09 28.67 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -176.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 89.7 p -70.18 151.27 45.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.975 0.893 . . . . 0.0 111.032 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 16.1 m -64.0 -36.98 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -58.75 -52.04 67.39 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.778 -0.576 . . . . 0.0 111.551 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.542 ' HB3' ' HE1' ' B' ' 131' ' ' MET . 57.8 m -71.11 -21.52 62.2 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -70.49 -60.16 2.42 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.716 -0.615 . . . . 0.0 111.832 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 4.4 mp -69.31 -26.71 32.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.953 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -59.85 -35.85 75.64 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.046 169.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' GLN . . . . . 0.478 HE21 ' HA ' ' B' ' 139' ' ' GLN . 2.1 tp60 -77.87 -20.47 52.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.831 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 84.3 mt -79.8 -35.08 39.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.566 1.076 . . . . 0.0 112.167 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 32.9 m -70.06 -24.29 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.375 170.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 32.1 mmt -86.21 -27.87 24.22 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.502 -0.749 . . . . 0.0 112.383 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.92 -28.85 63.76 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.093 170.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 63.8 m -79.68 -47.82 14.73 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.43 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.668 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 14.0 m-30 -78.21 94.23 4.73 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' B' ' 145' ' ' PHE . 1.4 mtpt 157.89 -20.99 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.163 -1.015 . . . . 0.0 113.255 -167.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.852 ' HB3' ' NH2' ' B' ' 150' ' ' ARG . 8.1 tmtt? -56.55 -29.68 62.24 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.973 0.892 . . . . 0.0 112.046 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.37 -26.23 4.3 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.142 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 113.58 62.37 0.42 Allowed Glycine 0 N--CA 1.467 0.724 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 -172.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . 0.852 ' NH2' ' HB3' ' B' ' 147' ' ' LYS . 0.1 OUTLIER -87.28 -80.24 0.26 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.827 0.823 . . . . 0.0 109.081 -176.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 8.2 tp -58.09 -45.41 88.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.203 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 165.91 86.95 0.06 OUTLIER Glycine 0 CA--C 1.524 0.638 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.452 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.145 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -140.66 92.51 2.52 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 175.54 84.15 0.06 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.873 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.514 ' HB2' ' H ' ' A' ' 9' ' ' GLN . 66.9 mtt -134.08 -69.58 0.53 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.7 t -95.95 -111.9 0.13 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 7' ' ' MET . 19.3 ptpt -107.35 -55.17 2.38 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 166.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.521 ' N ' ' HG3' ' A' ' 6' ' ' LYS . 65.9 mtt -95.78 146.02 30.57 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 166.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 1.044 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 35.1 Cg_exo -41.5 123.18 2.05 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.14 2.56 . . . . 0.0 116.538 -176.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.514 ' H ' ' HB2' ' A' ' 4' ' ' MET . 28.4 tt0 -79.0 148.68 32.45 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.717 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -133.72 110.73 10.03 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -174.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -89.98 141.9 28.22 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.052 0.929 . . . . 0.0 112.011 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.452 HD11 ' CZ2' ' A' ' 14' ' ' TRP . 56.4 mt -123.63 168.11 13.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.785 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -130.61 84.8 2.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.477 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.452 ' CZ2' HD11 ' A' ' 12' ' ' LEU . 43.8 m0 -120.0 143.36 35.21 Favored Pre-proline 0 N--CA 1.474 0.749 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.643 -171.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.72 147.83 48.08 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.005 1.803 . . . . 0.0 111.428 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.694 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 12.6 ttp180 -59.83 -38.78 83.02 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.16 -35.14 79.32 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.8 t -65.61 -38.62 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.627 -0.671 . . . . 0.0 111.274 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 74.2 mt -62.49 -46.09 90.05 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.059 172.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -51.57 -29.94 19.07 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.0 tp -81.3 -36.45 29.81 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.92 -34.34 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 121.774 -0.579 . . . . 0.0 110.946 173.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -68.84 -39.81 79.74 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.088 -0.382 . . . . 0.0 110.422 170.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -61.05 -57.72 11.39 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.56 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 p -57.49 -38.86 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.83 85.01 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.14 -36.95 82.97 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -62.45 -45.31 93.66 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -75.41 -11.82 60.12 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.622 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.8 62.09 4.79 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.008 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.6 ttt -146.9 144.64 29.41 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.845 0.831 . . . . 0.0 109.412 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.8 t -70.4 143.44 51.87 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.709 0.766 . . . . 0.0 110.187 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.0 m -61.47 -39.87 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 114.995 1.479 . . . . 0.0 114.995 -173.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -59.88 -49.1 79.02 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.915 -1.116 . . . . 0.0 112.385 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.9 m -73.63 -17.12 61.2 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -73.67 -57.1 4.22 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.723 -0.61 . . . . 0.0 111.912 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mp -67.15 -29.27 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -57.31 -38.93 74.78 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.827 0.823 . . . . 0.0 109.821 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -78.68 -19.24 52.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.456 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.4 mt -78.45 -40.3 36.06 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.748 1.158 . . . . 0.0 111.375 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.94 -11.3 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.765 174.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.554 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 26.0 mmt -105.62 -13.72 15.5 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.116 -0.99 . . . . 0.0 112.923 176.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -93.87 -26.31 16.96 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.959 171.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 1.027 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 36.9 t -94.18 -70.15 0.72 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.943 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 3.5 t80 -74.14 156.4 37.4 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 167.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 1.056 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER 167.28 -51.55 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 120.717 -1.239 . . . . 0.0 110.06 -177.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 1.056 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 2.2 tmtt? 134.51 59.19 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -151.55 -43.74 0.11 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.786 -169.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.31 65.85 0.02 OUTLIER Glycine 0 N--CA 1.467 0.712 0 N-CA-C 106.669 -2.572 . . . . 0.0 106.669 -171.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 1.027 ' HB3' ' O ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -108.31 -122.46 0.25 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.532 1.158 . . . . 0.0 109.834 -167.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.4 tp -46.28 -45.34 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 113.629 -1.623 . . . . 0.0 113.922 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 177.41 91.51 0.08 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.191 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.899 -179.915 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.451 ' HB3' ' H ' ' B' ' 103' ' ' GLY . 99.6 mttt -95.33 -138.99 0.24 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.694 0.759 . . . . 0.0 110.275 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . 0.451 ' H ' ' HB3' ' B' ' 102' ' ' LYS . . . 89.49 80.92 1.33 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.129 -1.034 . . . . 0.0 110.61 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 66.5 mtt -91.12 -62.53 1.43 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.992 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.421 ' HB2' HE21 ' B' ' 109' ' ' GLN . 32.2 t -85.72 -102.61 0.06 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -118.47 -54.77 2.26 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 168.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' MET . . . . . . . . . . . . . 23.8 mmt -93.32 152.34 41.03 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 165.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.694 ' HG2' ' HB2' ' A' ' 16' ' ' ARG . 66.9 Cg_exo -45.95 127.76 10.71 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.787 2.325 . . . . 0.0 115.964 -176.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 24.8 tt0 -81.23 153.36 27.2 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.257 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -139.74 108.33 5.89 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -95.32 131.69 41.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.224 -173.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.467 HD11 ' CZ2' ' B' ' 114' ' ' TRP . 61.9 mt -111.7 175.36 5.46 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.68 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -133.34 86.52 2.3 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.792 0.806 . . . . 0.0 109.468 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' TRP . . . . . 0.467 ' CZ2' HD11 ' B' ' 112' ' ' LEU . 47.1 m0 -117.41 143.87 32.9 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.497 -172.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.405 ' HG3' ' SD ' ' A' ' 7' ' ' MET . 52.4 Cg_exo -54.38 142.75 68.53 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 121.923 1.749 . . . . 0.0 111.022 171.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 1.044 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . 6.6 ttp180 -60.32 -31.76 70.59 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.803 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.31 -40.3 93.59 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.592 -0.693 . . . . 0.0 112.125 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 64.5 t -66.37 -44.64 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.025 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.894 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 59.9 tp -67.22 -32.95 74.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 18.6 m-20 -69.95 -28.65 65.73 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.357 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 16.7 tp -78.13 -31.33 49.8 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.604 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 72.0 t -64.03 -34.14 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 167.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . 0.894 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 28.0 mmm-85 -64.94 -37.26 87.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 171.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.38 -55.64 22.79 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.044 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 92.0 t -54.55 -39.29 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.38 -34.21 76.26 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.29 -41.54 69.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 175.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -60.39 -49.67 76.65 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -76.94 -12.72 59.99 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.631 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 63.72 58.79 9.97 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.006 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 26.1 ttt -146.46 148.15 31.96 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 91.9 p -67.78 147.3 52.78 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.039 0.923 . . . . 0.0 111.084 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 16.2 m -64.86 -36.44 77.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -61.02 -47.65 85.43 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.403 -0.811 . . . . 0.0 112.113 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 57.3 m -71.64 -21.56 61.81 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -70.89 -58.96 3.08 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.847 -0.533 . . . . 0.0 112.089 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 4.5 mp -69.24 -26.62 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -59.12 -36.59 75.46 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.779 0.8 . . . . 0.0 109.886 169.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' GLN . . . . . 0.507 HE21 ' HA ' ' B' ' 139' ' ' GLN . 1.6 tp60 -78.55 -20.64 50.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.988 177.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.65 -30.09 32.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.435 1.016 . . . . 0.0 112.422 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 31.3 m -72.41 -28.64 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.448 169.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.507 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 0.9 OUTLIER -78.1 -30.5 49.54 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.903 0.774 . . . . 0.0 112.313 175.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -73.1 -28.65 62.4 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.418 -0.801 . . . . 0.0 111.354 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 70.0 m -75.63 -37.79 59.45 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.677 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.643 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 23.5 m-85 -81.06 79.3 7.76 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' B' ' 145' ' ' PHE . 10.7 mtpt 177.8 -30.38 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.39 -168.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -84.79 35.94 0.59 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 118.961 -1.095 . . . . 0.0 112.418 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' B' ' 146' ' ' LYS . 30.5 mm-40 -155.69 -17.05 0.11 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.216 174.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' B' ' 148' ' ' GLU . . . 76.65 65.68 1.95 Allowed Glycine 0 N--CA 1.468 0.791 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -170.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . 0.518 ' HB2' ' H ' ' B' ' 151' ' ' ILE . 43.8 mtt180 -101.51 -82.22 0.47 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.573 1.178 . . . . 0.0 109.285 -168.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.518 ' H ' ' HB2' ' B' ' 150' ' ' ARG . 7.7 tp -59.54 -39.89 80.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 113.577 -1.647 . . . . 0.0 113.183 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -85.67 -96.56 0.76 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.225 -0.988 . . . . 0.0 110.875 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.404 -179.597 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -174.8 125.32 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.351 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.09 -55.84 0.03 OUTLIER Glycine 0 CA--C 1.526 0.767 0 C-N-CA 119.943 -1.122 . . . . 0.0 110.947 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.7 mtt -140.06 -59.69 0.54 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.665 ' HB2' ' CB ' ' B' ' 113' ' ' ARG . 79.1 p -160.23 90.35 0.89 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 122.117 0.96 . . . . 0.0 109.371 174.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -129.43 -24.33 2.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.431 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.426 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 26.8 ttt -156.77 -43.66 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.426 ' HD2' ' H ' ' A' ' 7' ' ' MET . 52.1 Cg_exo -63.02 99.81 0.23 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.508 2.139 . . . . 0.0 113.404 -176.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 18.2 tt0 -102.58 155.99 17.91 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.492 -175.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -136.46 107.4 6.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -94.61 124.96 38.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.25 -169.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.491 HD11 ' CZ2' ' A' ' 14' ' ' TRP . 46.5 mt -115.38 169.9 8.8 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.795 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -142.52 102.16 4.02 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.281 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.491 ' CZ2' HD11 ' A' ' 12' ' ' LEU . 54.5 m0 -122.29 143.47 39.39 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.215 -173.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.17 139.43 11.97 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 121.916 1.744 . . . . 0.0 111.544 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -57.93 -31.26 66.64 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -173.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.15 -43.11 96.2 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.582 -0.699 . . . . 0.0 111.896 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.06 -49.83 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.122 0.487 . . . . 0.0 111.409 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.984 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 63.1 tp -63.36 -35.87 81.81 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.8 -28.62 63.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.31 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.4 tp -79.24 -31.27 43.5 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.878 173.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.46 -35.63 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 O-C-N 121.462 -0.774 . . . . 0.0 109.017 168.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.984 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 29.3 mmm-85 -64.06 -39.07 93.27 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 171.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -64.11 -53.95 41.53 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.191 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.2 t -56.32 -36.87 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.94 -35.78 81.23 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.52 -0.738 . . . . 0.0 112.931 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -71.57 -40.91 69.62 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -61.92 -47.35 85.3 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -74.19 -12.94 60.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.612 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.32 57.49 13.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.036 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 53.7 tpp -147.51 148.14 30.89 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.983 0.897 . . . . 0.0 108.703 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.7 m -65.71 149.84 49.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 122.31 1.053 . . . . 0.0 111.555 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -63.75 -36.44 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -59.08 -53.98 52.26 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.856 -0.528 . . . . 0.0 111.698 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.8 m -70.45 -22.49 62.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -69.43 -59.6 2.88 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.796 -0.565 . . . . 0.0 112.128 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.1 mp -70.83 -27.0 28.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.728 -0.389 . . . . 0.0 109.981 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -56.52 -37.81 70.97 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.612 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.53 HE21 ' HA ' ' A' ' 39' ' ' GLN . 2.4 tp60 -79.21 -24.56 43.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.591 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 47.5 mt -79.23 -37.75 37.29 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 118.669 -1.213 . . . . 0.0 112.213 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 m -69.09 -28.65 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.583 172.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -85.41 -26.34 26.46 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.356 -0.84 . . . . 0.0 113.261 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -75.86 -35.48 59.9 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.867 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.1 t -87.72 -68.01 0.79 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.868 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -73.11 114.02 10.8 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 176.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 1.029 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 39.7 ttpt -169.26 -46.71 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.062 0.934 . . . . 0.0 110.047 -169.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 1.029 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 2.3 tmtt? 143.66 53.47 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -155.93 -35.61 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.244 -173.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.88 -60.77 0.04 OUTLIER Glycine 0 N--CA 1.465 0.57 0 N-CA-C 108.171 -1.971 . . . . 0.0 108.171 -172.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.868 ' HG2' ' HA ' ' A' ' 45' ' ' PHE . 89.6 mtt180 73.57 -86.57 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 168.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.654 HG23 ' HB3' ' A' ' 50' ' ' ARG . 2.4 tp -146.84 -54.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 112.872 -1.967 . . . . 0.0 110.005 -159.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.405 ' H ' HG21 ' A' ' 51' ' ' ILE . . . -89.51 -92.44 1.17 Allowed Glycine 0 N--CA 1.467 0.735 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.622 179.433 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' B' ' 106' ' ' LYS . 63.0 pttt -89.46 167.75 12.74 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 122.126 0.965 . . . . 0.0 111.059 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -167.06 -78.48 0.04 OUTLIER Glycine 0 N--CA 1.466 0.666 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.203 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 66.1 mtt -82.46 -59.08 2.65 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.944 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 40.9 t -96.05 -84.76 0.34 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . 0.434 ' H ' ' HD3' ' B' ' 108' ' ' PRO . 60.4 pttt 178.48 54.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' MET . . . . . 0.557 ' O ' ' SD ' ' B' ' 107' ' ' MET . 0.0 OUTLIER 54.21 63.54 7.4 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -173.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.434 ' HD3' ' H ' ' B' ' 106' ' ' LYS . 41.1 Cg_endo -98.76 76.06 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 121.703 1.602 . . . . 0.0 110.084 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 14.6 tt0 -84.67 146.46 27.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.193 0.997 . . . . 0.0 111.389 -173.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -133.31 109.5 9.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -95.38 118.84 32.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.203 -169.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.476 HD11 ' CZ2' ' B' ' 114' ' ' TRP . 56.8 mt -107.33 169.5 8.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.628 0.728 . . . . 0.0 109.892 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.665 ' CB ' ' HB2' ' A' ' 5' ' ' SER . 95.4 mtt180 -139.62 94.92 2.84 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.766 0.793 . . . . 0.0 109.045 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' TRP . . . . . 0.476 ' CZ2' HD11 ' B' ' 112' ' ' LEU . 50.6 m0 -116.28 149.4 43.51 Favored Pre-proline 0 N--CA 1.474 0.737 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.945 -173.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.52 142.04 40.33 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 121.799 1.666 . . . . 0.0 110.978 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -59.1 -35.81 74.06 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.79 -38.03 89.62 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.725 -0.609 . . . . 0.0 112.385 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 78.2 t -63.46 -38.73 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.346 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.424 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 57.6 mt -62.2 -45.61 92.59 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 119.971 -0.692 . . . . 0.0 112.834 173.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -57.63 -31.45 66.28 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 24.8 tp -76.54 -35.54 58.2 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.611 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 79.6 t -63.2 -32.72 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.855 -0.528 . . . . 0.0 110.501 168.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 10.9 mmt180 -68.32 -36.83 79.89 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.99 -0.443 . . . . 0.0 110.724 172.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -64.19 -55.84 18.91 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.037 -0.415 . . . . 0.0 110.714 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.38 -37.48 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.65 -32.31 73.76 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.49 -42.85 64.41 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 174.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.16 -50.54 73.66 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -78.56 -13.47 59.81 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.448 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.02 58.88 11.45 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.104 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' MET . . . . . 0.54 ' HE1' ' HB3' ' B' ' 135' ' ' SER . 21.7 ttt -138.49 144.51 40.05 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.896 0.855 . . . . 0.0 109.065 -176.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 66.3 m -68.44 155.33 40.08 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.129 0.966 . . . . 0.0 111.068 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 17.5 m -63.38 -39.43 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -62.33 -50.65 70.79 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.548 -0.72 . . . . 0.0 112.4 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.54 ' HB3' ' HE1' ' B' ' 131' ' ' MET . 59.9 m -71.52 -29.55 64.91 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -66.34 -58.71 4.72 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.77 -0.581 . . . . 0.0 112.257 -177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 3.6 mp -70.43 -23.35 24.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.417 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -57.97 -40.27 80.19 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.052 167.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -73.25 -22.2 60.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.679 -0.809 . . . . 0.0 112.591 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 68.0 mt -83.66 -32.11 25.8 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.831 1.196 . . . . 0.0 112.685 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 17.4 m -75.0 -12.01 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.482 169.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.823 ' O ' ' HG2' ' B' ' 146' ' ' LYS . 27.2 mmt -99.63 -18.17 17.44 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.269 -0.894 . . . . 0.0 112.791 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -89.39 -24.5 21.92 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.301 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' SER . . . . . 1.129 ' O ' ' HB3' ' B' ' 150' ' ' ARG . 66.1 m -95.82 -72.31 0.64 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.807 ' O ' ' HB2' ' B' ' 146' ' ' LYS . 2.3 t80 -71.8 158.72 35.57 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 165.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.823 ' HG2' ' O ' ' B' ' 142' ' ' MET . 0.0 OUTLIER 170.87 -51.31 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 120.207 -1.558 . . . . 0.0 109.843 -175.257 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.683 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 21.5 mmmt 128.78 64.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -176.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -151.47 -25.34 0.2 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.129 -175.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 108.39 79.39 1.15 Allowed Glycine 0 N--CA 1.469 0.883 0 N-CA-C 105.108 -3.197 . . . . 0.0 105.108 -169.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . 1.129 ' HB3' ' O ' ' B' ' 144' ' ' SER . 0.0 OUTLIER -110.41 -99.8 0.4 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 122.546 1.165 . . . . 0.0 109.915 -162.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.487 ' H ' ' HB2' ' B' ' 150' ' ' ARG . 6.6 tp -47.59 -49.26 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 113.448 -1.705 . . . . 0.0 113.799 172.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.31 82.23 0.05 OUTLIER Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.79 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.815 ' NZ ' HH22 ' B' ' 123' ' ' ARG . 99.6 mttt -97.82 -140.37 0.3 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.636 0.732 . . . . 0.0 110.222 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' A' ' 2' ' ' LYS . . . 147.41 96.16 0.17 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.6 mtt -122.07 -65.46 1.12 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.546 ' HB2' HE21 ' A' ' 9' ' ' GLN . 35.5 t -83.47 -81.61 0.16 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 174.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -136.74 -63.8 0.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 170.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.43 ' SD ' ' HG3' ' B' ' 115' ' ' PRO . 67.8 mtt -87.31 155.88 54.3 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 165.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.931 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 64.2 Cg_exo -47.19 127.11 12.47 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.522 2.148 . . . . 0.0 116.065 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.546 HE21 ' HB2' ' A' ' 5' ' ' SER . 26.3 tt0 -82.34 154.6 25.19 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.096 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -135.76 107.8 7.17 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -173.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -98.79 130.3 45.23 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.783 -171.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.475 HD11 ' CZ2' ' A' ' 14' ' ' TRP . 31.6 mt -115.28 174.46 5.98 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.623 0.725 . . . . 0.0 110.584 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.611 ' HD3' ' HA ' ' B' ' 106' ' ' LYS . 96.6 mtt180 -138.89 94.23 2.8 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.481 0.658 . . . . 0.0 109.422 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.475 ' CZ2' HD11 ' A' ' 12' ' ' LEU . 53.6 m0 -119.98 150.02 50.07 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.741 -175.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.18 143.47 63.43 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 121.733 1.622 . . . . 0.0 110.931 170.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.27 -30.56 66.69 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.93 -39.23 79.74 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.52 -0.737 . . . . 0.0 111.995 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.2 t -67.26 -42.7 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.16 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.947 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 60.0 tp -66.65 -35.78 80.99 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -71.9 -21.52 61.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.774 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.1 tp -80.15 -34.54 37.6 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.859 -0.526 . . . . 0.0 111.257 171.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.52 -32.95 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.528 -0.733 . . . . 0.0 109.403 170.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.947 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 27.4 mmm-85 -65.84 -38.64 89.42 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.773 0.321 . . . . 0.0 111.57 170.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -62.87 -56.76 14.42 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 122.252 -0.28 . . . . 0.0 111.031 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.415 HG23 ' CE1' ' B' ' 145' ' ' PHE . 98.9 t -56.68 -36.84 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.21 -33.38 75.36 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.84 -41.58 64.65 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -60.83 -49.19 78.47 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -77.63 -6.68 54.64 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.194 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.65 59.77 8.77 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.491 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.414 ' HE1' ' CB ' ' A' ' 35' ' ' SER . 25.5 ttt -146.97 147.25 30.54 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.4 m -68.47 145.29 54.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.027 0.918 . . . . 0.0 110.514 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.7 m -61.81 -36.63 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -57.59 -52.48 65.22 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.431 -0.793 . . . . 0.0 111.582 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.414 ' CB ' ' HE1' ' A' ' 31' ' ' MET . 58.2 m -72.14 -19.76 61.72 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 177.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -73.03 -57.44 4.03 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.636 -0.665 . . . . 0.0 111.982 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mp -69.66 -26.64 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -58.11 -39.46 78.7 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.038 0.923 . . . . 0.0 109.538 168.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.461 HE21 ' HA ' ' A' ' 39' ' ' GLN . 3.0 tp60 -73.68 -20.69 60.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.981 177.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.55 -34.0 41.39 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.043 -1.036 . . . . 0.0 111.673 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 m -78.47 2.23 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.48 170.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.714 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 1.9 mmt -113.88 -19.62 11.4 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.159 -0.963 . . . . 0.0 111.806 169.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -84.87 -22.92 29.19 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.884 171.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.482 ' HG ' HD21 ' B' ' 140' ' ' LEU . 68.2 m -87.59 -48.21 8.08 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -72.93 95.62 2.0 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.714 ' HG2' ' O ' ' A' ' 42' ' ' MET . 8.4 mmmt -156.64 19.05 0.33 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 118.621 -1.232 . . . . 0.0 113.832 -165.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.702 ' CB ' ' O ' ' A' ' 46' ' ' LYS . 5.4 tmtt? 91.45 -12.83 0.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 1.342 ' HB2' ' NH2' ' A' ' 50' ' ' ARG . 2.2 mp0 -58.53 -37.13 75.0 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.63 -0.669 . . . . 0.0 110.267 169.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.23 36.65 0.05 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 119.615 -1.278 . . . . 0.0 114.089 172.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 1.342 ' NH2' ' HB2' ' A' ' 48' ' ' GLU . 0.2 OUTLIER -121.36 -93.04 0.53 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.038 0.919 . . . . 0.0 109.096 -176.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.8 tp -62.98 -40.17 87.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.5 -157.96 34.17 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.226 -0.987 . . . . 0.0 111.324 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.848 179.727 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -167.97 114.37 0.7 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.89 99.29 1.57 Allowed Glycine 0 N--CA 1.466 0.653 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 26.3 mmt -131.26 -42.98 1.06 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 75.0 m -154.48 -46.16 0.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.864 0.364 . . . . 0.0 110.087 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . 0.611 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 98.1 mttt -66.2 -35.67 81.07 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -176.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' MET . . . . . 0.458 ' HB2' ' HD3' ' B' ' 108' ' ' PRO . 64.4 mtt -72.63 -49.29 8.49 Favored Pre-proline 0 N--CA 1.472 0.651 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' B' ' 107' ' ' MET . 23.4 Cg_exo -67.47 98.08 0.46 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.381 2.054 . . . . 0.0 111.214 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -99.1 147.97 24.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.936 0.874 . . . . 0.0 110.218 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -133.58 108.91 8.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.756 -173.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -90.87 140.11 30.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.044 0.926 . . . . 0.0 111.956 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.451 HD12 ' CZ2' ' B' ' 114' ' ' TRP . 55.7 mt -125.14 164.65 19.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.683 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.504 ' CD ' ' HG ' ' A' ' 5' ' ' SER . 99.0 mtt180 -127.31 87.88 2.71 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.78 0.8 . . . . 0.0 109.563 -173.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' TRP . . . . . 0.451 ' CZ2' HD12 ' B' ' 112' ' ' LEU . 47.5 m0 -120.0 146.07 41.29 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.972 -170.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.43 ' HG3' ' SD ' ' A' ' 7' ' ' MET . 47.7 Cg_exo -54.99 142.96 75.19 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 121.924 1.75 . . . . 0.0 110.922 169.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.931 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . 7.6 ttp180 -60.21 -32.0 70.69 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.639 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.04 -38.96 89.71 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.619 -0.676 . . . . 0.0 112.304 175.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 95.4 t -66.98 -42.64 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.789 -0.569 . . . . 0.0 111.184 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' B' ' 123' ' ' ARG . 57.5 tp -65.89 -39.93 91.09 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 176.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -66.57 -22.0 66.14 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.33 -34.62 65.77 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.235 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.37 -28.61 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.738 -0.601 . . . . 0.0 110.723 168.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . 0.815 HH22 ' NZ ' ' A' ' 2' ' ' LYS . 94.4 mtt180 -74.92 -34.99 62.21 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.849 -0.532 . . . . 0.0 111.762 173.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -63.32 -54.04 43.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.447 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.507 HG22 ' HG3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -60.39 -37.58 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.43 -30.4 71.53 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.67 -47.19 55.89 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.863 -0.523 . . . . 0.0 111.907 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -56.61 -52.97 62.82 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 -80.24 -13.97 58.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.566 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.54 60.29 8.44 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.946 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 25.8 ttt -137.13 144.17 42.87 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.938 0.875 . . . . 0.0 109.239 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 66.7 m -70.76 141.44 51.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.863 0.84 . . . . 0.0 110.37 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 19.3 m -64.82 -35.59 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -59.55 -52.56 65.02 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.328 -0.858 . . . . 0.0 111.623 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 61.5 m -70.57 -18.41 62.91 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -73.16 -56.19 5.45 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.635 -0.665 . . . . 0.0 112.239 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 4.4 mp -69.8 -26.37 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -57.76 -36.44 72.12 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.849 0.833 . . . . 0.0 109.853 168.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' GLN . . . . . 0.456 HE21 ' HA ' ' B' ' 139' ' ' GLN . 2.9 tp60 -78.99 -21.82 46.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.135 176.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . 0.482 HD21 ' HG ' ' A' ' 44' ' ' SER . 82.9 mt -78.89 -29.55 44.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.892 1.223 . . . . 0.0 112.344 176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 29.6 m -73.57 -29.07 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.994 171.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.93 -23.61 33.41 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.378 -0.826 . . . . 0.0 112.632 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.67 -29.71 56.48 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.21 -0.931 . . . . 0.0 110.947 170.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 36.4 t -75.11 -44.7 45.71 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.147 -0.345 . . . . 0.0 110.392 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.674 ' HD1' ' HB2' ' B' ' 150' ' ' ARG . 9.9 m-30 -79.14 102.09 8.28 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.9 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 0.0 OUTLIER -174.7 -56.58 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 118.185 -1.406 . . . . 0.0 110.9 -159.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.9 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 2.3 tmtp? 158.02 61.37 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -148.35 -48.66 0.16 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.284 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . 0.589 ' H ' ' HG3' ' B' ' 150' ' ' ARG . . . 163.19 89.45 0.07 OUTLIER Glycine 0 N--CA 1.467 0.738 0 N-CA-C 106.675 -2.57 . . . . 0.0 106.675 -174.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . 0.685 ' HG2' ' H ' ' B' ' 146' ' ' LYS . 0.1 OUTLIER -159.27 -129.68 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.298 -164.014 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.457 ' H ' ' HB2' ' B' ' 150' ' ' ARG . 0.0 OUTLIER -47.76 -43.56 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.84 72.54 0.1 Allowed Glycine 0 N--CA 1.467 0.736 0 C-N-CA 119.374 -1.393 . . . . 0.0 111.526 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.589 -0.719 . . . . 0.0 109.862 179.93 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.894 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 66.5 mtt . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.894 ' CB ' ' O ' ' A' ' 1' ' ' MET . 63.3 tttp 120.6 105.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.241 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.67 -76.99 0.02 OUTLIER Glycine 0 N--CA 1.465 0.621 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.314 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.7 mtt -99.24 -67.87 0.83 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.662 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.471 ' HB2' HE21 ' A' ' 9' ' ' GLN . 33.1 t -92.31 -91.32 0.17 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -127.51 -64.37 0.99 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 169.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.412 ' SD ' ' HG3' ' B' ' 115' ' ' PRO . 67.1 mtt -86.01 148.91 49.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 165.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.951 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 52.2 Cg_exo -44.72 127.31 7.93 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.773 2.315 . . . . 0.0 116.437 -175.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.471 HE21 ' HB2' ' A' ' 5' ' ' SER . 27.5 tt0 -81.41 155.58 25.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.596 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -139.72 109.52 6.34 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -174.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -95.84 133.39 40.05 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.307 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.469 HD12 ' CZ2' ' A' ' 14' ' ' TRP . 51.8 mt -114.69 174.69 5.84 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.661 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -133.2 87.68 2.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.853 0.835 . . . . 0.0 109.441 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.469 ' CZ2' HD12 ' A' ' 12' ' ' LEU . 47.5 m0 -117.49 142.95 31.22 Favored Pre-proline 0 N--CA 1.473 0.714 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.341 -172.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.14 142.02 67.75 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 121.831 1.687 . . . . 0.0 111.045 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.99 ' HB3' ' HG2' ' B' ' 108' ' ' PRO . 0.3 OUTLIER -59.18 -29.75 67.69 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -67.56 -40.21 84.92 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.58 -0.7 . . . . 0.0 111.822 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.64 -45.3 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.953 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.876 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 54.8 tp -67.1 -34.72 78.24 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 68.0 m-20 -71.88 -25.47 61.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.589 176.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.8 tp -80.0 -30.7 39.69 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.346 172.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.0 t -64.77 -32.99 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 166.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.876 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 32.2 mmm-85 -64.9 -38.37 90.74 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.838 0.351 . . . . 0.0 111.821 171.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -63.59 -53.25 54.55 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.176 -0.327 . . . . 0.0 110.885 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -55.84 -40.56 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.4 -31.92 71.85 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -72.2 -41.73 66.62 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 174.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.96 -49.65 76.6 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -76.3 -8.75 57.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.137 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.65 56.68 21.64 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.864 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.5 tpt -150.83 148.03 27.98 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.4 t -65.12 147.87 52.7 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.123 0.964 . . . . 0.0 111.459 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.1 m -63.6 -34.88 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -58.8 -50.51 73.68 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.649 -0.657 . . . . 0.0 111.483 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -72.57 -19.63 61.46 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -71.98 -58.36 3.51 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.66 -0.65 . . . . 0.0 111.82 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.84 -29.84 46.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -57.63 -37.06 72.68 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.018 170.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.515 HE21 ' HA ' ' A' ' 39' ' ' GLN . 2.6 tp60 -74.28 -27.83 60.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.739 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.7 mt -76.32 -26.45 55.8 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 119.015 -1.074 . . . . 0.0 112.301 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.5 t -84.16 -3.52 7.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.659 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.748 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 1.8 mmt -114.23 -12.93 12.4 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.05 -1.031 . . . . 0.0 111.674 168.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -86.2 -27.17 24.68 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.529 171.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.0 t -83.55 -51.18 7.54 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.45 97.28 2.05 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.961 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 7.4 mmmt -160.72 -57.19 0.05 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.183 -1.007 . . . . 0.0 108.994 -164.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.961 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 157.9 22.85 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.6 173.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 1.259 ' HB2' ' NH2' ' A' ' 50' ' ' ARG . 42.4 mt-10 -83.19 -34.2 25.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 169.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.4 34.16 0.05 OUTLIER Glycine 0 CA--C 1.531 1.086 0 C-N-CA 119.707 -1.235 . . . . 0.0 114.263 174.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 1.259 ' NH2' ' HB2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -118.51 -91.56 0.55 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.137 0.969 . . . . 0.0 108.945 -177.36 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.77 -42.41 96.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.484 ' HA3' ' HD3' ' A' ' 47' ' ' LYS . . . -96.02 -137.18 9.14 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.97 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.151 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.996 ' O ' ' HB2' ' B' ' 102' ' ' LYS . 66.0 mtt . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.996 ' HB2' ' O ' ' B' ' 101' ' ' MET . 88.2 tttt 149.9 -79.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.893 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.54 89.43 2.11 Favored Glycine 0 N--CA 1.467 0.704 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.421 ' HE1' ' HZ1' ' B' ' 102' ' ' LYS . 67.1 mtt -91.27 -55.69 3.43 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.382 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 29.5 t -91.09 -109.01 0.09 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -110.56 -65.37 1.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 168.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' MET . . . . . . . . . . . . . 67.5 mtt -83.12 136.93 43.23 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 164.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.99 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 34.8 Cg_exo -41.46 124.85 2.53 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 123.044 2.496 . . . . 0.0 116.849 -174.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -77.52 149.07 34.97 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.887 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -133.47 110.65 10.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.631 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -90.42 141.93 28.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.047 0.927 . . . . 0.0 111.881 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.485 HD11 ' CZ2' ' B' ' 114' ' ' TRP . 50.5 mt -123.91 165.73 16.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.002 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.412 ' CD ' ' HG ' ' A' ' 5' ' ' SER . 99.1 mtt180 -129.36 88.67 2.73 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.86 0.838 . . . . 0.0 109.575 -173.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' TRP . . . . . 0.485 ' CZ2' HD11 ' B' ' 112' ' ' LEU . 48.9 m0 -121.58 147.48 47.96 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.91 -171.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . 0.412 ' HG3' ' SD ' ' A' ' 7' ' ' MET . 50.1 Cg_exo -54.95 143.94 70.19 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 121.914 1.742 . . . . 0.0 111.083 170.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.951 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . 9.9 ttp180 -59.9 -33.34 71.72 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.44 -38.77 90.86 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.602 -0.686 . . . . 0.0 112.32 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.59 -42.1 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.82 -0.55 . . . . 0.0 111.069 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.848 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 57.5 tp -68.4 -33.21 73.82 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 176.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -69.36 -24.52 63.9 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.949 -0.469 . . . . 0.0 111.624 175.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 48.2 tp -78.44 -33.76 48.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.218 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.23 -35.08 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 121.633 -0.667 . . . . 0.0 109.738 169.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . 0.848 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 7.0 mmm180 -66.75 -37.48 84.71 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.732 0.301 . . . . 0.0 111.555 172.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -65.3 -56.5 12.36 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.15 -0.344 . . . . 0.0 111.136 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.61 HG22 ' HG3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -57.69 -38.5 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.67 80.57 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.74 -42.51 77.45 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -59.64 -50.19 74.82 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -78.41 -12.73 60.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.588 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 63.93 62.28 5.37 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.85 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 59.7 tpp -139.59 144.34 37.71 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.933 0.873 . . . . 0.0 108.94 -176.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 66.4 m -70.84 140.53 51.18 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.893 0.854 . . . . 0.0 110.468 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 17.6 m -65.19 -35.72 76.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -59.34 -52.79 64.12 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.345 -0.847 . . . . 0.0 111.722 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 60.9 m -71.47 -17.77 62.34 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -72.57 -56.62 5.07 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.645 -0.659 . . . . 0.0 112.077 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 4.4 mp -69.94 -26.77 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -58.02 -37.37 74.19 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.106 0.955 . . . . 0.0 109.601 168.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' GLN . . . . . 0.418 HE21 ' HA ' ' B' ' 139' ' ' GLN . 3.4 tp60 -79.85 -16.27 55.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.416 177.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 87.0 mt -81.88 -35.72 28.96 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.066 1.303 . . . . 0.0 111.881 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.11 -19.84 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.438 170.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 0.509 ' O ' ' HB2' ' B' ' 146' ' ' LYS . 0.5 OUTLIER -95.78 -26.34 15.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.146 0.885 . . . . 0.0 112.979 177.056 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.94 -31.16 56.42 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.262 -0.899 . . . . 0.0 111.719 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 74.9 m -90.17 -63.3 1.3 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.96 ' HA ' ' CB ' ' B' ' 150' ' ' ARG . 0.3 OUTLIER -88.29 80.62 7.48 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.789 1.28 . . . . 0.0 108.266 176.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 1.114 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 36.9 ttpt -107.58 -42.62 4.72 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.537 -173.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 1.114 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 0.0 OUTLIER 126.84 55.79 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 122.809 1.29 . . . . 0.0 108.699 -176.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -156.32 -23.16 0.1 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.916 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 145.09 58.85 0.02 OUTLIER Glycine 0 N--CA 1.465 0.58 0 N-CA-C 106.102 -2.799 . . . . 0.0 106.102 -169.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . 0.96 ' CB ' ' HA ' ' B' ' 145' ' ' PHE . 0.0 OUTLIER -81.64 -117.95 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.8 -1.2 . . . . 0.0 110.365 -169.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.594 HG23 ' CG ' ' B' ' 150' ' ' ARG . 4.7 tp -43.91 -48.23 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 113.597 -1.638 . . . . 0.0 113.656 169.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.79 88.34 0.07 OUTLIER Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.258 -179.391 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.901 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 66.1 mtt . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.901 ' CB ' ' O ' ' A' ' 1' ' ' MET . 55.1 tptt 117.47 109.32 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.169 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.55 104.11 0.17 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.4 mtt -131.6 -42.8 1.03 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 1.109 ' CB ' ' HB3' ' B' ' 113' ' ' ARG . 68.9 m -137.63 -42.77 0.54 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.742 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -82.77 39.36 0.62 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 26.0 ttt -154.61 -65.82 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -80.73 77.01 4.22 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.412 2.075 . . . . 0.0 111.092 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 42.3 mt-30 -93.9 142.17 27.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.924 0.869 . . . . 0.0 109.323 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -116.79 98.82 6.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.052 -173.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -85.21 138.4 32.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.034 0.921 . . . . 0.0 111.731 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.473 HD11 ' CZ2' ' A' ' 14' ' ' TRP . 28.8 mt -123.99 173.6 8.14 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.786 -174.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.839 ' HB3' ' HB3' ' B' ' 105' ' ' SER . 88.9 mtt180 -138.06 93.04 2.72 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.624 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.473 ' CZ2' HD11 ' A' ' 12' ' ' LEU . 52.5 m0 -119.65 139.41 27.91 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.937 -173.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.02 139.79 19.87 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.109 1.873 . . . . 0.0 111.528 171.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -26.09 61.23 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -174.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.22 -44.18 80.18 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.348 -0.845 . . . . 0.0 111.546 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.86 -44.47 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.541 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.787 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 64.4 tp -67.4 -35.63 79.68 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -74.92 -18.16 60.45 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.931 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.7 tt -82.7 -31.06 28.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.288 169.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.6 t -65.1 -34.4 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.939 -1.101 . . . . 0.0 109.348 168.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.787 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 28.0 mmm-85 -68.31 -39.28 82.06 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.167 -0.333 . . . . 0.0 111.472 171.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.04 -57.47 7.67 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.126 -0.359 . . . . 0.0 111.56 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 p -52.68 -39.97 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.07 -36.24 83.35 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.45 -41.16 76.63 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -58.82 -50.25 74.68 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -79.44 -12.69 59.89 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.545 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.84 62.43 5.51 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.644 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -145.46 135.51 23.76 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -174.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.0 p -62.54 142.84 57.78 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.961 0.886 . . . . 0.0 112.772 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.6 m -67.98 -37.3 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -58.76 -50.98 71.91 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.367 -0.833 . . . . 0.0 111.634 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.2 m -70.99 -21.27 62.32 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -70.75 -58.48 3.59 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.487 -0.758 . . . . 0.0 112.318 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 mp -67.6 -27.46 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.816 176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -57.21 -38.1 73.21 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.865 168.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -76.95 -18.11 58.46 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.767 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.4 mt -82.02 -33.26 30.13 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.787 1.176 . . . . 0.0 112.439 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.36 -25.62 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.044 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.427 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 1.3 mmt -77.69 -33.57 53.16 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.73 -0.606 . . . . 0.0 111.946 174.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.66 -28.55 64.88 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.392 -0.818 . . . . 0.0 111.363 172.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 66.7 m -76.35 -37.21 57.63 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.918 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.685 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 22.3 m-85 -81.65 78.95 8.33 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 172.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.685 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 14.5 mtpt 179.2 -23.56 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.374 -0.93 . . . . 0.0 113.127 -168.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 2.0 tmtt? -83.25 37.88 0.58 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 118.808 -1.157 . . . . 0.0 111.631 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' A' ' 46' ' ' LYS . 34.5 mt-10 -164.15 -23.2 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.633 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.07 69.6 1.38 Allowed Glycine 0 N--CA 1.468 0.777 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 -170.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -102.0 -70.33 0.75 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.558 1.171 . . . . 0.0 110.064 -168.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.408 HG21 ' H ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -72.07 -50.2 38.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.839 178.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 170.99 87.55 0.07 OUTLIER Glycine 0 N--CA 1.466 0.649 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.145 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.791 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.964 ' O ' ' HB2' ' B' ' 102' ' ' LYS . 15.9 tpt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.964 ' HB2' ' O ' ' B' ' 101' ' ' MET . 88.6 tttt 135.93 94.05 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.283 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.9 93.5 0.09 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 67.0 mtt -128.35 -53.06 1.28 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' SER . . . . . 0.839 ' HB3' ' HB3' ' A' ' 13' ' ' ARG . 73.0 m -119.38 -48.51 2.41 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.591 177.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -54.29 -40.7 68.12 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' MET . . . . . 0.467 ' HB2' ' HD3' ' B' ' 108' ' ' PRO . 26.3 mmt -91.12 -48.18 0.35 Allowed Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 118.438 -0.792 . . . . 0.0 113.018 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' B' ' 107' ' ' MET . 32.7 Cg_exo -70.94 84.44 0.84 Allowed 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.441 2.094 . . . . 0.0 112.709 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 17.7 tt0 -102.23 149.78 23.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.957 0.884 . . . . 0.0 110.0 -176.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -140.59 102.04 4.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.815 -173.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -92.14 141.63 28.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.06 0.933 . . . . 0.0 111.313 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.462 HD12 ' CZ2' ' B' ' 114' ' ' TRP . 30.0 mt -114.24 179.96 3.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.556 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 1.109 ' HB3' ' CB ' ' A' ' 5' ' ' SER . 95.5 mtt180 -135.2 88.99 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.645 -177.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' TRP . . . . . 0.462 ' CZ2' HD12 ' B' ' 112' ' ' LEU . 51.2 m0 -121.76 136.8 26.42 Favored Pre-proline 0 N--CA 1.473 0.704 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.098 -172.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.19 145.06 36.11 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 121.952 1.768 . . . . 0.0 111.382 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.83 -28.95 64.56 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -175.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.16 -41.77 85.43 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.462 -0.774 . . . . 0.0 111.925 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.22 -43.65 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.496 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.454 ' O ' ' HG3' ' B' ' 123' ' ' ARG . 64.4 tp -62.81 -43.47 98.71 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' B' ' 124' ' ' LYS . 76.1 m-20 -69.17 -21.19 64.0 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 50.1 tp -75.29 -31.69 60.77 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.731 -0.606 . . . . 0.0 110.305 168.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.97 -27.15 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.668 -0.645 . . . . 0.0 110.702 168.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' B' ' 119' ' ' LEU . 89.6 mtt180 -77.44 -35.84 53.58 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.748 -0.595 . . . . 0.0 111.322 171.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' B' ' 120' ' ' ASP . 69.8 mmtt -63.06 -54.13 42.87 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.264 -0.273 . . . . 0.0 110.92 176.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.6 -39.13 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.84 -33.11 74.55 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.02 -40.92 71.47 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.85 -49.54 77.31 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -76.55 -14.74 59.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.457 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.3 59.14 9.9 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.949 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 57.7 tpp -142.29 151.45 42.02 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.96 0.886 . . . . 0.0 108.962 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 63.8 m -62.97 136.46 57.85 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.815 0.817 . . . . 0.0 110.811 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 4.3 p -70.43 -37.87 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.001 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -62.87 -41.88 99.55 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.434 -0.791 . . . . 0.0 112.335 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 54.4 m -72.52 -19.34 61.54 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -72.36 -54.92 8.04 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.832 -0.543 . . . . 0.0 112.051 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 4.2 mp -68.86 -28.83 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -57.92 -35.81 71.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.203 169.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' GLN . . . . . 0.475 HE21 ' HA ' ' B' ' 139' ' ' GLN . 2.9 tp60 -77.75 -22.18 50.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.123 176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 72.3 mt -78.83 -35.39 44.11 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.593 1.088 . . . . 0.0 112.27 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.99 -27.88 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.966 170.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 1.6 mmt -81.02 -28.04 35.6 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.492 -0.755 . . . . 0.0 112.447 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.28 -29.91 61.86 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 119.626 -0.829 . . . . 0.0 111.169 171.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 66.9 m -75.01 -40.9 60.36 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.678 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.8 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 19.3 m-30 -79.92 86.59 5.42 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 173.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.8 ' HG3' ' O ' ' B' ' 145' ' ' PHE . 13.4 mtpt 164.94 -35.43 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.581 -165.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' B' ' 147' ' ' LYS . 0.2 OUTLIER -79.45 62.45 3.78 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.773 1.273 . . . . 0.0 109.741 177.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' B' ' 147' ' ' LYS . 21.7 tt0 165.81 -38.06 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.684 -173.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.93 70.8 1.21 Allowed Glycine 0 N--CA 1.467 0.733 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 -171.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . 0.522 ' HB2' ' H ' ' B' ' 151' ' ' ILE . 47.1 mtt180 -104.33 -83.74 0.49 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.388 1.089 . . . . 0.0 108.925 -169.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.522 ' H ' ' HB2' ' B' ' 150' ' ' ARG . 7.3 tp -57.93 -39.0 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 113.878 -1.51 . . . . 0.0 113.208 173.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -154.92 101.98 0.21 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.148 -179.686 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.945 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 26.4 mmt . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.945 ' HB2' ' O ' ' A' ' 1' ' ' MET . 65.5 tttm 153.41 109.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.358 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -160.67 -70.78 0.02 OUTLIER Glycine 0 N--CA 1.466 0.655 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.378 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.8 mtt -109.91 -61.37 1.66 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.89 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -90.17 -122.22 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.532 ' HG3' ' H ' ' A' ' 7' ' ' MET . 42.6 pttt -99.41 -57.23 2.2 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.532 ' H ' ' HG3' ' A' ' 6' ' ' LYS . 1.8 mpt? -93.52 139.09 22.76 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 165.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.743 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 46.9 Cg_exo -41.25 125.18 2.44 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.067 2.512 . . . . 0.0 116.561 -174.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 26.4 tt0 -77.57 153.71 33.06 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.683 -176.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -138.65 109.43 6.67 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -174.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -96.6 130.28 43.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.766 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.468 HD11 ' CZ2' ' A' ' 14' ' ' TRP . 38.5 mt -113.81 169.86 8.69 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.634 0.731 . . . . 0.0 110.056 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -130.38 91.26 3.07 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.695 0.76 . . . . 0.0 109.284 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.468 ' CZ2' HD11 ' A' ' 12' ' ' LEU . 49.2 m0 -125.79 151.36 70.88 Favored Pre-proline 0 N--CA 1.475 0.79 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.509 -170.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HG3' ' SD ' ' B' ' 107' ' ' MET . 38.8 Cg_exo -58.45 150.49 67.85 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.038 1.825 . . . . 0.0 111.819 168.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.727 ' HB3' ' HG2' ' B' ' 108' ' ' PRO . 4.0 ptm180 -59.06 -40.33 84.81 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -64.07 -31.32 72.47 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 177.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.74 -53.21 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.206 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 1.142 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 3.1 pp -81.2 -1.62 45.48 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -79.95 -28.09 39.71 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.786 -1.196 . . . . 0.0 110.0 167.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' B' ' 150' ' ' ARG . 50.6 tp -77.74 -35.09 52.2 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.841 -0.537 . . . . 0.0 111.908 174.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.18 -30.59 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.337 -0.852 . . . . 0.0 110.247 169.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 1.142 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 5.9 mmm180 -66.05 -41.01 91.39 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.281 170.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -65.91 -57.36 8.04 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.133 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.83 -39.54 71.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.04 -35.79 82.28 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.15 -37.69 84.23 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 175.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.65 -46.8 88.22 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -76.89 -13.76 59.95 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.557 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.27 62.13 5.15 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.231 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.4 ttt -141.94 145.77 34.9 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.999 0.904 . . . . 0.0 109.653 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.8 m -69.98 142.6 52.81 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.756 0.789 . . . . 0.0 110.303 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -62.43 -39.12 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -58.26 -51.81 68.2 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.063 -1.023 . . . . 0.0 112.709 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 64.5 m -72.16 -22.97 61.22 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 175.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -71.38 -55.38 8.09 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.512 -0.743 . . . . 0.0 112.537 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mp -67.3 -26.66 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -56.72 -39.35 73.74 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.583 168.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -76.62 -20.4 56.77 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.2 mt -82.99 -35.26 26.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.282 1.401 . . . . 0.0 112.265 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.401 ' HA ' HD11 ' B' ' 140' ' ' LEU . 18.4 m -70.1 -26.95 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.871 171.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -87.79 -25.53 23.31 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -83.19 -25.86 31.39 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.13 174.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.8 t -92.85 -70.52 0.69 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.921 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -70.44 135.54 48.78 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 171.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 1.081 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 40.1 ttpt 177.56 -50.64 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.118 0.961 . . . . 0.0 109.929 -171.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 1.081 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 2.6 tmtp? 142.46 54.73 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -153.52 -36.74 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.457 -170.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 50' ' ' ARG . . . -176.64 -58.1 0.06 OUTLIER Glycine 0 N--CA 1.464 0.559 0 N-CA-C 107.582 -2.207 . . . . 0.0 107.582 -173.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.921 ' HG2' ' HA ' ' A' ' 45' ' ' PHE . 96.3 mtt180 72.52 -87.73 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 168.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.702 HG23 ' HB3' ' A' ' 50' ' ' ARG . 2.9 tp -145.48 -51.86 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 112.726 -2.034 . . . . 0.0 110.777 -159.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.7 100.04 0.16 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.527 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.802 179.045 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.907 ' O ' ' CB ' ' B' ' 102' ' ' LYS . 67.0 mtt . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.907 ' CB ' ' O ' ' B' ' 101' ' ' MET . 87.9 tttt 113.65 -76.32 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.047 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 158.5 84.83 0.05 OUTLIER Glycine 0 N--CA 1.466 0.684 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 66.9 mtt -92.75 -62.27 1.42 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.525 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 29.0 m -64.88 -55.66 18.05 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.083 0.944 . . . . 0.0 110.786 174.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -173.55 -49.95 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' MET . . . . . 0.434 ' SD ' ' HG3' ' A' ' 15' ' ' PRO . 67.7 mtt -106.81 156.17 37.74 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 167.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.727 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 41.5 Cg_exo -41.64 122.18 1.84 Allowed 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.969 2.446 . . . . 0.0 116.461 -177.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -81.86 152.72 26.73 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.043 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -136.75 110.68 8.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.522 0.677 . . . . 0.0 109.699 -172.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -92.73 140.59 29.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.96 0.886 . . . . 0.0 111.806 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.467 HD12 ' CZ2' ' B' ' 114' ' ' TRP . 58.6 mt -124.0 172.79 8.7 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.918 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -132.95 88.79 2.54 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.815 0.817 . . . . 0.0 109.342 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' TRP . . . . . 0.467 ' CZ2' HD12 ' B' ' 112' ' ' LEU . 48.4 m0 -118.22 141.8 30.11 Favored Pre-proline 0 N--CA 1.472 0.652 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.579 -172.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.52 143.88 65.46 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 121.899 1.732 . . . . 0.0 111.022 171.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.743 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . 7.8 ttp180 -58.7 -32.04 68.8 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.1 -40.85 95.13 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.542 -0.724 . . . . 0.0 112.27 176.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.63 -46.02 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.802 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.98 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 56.0 tp -65.13 -32.07 73.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -69.08 -32.46 71.92 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.179 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 42.6 tp -76.31 -32.01 58.5 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.682 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 79.8 t -64.99 -36.14 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.565 -0.709 . . . . 0.0 109.166 169.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . 0.98 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 24.6 mmm-85 -64.97 -38.93 92.58 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.817 172.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -62.5 -51.38 67.65 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.232 -0.292 . . . . 0.0 111.775 177.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 99.5 t -59.31 -38.55 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 120.404 -0.518 . . . . 0.0 112.163 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.36 72.39 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.68 -40.28 66.4 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.27 -49.45 77.58 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -78.44 -10.91 59.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.856 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.37 59.2 11.08 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.702 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' B' ' 132' ' ' SER . 0.0 OUTLIER -145.65 147.71 32.29 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -176.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.464 ' N ' ' SD ' ' B' ' 131' ' ' MET . 56.2 m -61.04 150.78 32.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.441 1.115 . . . . 0.0 112.317 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 17.7 m -67.81 -37.79 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -175.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -60.74 -47.84 84.47 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.477 -0.765 . . . . 0.0 112.559 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 64.6 m -70.72 -26.58 63.46 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -65.83 -59.78 3.53 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.755 -0.591 . . . . 0.0 112.293 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.88 -24.16 26.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.375 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -58.64 -38.31 77.83 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.411 168.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -76.63 -19.55 57.68 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.675 -0.81 . . . . 0.0 112.684 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . 0.401 HD11 ' HA ' ' A' ' 41' ' ' VAL . 71.1 mt -82.81 -32.25 27.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.798 1.181 . . . . 0.0 112.536 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.84 -28.08 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 119.521 -0.871 . . . . 0.0 109.913 169.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' MET . . . . . 1.045 ' O ' ' HG2' ' B' ' 146' ' ' LYS . 9.1 mmt -78.99 -33.33 45.12 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.612 -0.68 . . . . 0.0 112.131 174.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . 0.531 ' HA ' ' HG3' ' B' ' 146' ' ' LYS . 38.1 mt-10 -72.3 -22.9 61.13 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.294 -0.879 . . . . 0.0 112.152 174.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 68.5 m -85.21 -39.81 17.38 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.118 -0.364 . . . . 0.0 110.69 173.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 0.652 ' O ' ' HB2' ' B' ' 146' ' ' LYS . 12.4 m-30 -72.2 -99.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 172.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 1.045 ' HG2' ' O ' ' B' ' 142' ' ' MET . 3.0 mmmt 81.63 -134.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.484 -0.887 . . . . 0.0 109.584 166.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -109.8 45.87 1.06 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 122.889 1.328 . . . . 0.0 109.853 170.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 1.436 ' HB2' ' NH2' ' B' ' 150' ' ' ARG . 37.5 mm-40 -86.23 -29.69 22.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.825 167.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 148.0 40.22 0.04 OUTLIER Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.286 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . 1.436 ' NH2' ' HB2' ' B' ' 148' ' ' GLU . 0.1 OUTLIER -126.84 -93.46 0.47 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.572 0.701 . . . . 0.0 110.488 -172.171 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 10.6 tp -67.54 -39.34 82.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -172.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.8 -80.7 1.19 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.905 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.464 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.934 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 28.0 ttt . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.934 ' HB2' ' O ' ' A' ' 1' ' ' MET . 88.5 tttt 139.29 103.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.125 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.57 42.08 6.24 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.905 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.6 mtt -144.12 -55.51 0.36 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.6 ' HB3' ' HB3' ' B' ' 113' ' ' ARG . 61.9 m -146.39 40.36 1.11 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.42 0.629 . . . . 0.0 110.109 172.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.524 ' HZ2' ' HG3' ' A' ' 2' ' ' LYS . 38.1 ttpt -76.66 -31.78 57.53 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.486 ' H ' ' HD2' ' A' ' 8' ' ' PRO . 61.1 mtt -142.07 -42.53 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -177.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 7' ' ' MET . 70.1 Cg_exo -60.83 98.89 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.48 2.12 . . . . 0.0 114.622 -174.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -108.04 156.63 19.04 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.801 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -146.26 120.98 9.85 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -91.52 128.89 37.52 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.755 0.788 . . . . 0.0 110.785 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 28.7 mt -102.47 165.49 11.07 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.663 ' HD3' ' HA ' ' B' ' 106' ' ' LYS . 94.6 mtt180 -133.98 94.74 3.31 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.824 -175.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.421 ' CZ2' HD11 ' A' ' 12' ' ' LEU . 53.3 m0 -124.06 149.3 59.85 Favored Pre-proline 0 N--CA 1.474 0.736 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.142 -173.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.7 144.38 65.24 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 121.815 1.677 . . . . 0.0 111.181 170.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.58 -29.39 66.38 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.5 -40.83 80.72 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.52 -0.738 . . . . 0.0 111.798 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.06 -47.29 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.942 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.489 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 64.6 tp -59.79 -43.72 94.3 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -69.7 -24.24 63.55 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 120.097 -0.641 . . . . 0.0 112.076 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.6 tp -76.42 -33.58 58.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.035 170.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.38 -33.67 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.59 -0.694 . . . . 0.0 109.934 169.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 21.9 mmt180 -66.41 -36.71 83.51 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.143 -0.348 . . . . 0.0 111.659 171.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -63.61 -56.28 17.05 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.026 -0.421 . . . . 0.0 110.769 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.5 t -56.32 -37.33 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.81 -34.97 79.11 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.54 -40.24 70.17 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 175.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.27 -48.39 81.63 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -76.46 -12.35 60.03 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.56 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.89 60.38 8.17 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.676 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.3 tpt -141.43 149.1 40.57 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 122.056 0.931 . . . . 0.0 108.879 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.4 t -64.38 141.77 58.65 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 122.104 0.954 . . . . 0.0 110.811 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -63.22 -37.9 80.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -63.08 -47.98 80.58 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.551 -0.718 . . . . 0.0 111.957 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.8 m -70.43 -26.03 63.48 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -67.19 -58.01 5.65 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.663 -0.648 . . . . 0.0 112.146 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -69.84 -25.44 28.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.249 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -57.05 -39.04 74.1 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.474 168.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -76.91 -22.73 52.94 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.732 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.5 mt -81.13 -36.05 30.79 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.056 1.298 . . . . 0.0 112.615 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.4 m -67.95 -30.31 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.139 169.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.71 ' CE ' ' HA ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -82.23 -16.97 47.69 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.018 -1.051 . . . . 0.0 113.707 178.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.17 -28.07 21.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.389 173.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 1.051 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 33.1 t -93.6 -72.4 0.61 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.986 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 5.6 t80 -66.53 164.76 15.89 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 165.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 1.001 ' O ' ' CB ' ' A' ' 47' ' ' LYS . 25.5 ttpt 161.17 52.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 119.752 -1.843 . . . . 0.0 111.439 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 1.467 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 45.3 tptt 117.92 -16.74 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 117.769 -1.573 . . . . 0.0 110.536 -168.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 79.76 7.87 1.69 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -105.28 36.82 4.15 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 169.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 1.467 ' NH2' ' HB3' ' A' ' 47' ' ' LYS . 1.3 mpp_? -127.36 -84.21 0.6 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -169.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.0 tp -63.26 -35.52 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.285 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.07 96.46 0.16 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.031 179.966 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -165.6 123.98 1.6 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.02 122.67 0.63 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 66.9 mtt -126.83 -38.01 2.08 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 61.7 m -157.91 -51.08 0.07 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' LYS . . . . . 0.663 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 98.3 mttt -65.71 -40.96 92.77 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' MET . . . . . 0.425 ' HB2' ' HD3' ' B' ' 108' ' ' PRO . 61.6 mtt -73.09 -48.18 7.77 Favored Pre-proline 0 N--CA 1.473 0.679 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -177.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' B' ' 107' ' ' MET . 31.3 Cg_exo -66.71 94.73 0.33 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.346 2.031 . . . . 0.0 111.503 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 79.9 mt-30 -100.17 160.87 13.99 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.648 1.213 . . . . 0.0 111.355 -176.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -137.5 101.49 4.51 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -90.64 125.39 35.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.53 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.83 176.55 7.95 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.741 176.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' A' ' 5' ' ' SER . 99.8 mtt180 -131.91 113.57 13.61 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.504 0.669 . . . . 0.0 110.9 -171.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -123.53 154.65 66.37 Favored Pre-proline 0 N--CA 1.474 0.737 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.623 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.58 144.33 52.68 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 121.676 1.584 . . . . 0.0 110.443 170.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -59.99 -30.09 68.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.923 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.15 -40.4 94.3 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.577 -0.702 . . . . 0.0 112.003 174.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 82.3 t -66.51 -43.85 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.862 -0.524 . . . . 0.0 111.608 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 1.027 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 65.4 tp -67.85 -37.13 81.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.0 -20.91 60.18 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.778 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 25.8 tp -85.46 -32.26 22.38 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.927 -0.483 . . . . 0.0 111.795 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.91 -25.99 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.07 167.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . 1.027 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 27.6 mmm-85 -67.35 -42.68 83.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.983 170.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -65.27 -52.37 54.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.894 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.57 -40.33 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.75 -35.81 80.99 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.01 -38.78 86.59 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -61.36 -47.65 84.88 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.232 0.539 . . . . 0.0 112.454 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -75.72 -11.91 60.09 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.734 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 65.35 61.83 5.38 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.856 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 57.4 tpp -141.94 144.1 33.58 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.945 0.879 . . . . 0.0 109.104 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 64.3 m -69.02 142.01 54.71 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.876 0.846 . . . . 0.0 110.183 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 18.2 m -64.88 -37.51 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -60.6 -48.85 79.96 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.286 -0.884 . . . . 0.0 112.377 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 60.9 m -71.21 -23.66 62.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -70.58 -55.06 9.71 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.648 -0.658 . . . . 0.0 112.208 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.03 -26.31 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.107 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -56.33 -39.8 73.4 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.502 168.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -74.81 -24.2 58.6 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.882 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 60.7 mt -82.34 -34.13 28.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.071 1.305 . . . . 0.0 112.537 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 20.8 m -70.32 -26.67 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.832 171.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -86.22 -29.6 23.03 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.397 -0.815 . . . . 0.0 112.907 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.04 -27.95 48.89 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.195 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 37.2 t -91.84 -72.13 0.6 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . 1.183 ' HA ' ' CB ' ' B' ' 150' ' ' ARG . 0.1 OUTLIER -68.58 112.77 5.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 1.092 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 37.8 ttpt -154.07 -43.17 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.838 0.828 . . . . 0.0 111.143 -171.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 1.092 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 0.0 OUTLIER 132.35 53.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.877 1.322 . . . . 0.0 108.736 178.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -156.09 -21.18 0.1 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.891 -177.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 145.17 57.44 0.02 OUTLIER Glycine 0 N--CA 1.466 0.644 0 N-CA-C 106.132 -2.787 . . . . 0.0 106.132 -169.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' ARG . . . . . 1.183 ' CB ' ' HA ' ' B' ' 145' ' ' PHE . 0.0 OUTLIER -76.16 -40.78 51.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -170.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . 0.748 HG23 ' HG2' ' B' ' 150' ' ' ARG . 3.4 tp -156.63 -49.11 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -168.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.88 97.7 0.13 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.886 -179.917 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.715 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 15.5 tpt . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.715 ' HB3' ' O ' ' A' ' 1' ' ' MET . 40.4 ttmt 84.22 112.26 0.06 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.19 0.519 . . . . 0.0 109.957 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 94.3 95.26 1.6 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.194 -1.003 . . . . 0.0 110.915 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.5 mtt -135.8 -52.75 0.75 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.4 m -146.51 -56.04 0.27 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.057 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 1.004 ' HA ' ' HB3' ' B' ' 113' ' ' ARG . 98.6 mttt -85.85 56.72 4.1 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.472 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 44.8 mtt -137.26 -60.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 171.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 7' ' ' MET . 31.5 Cg_exo -61.11 103.96 0.26 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.511 2.141 . . . . 0.0 111.493 170.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 82.6 mt-30 -94.7 143.66 26.26 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.656 1.217 . . . . 0.0 111.573 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -116.25 96.95 5.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.727 -1.579 . . . . 0.0 106.945 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -99.24 131.92 44.92 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.807 0.813 . . . . 0.0 111.044 -175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.53 -173.93 3.56 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.242 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -137.63 118.41 14.12 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.162 -0.962 . . . . 0.0 111.646 -175.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -125.36 146.68 55.08 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.389 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -47.12 143.37 10.32 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 121.875 1.717 . . . . 0.0 111.506 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -58.35 -36.91 74.17 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -172.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.53 -36.59 84.28 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.719 -0.613 . . . . 0.0 112.518 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.3 t -62.98 -44.01 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.878 -0.514 . . . . 0.0 111.582 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.433 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 56.5 mt -58.22 -49.55 76.7 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.43 -0.508 . . . . 0.0 112.254 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -56.44 -25.86 51.84 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 tt -78.11 -39.29 41.8 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.577 173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.7 t -60.69 -38.34 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 121.452 -0.78 . . . . 0.0 110.989 170.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 95.8 mtt180 -72.06 -30.84 65.54 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.492 175.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -66.5 -54.08 27.92 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.26 174.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.8 t -59.89 -34.86 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.09 -32.97 74.72 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -72.47 -41.21 66.29 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.85 -48.82 80.06 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.729 0.641 . . . . 0.0 112.729 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -75.35 -13.77 60.43 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.524 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.45 58.3 11.89 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.031 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.9 ttt -145.33 147.63 32.53 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.93 0.871 . . . . 0.0 108.898 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.5 t -67.19 143.72 56.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.9 0.857 . . . . 0.0 110.368 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -61.46 -37.7 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -55.58 -53.73 52.77 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.274 -0.891 . . . . 0.0 111.84 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.4 m -71.46 -22.1 61.87 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -71.21 -57.17 4.75 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.5 -0.75 . . . . 0.0 112.163 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 37' ' ' ILE . 4.2 mp -66.38 -28.37 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -56.73 -41.09 76.9 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.642 169.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -74.92 -16.31 60.66 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.44 -36.15 20.82 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.078 1.308 . . . . 0.0 111.748 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.6 m -73.83 -7.95 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.954 172.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.638 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -108.97 -25.13 10.88 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.978 0.808 . . . . 0.0 112.208 174.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -83.56 -16.01 47.05 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.968 172.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.1 t -108.15 -50.52 3.03 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.427 ' O ' ' CG ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -103.4 69.09 0.98 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 123.143 1.449 . . . . 0.0 107.623 175.166 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.049 ' HB2' ' NH2' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -84.89 -43.46 14.07 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 120.98 -1.075 . . . . 0.0 111.291 -176.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.706 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 27.5 mmmt 118.44 33.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.127 0.965 . . . . 0.0 110.438 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -94.47 -30.32 14.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.744 167.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.56 65.29 0.1 OUTLIER Glycine 0 N--CA 1.467 0.739 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 1.049 ' NH2' ' HB2' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -112.38 -87.81 0.54 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -177.126 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.6 tp -60.8 -37.88 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.6 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.16 -88.34 0.75 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.26 -0.971 . . . . 0.0 110.919 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.149 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 16.0 tpt . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' B' ' 102' ' ' LYS . 22.9 pttp -171.88 109.44 0.26 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.139 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.11 62.22 0.01 OUTLIER Glycine 0 N--CA 1.466 0.684 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 16.4 tpt -101.25 -64.32 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 27.3 t -85.5 -71.81 0.51 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' LYS . . . . . 0.515 ' H ' ' HD3' ' B' ' 108' ' ' PRO . 58.2 mtmt -145.11 -86.96 0.11 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 174.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' MET . . . . . . . . . . . . . 65.3 mtt -143.08 63.28 12.86 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 169.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.515 ' HD3' ' H ' ' B' ' 106' ' ' LYS . 54.4 Cg_endo -93.11 79.3 0.26 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 121.797 1.665 . . . . 0.0 110.39 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -86.98 144.66 26.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 122.53 1.157 . . . . 0.0 111.571 -173.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -140.68 110.06 6.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.307 -174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -93.84 130.61 39.81 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.811 0.815 . . . . 0.0 111.135 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 34.8 mt -104.7 171.4 7.35 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 1.004 ' HB3' ' HA ' ' A' ' 6' ' ' LYS . 97.2 mtt180 -134.09 94.1 3.19 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.812 0.815 . . . . 0.0 109.596 -176.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' TRP . . . . . 0.42 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 54.7 m0 -121.29 151.1 55.49 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.87 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -55.61 144.06 76.5 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 121.673 1.582 . . . . 0.0 110.586 170.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.91 -30.29 67.71 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.96 -38.54 82.89 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.63 -0.669 . . . . 0.0 112.092 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.59 -44.44 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.204 0.526 . . . . 0.0 111.015 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.407 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 58.4 tp -67.7 -34.01 76.03 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ASP . . . . . 0.699 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 68.0 m-20 -70.61 -25.85 63.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.564 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 15.2 tp -78.17 -32.59 50.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.228 172.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.78 -39.19 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 167.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ARG . . . . . 0.699 ' HB2' ' O ' ' B' ' 120' ' ' ASP . 2.9 mmp_? -54.34 -48.91 70.86 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.108 0.48 . . . . 0.0 111.797 169.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -56.92 -57.51 12.19 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.277 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.93 -39.04 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.82 -30.97 72.0 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -73.19 -44.77 59.29 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.795 -0.565 . . . . 0.0 112.192 174.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.93 -51.83 67.99 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -79.36 -12.75 59.91 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.467 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.96 59.85 8.97 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.268 -0.967 . . . . 0.0 111.932 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 59.2 tpp -141.38 146.18 36.29 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 65.2 m -67.66 142.0 56.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.038 0.923 . . . . 0.0 110.982 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 14.0 m -64.82 -33.38 63.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -58.8 -53.34 59.53 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.807 -0.558 . . . . 0.0 111.43 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 59.0 m -71.98 -19.5 61.87 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -71.83 -57.29 4.46 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.743 -0.598 . . . . 0.0 111.756 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 2.6 mp -69.7 -25.85 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -58.59 -37.71 76.37 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.882 0.849 . . . . 0.0 109.694 168.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -78.61 -21.4 48.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.111 177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 84.9 mt -81.57 -31.67 32.5 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.562 1.074 . . . . 0.0 112.189 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.21 -25.61 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.926 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.495 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 30.6 mmt -84.48 -28.81 26.51 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.383 -0.823 . . . . 0.0 112.539 175.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -74.08 -24.79 59.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.654 171.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 67.3 m -84.83 -43.32 14.28 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.154 -0.341 . . . . 0.0 110.301 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.776 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 18.1 m-30 -77.27 95.92 4.46 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.776 ' HG3' ' O ' ' B' ' 145' ' ' PHE . 10.9 mtpt 165.69 -36.94 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.817 -166.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' B' ' 148' ' ' GLU . 13.6 tptm -81.16 63.63 5.58 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 123.201 1.477 . . . . 0.0 109.797 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 147' ' ' LYS . 26.6 tt0 169.7 -32.85 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 112.804 -1.998 . . . . 0.0 108.786 -174.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 89.01 68.28 1.26 Allowed Glycine 0 N--CA 1.466 0.691 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' ARG . . . . . 0.435 ' HB2' ' H ' ' B' ' 151' ' ' ILE . 48.1 mtt180 -105.49 -84.21 0.5 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.277 1.037 . . . . 0.0 108.821 -169.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.435 ' H ' ' HB2' ' B' ' 150' ' ' ARG . 6.9 tp -58.93 -43.34 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 114.11 -1.405 . . . . 0.0 112.769 174.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -90.59 -112.16 1.57 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.726 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.491 -179.409 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.62 ' HG3' ' CE ' ' A' ' 4' ' ' MET . 27.9 ttt . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -169.37 103.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.76 78.38 1.41 Allowed Glycine 0 N--CA 1.468 0.804 0 C-N-CA 120.245 -0.978 . . . . 0.0 111.025 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.62 ' CE ' ' HG3' ' A' ' 1' ' ' MET . 26.4 mmt -93.73 -50.36 5.42 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.426 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.5 t -77.59 -95.17 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.43 ' HG3' ' H ' ' A' ' 7' ' ' MET . 53.6 pttt -126.83 -54.33 1.41 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 168.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.43 ' H ' ' HG3' ' A' ' 6' ' ' LYS . 24.4 mmt -90.58 149.68 41.18 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 165.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.987 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 69.4 Cg_exo -46.4 128.9 12.91 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 122.659 2.239 . . . . 0.0 115.739 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 27.2 tt0 -83.19 149.43 26.84 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.628 -176.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -133.44 113.12 12.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.369 -172.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -96.6 142.29 28.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.813 0.816 . . . . 0.0 111.987 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.459 HD13 ' CZ2' ' A' ' 14' ' ' TRP . 41.2 mt -122.52 171.58 9.0 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.573 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.406 ' HB3' ' HA ' ' B' ' 106' ' ' LYS . 97.7 mtt180 -137.28 93.15 2.78 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.504 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.459 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 53.7 m0 -119.2 153.75 53.38 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.476 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.77 142.05 74.9 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 121.55 1.5 . . . . 0.0 110.479 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -58.79 -33.32 70.19 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.39 -39.75 89.23 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.65 -0.656 . . . . 0.0 112.167 175.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.9 t -64.46 -46.65 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.92 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 56.2 tp -61.66 -40.78 96.14 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 91.7 m-20 -68.94 -26.81 65.26 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.876 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.3 tp -75.68 -31.48 59.76 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.175 171.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -64.21 -36.06 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.523 -0.736 . . . . 0.0 109.74 168.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 21.5 mmt180 -64.15 -38.72 92.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.875 0.369 . . . . 0.0 111.746 170.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 20' ' ' ASP . 68.5 mmtt -61.35 -54.35 44.91 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.2 t -58.21 -38.03 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.11 -32.5 73.9 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.93 -41.76 67.47 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.98 -50.27 74.41 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -76.69 -13.08 60.07 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.513 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.63 59.63 8.99 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.668 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.2 tpt -140.41 147.16 39.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.004 0.907 . . . . 0.0 108.75 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 63.0 m -66.77 144.94 56.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.118 0.961 . . . . 0.0 110.999 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -62.88 -36.76 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -60.59 -52.96 62.95 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.838 -0.539 . . . . 0.0 112.081 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.1 m -71.44 -20.66 62.07 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -69.8 -59.69 2.78 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.785 -0.572 . . . . 0.0 111.74 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.1 mp -70.19 -25.84 28.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.264 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -59.26 -38.72 80.76 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 122.102 0.953 . . . . 0.0 109.441 169.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -77.89 -17.13 57.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.267 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.1 mt -83.83 -35.54 24.15 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.756 1.162 . . . . 0.0 111.828 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.8 m -71.68 -11.97 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.31 169.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.829 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -97.29 -28.87 13.86 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.375 0.989 . . . . 0.0 112.352 172.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.55 -15.47 59.24 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.417 -0.802 . . . . 0.0 112.332 172.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.4 m -118.87 -9.05 10.19 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.431 ' O ' ' CG ' ' A' ' 45' ' ' PHE . 1.6 t80 -152.26 67.35 0.84 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.829 ' HB2' ' O ' ' A' ' 42' ' ' MET . 0.1 OUTLIER -91.02 -45.43 8.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.505 -174.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 6.0 mmmm 126.67 33.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.766 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -95.93 -28.55 14.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.143 166.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.78 78.94 0.45 Allowed Glycine 0 N--CA 1.467 0.708 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.633 HH21 ' HB3' ' A' ' 46' ' ' LYS . 74.9 mtt-85 -123.71 -85.78 0.65 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.632 1.206 . . . . 0.0 109.052 -171.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.462 ' H ' ' HB2' ' A' ' 50' ' ' ARG . 9.2 tp -62.81 -45.55 98.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 113.542 -1.663 . . . . 0.0 112.912 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.95 99.09 0.15 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.091 -179.554 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.885 ' O ' ' HB2' ' B' ' 102' ' ' LYS . 15.6 tpt . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.885 ' HB2' ' O ' ' B' ' 101' ' ' MET . 88.3 tttt 133.5 108.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.382 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.96 87.46 1.23 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.115 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 26.2 mmt -139.02 -50.92 0.53 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 89.7 p -160.55 -33.89 0.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.972 175.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' LYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 97.7 mttt -87.02 35.66 0.7 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' MET . . . . . 0.495 ' H ' ' CD ' ' B' ' 108' ' ' PRO . 25.6 mmt -132.57 -49.47 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.663 173.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.495 ' CD ' ' H ' ' B' ' 107' ' ' MET . 18.5 Cg_exo -68.98 103.18 0.99 Allowed 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.521 2.147 . . . . 0.0 110.582 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -99.06 147.7 24.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.93 0.871 . . . . 0.0 110.548 -174.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -133.61 108.57 8.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.849 -174.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -91.4 141.65 28.52 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.962 0.887 . . . . 0.0 112.003 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 53.0 mt -125.87 168.82 13.34 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.261 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -127.26 85.53 2.38 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.829 0.823 . . . . 0.0 109.67 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' TRP . . . . . 0.419 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 44.7 m0 -119.32 142.49 32.52 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.628 -171.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.94 145.15 53.17 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 121.972 1.781 . . . . 0.0 111.661 172.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.987 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . 11.9 ttp180 -61.37 -34.96 76.19 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.87 -35.9 81.53 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.2 -42.76 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.982 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.911 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 80.7 mt -67.37 -32.06 72.72 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -65.31 -33.49 76.1 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.502 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 19.2 tp -77.72 -32.33 52.82 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.077 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.1 -36.34 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ARG . . . . . 0.911 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 25.5 mmm-85 -65.24 -35.3 80.61 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.984 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.64 -55.77 20.96 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.723 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 93.0 t -57.99 -36.18 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.77 73.09 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -72.06 -44.61 63.05 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.847 -0.533 . . . . 0.0 112.186 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -57.48 -51.77 68.11 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -80.46 -13.13 59.38 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.499 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.79 61.11 7.09 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.922 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 58.8 tpp -142.77 143.52 32.24 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.866 0.841 . . . . 0.0 109.011 -176.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 64.8 m -68.63 148.48 50.39 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 122.07 0.938 . . . . 0.0 110.929 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 16.5 m -64.04 -35.53 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -59.87 -53.55 56.56 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.62 -0.675 . . . . 0.0 111.681 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 60.0 m -70.73 -23.98 62.54 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -68.46 -57.77 5.34 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.528 -0.733 . . . . 0.0 112.286 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 3.9 mp -68.82 -26.42 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.211 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -56.29 -39.82 73.31 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.496 168.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -76.03 -22.98 55.13 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.821 -0.751 . . . . 0.0 112.917 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 58.9 mt -82.8 -34.38 26.99 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.124 1.329 . . . . 0.0 112.471 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 18.4 m -70.56 -24.86 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.964 172.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.64 -31.77 18.39 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.315 -0.866 . . . . 0.0 112.6 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -77.58 -23.62 49.94 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.418 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' SER . . . . . 0.843 ' C ' ' HB3' ' B' ' 150' ' ' ARG . 35.5 t -97.57 -66.67 0.89 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 1.176 ' HA ' ' CG ' ' B' ' 150' ' ' ARG . 0.1 OUTLIER -75.24 98.99 3.9 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 122.927 1.346 . . . . 0.0 107.892 174.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 1.103 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 27.9 ttpp -138.15 -42.52 0.51 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.535 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 1.103 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 2.5 tmtt? 138.64 48.18 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.889 0.852 . . . . 0.0 109.2 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -151.54 -30.63 0.17 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.276 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 157.05 64.24 0.01 OUTLIER Glycine 0 N--CA 1.466 0.66 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -173.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' ARG . . . . . 1.176 ' CG ' ' HA ' ' B' ' 145' ' ' PHE . 0.0 OUTLIER -90.52 -55.07 3.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.19 0.995 . . . . 0.0 111.249 -172.043 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 3.6 tp -120.65 -53.64 3.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.602 -168.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -178.64 98.01 0.11 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 119.884 -1.15 . . . . 0.0 110.25 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.569 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.96 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 61.5 tpp . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.96 ' HB2' ' O ' ' A' ' 1' ' ' MET . 88.6 tttt 143.87 99.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.203 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.3 98.17 0.12 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.1 mtt -140.26 -39.3 0.44 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.855 ' O ' ' HB3' ' B' ' 113' ' ' ARG . 90.0 p -159.92 -40.59 0.05 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.568 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -86.38 30.06 0.73 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.475 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 55.4 tpp -149.68 -48.64 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 118.736 -0.65 . . . . 0.0 112.534 173.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 7' ' ' MET . 15.9 Cg_exo -73.03 96.13 0.85 Allowed 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.248 1.965 . . . . 0.0 111.053 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 78.0 mt-30 -99.91 144.81 28.53 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.541 1.162 . . . . 0.0 111.126 -176.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -120.77 105.66 10.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.148 -1.387 . . . . 0.0 107.689 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -90.26 135.1 33.88 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.872 0.844 . . . . 0.0 111.279 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.91 171.08 14.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.33 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -129.91 106.54 8.73 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.093 -170.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 53.7 m0 -118.62 152.82 51.76 Favored Pre-proline 0 N--CA 1.474 0.755 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.228 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.26 146.23 32.38 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 121.776 1.651 . . . . 0.0 110.758 171.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.55 -33.48 72.73 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -174.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.75 -32.03 73.06 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.625 -0.672 . . . . 0.0 112.314 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.84 -43.38 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.13 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.9 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 59.6 mt -62.39 -40.49 96.66 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -69.81 -24.16 63.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.52 -0.472 . . . . 0.0 112.171 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.7 tp -80.17 -35.09 36.97 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.889 -0.507 . . . . 0.0 111.291 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.86 -33.74 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 170.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.9 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 29.5 mmm-85 -67.61 -40.04 84.72 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 122.18 -0.325 . . . . 0.0 111.255 171.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -63.67 -52.79 59.12 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.755 HG21 ' HG2' ' B' ' 150' ' ' ARG . 0.5 OUTLIER -60.03 -40.11 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.97 -34.34 77.31 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.4 -40.2 81.4 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -60.29 -49.19 78.58 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -76.38 -13.34 60.13 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.625 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.14 61.99 5.3 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.718 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.8 ttt -137.85 148.57 45.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.993 0.901 . . . . 0.0 109.118 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -67.91 135.79 53.0 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.021 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.85 -39.69 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -174.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -59.7 -48.76 80.39 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.435 -0.791 . . . . 0.0 112.039 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.8 m -72.16 -15.75 61.97 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -73.9 -55.77 5.77 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.683 -0.635 . . . . 0.0 111.849 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.498 HD12 ' H ' ' A' ' 37' ' ' ILE . 4.5 mp -65.82 -30.67 50.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -57.0 -37.83 72.22 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.125 170.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -77.04 -23.09 52.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.201 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.39 -37.22 37.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.773 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.32 -13.89 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.281 171.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.53 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 29.4 mmt -97.44 -14.79 20.95 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.531 -1.356 . . . . 0.0 112.869 175.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -94.64 -25.55 16.72 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 119.539 -0.865 . . . . 0.0 112.313 171.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 1.14 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 74.4 m -93.72 -71.94 0.63 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 175.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.967 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 14.7 t80 -71.07 178.35 3.29 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 164.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.967 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER 169.61 -58.83 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 O-C-N 119.923 -1.735 . . . . 0.0 108.8 177.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.854 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 4.5 tmtp? -132.5 23.23 4.37 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.23 169.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 73.86 9.2 4.8 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.43 46.73 1.08 Allowed Glycine 0 N--CA 1.47 0.964 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 171.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 1.14 ' HB3' ' O ' ' A' ' 44' ' ' SER . 1.9 mpp_? -131.57 -84.95 0.5 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -169.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.2 tp -66.66 -42.91 90.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.903 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.71 124.01 1.02 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.273 -179.642 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.883 ' O ' ' CB ' ' B' ' 102' ' ' LYS . 66.0 mtt . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.883 ' CB ' ' O ' ' B' ' 101' ' ' MET . 88.4 tttt 115.96 106.93 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.384 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.62 43.89 0.02 OUTLIER Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.237 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -173.71 36.56 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 88.7 p 48.57 69.03 0.6 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -77.89 -58.17 3.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 167.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' MET . . . . . 0.549 ' N ' ' HD3' ' B' ' 108' ' ' PRO . 24.5 ttt -162.07 46.05 0.17 Allowed Pre-proline 0 CA--C 1.552 1.046 0 CA-C-O 117.898 -1.049 . . . . 0.0 112.926 168.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' B' ' 107' ' ' MET . 17.2 Cg_exo -74.43 102.59 1.57 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 124.274 2.562 . . . . 0.0 109.646 174.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -95.51 154.19 17.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.083 0.944 . . . . 0.0 111.174 -172.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -148.76 115.13 5.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -92.1 126.91 37.37 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.38 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 31.4 mt -97.76 173.65 7.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.965 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.855 ' HB3' ' O ' ' A' ' 5' ' ' SER . 98.7 mtt180 -134.07 85.57 2.21 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.705 -175.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' TRP . . . . . 0.419 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 45.2 m0 -119.45 150.6 50.06 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.125 -172.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.02 145.35 64.02 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 121.747 1.631 . . . . 0.0 111.009 172.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -60.86 -36.58 79.52 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 119.776 -0.769 . . . . 0.0 112.849 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.9 -33.72 76.69 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.38 -42.13 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.904 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.909 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 64.4 mt -65.2 -34.74 79.09 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 75.6 m-20 -65.76 -34.72 78.84 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.516 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 28.2 tp -80.16 -29.46 38.77 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 120.394 -0.523 . . . . 0.0 112.176 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 67.8 t -64.94 -33.25 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 166.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ARG . . . . . 0.909 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 30.2 mmm-85 -62.98 -41.34 99.54 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 122.14 -0.35 . . . . 0.0 111.514 171.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.98 -48.69 51.9 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.272 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.84 -43.42 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.88 -42.57 81.03 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.4 -33.35 72.88 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -68.46 -41.13 80.65 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.047 -0.408 . . . . 0.0 111.749 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -72.04 -8.33 53.95 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.389 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.54 63.67 3.28 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.782 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 18.7 ttt -153.58 145.55 23.63 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.729 0.776 . . . . 0.0 109.281 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 66.4 m -73.35 144.81 46.35 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.61 0.719 . . . . 0.0 109.837 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 14.0 m -65.18 -38.04 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -64.0 -45.52 88.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.306 -0.871 . . . . 0.0 111.416 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 57.0 m -71.94 -19.24 61.93 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -73.15 -55.42 6.49 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.695 -0.628 . . . . 0.0 111.619 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 3.7 mp -68.16 -27.44 37.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.996 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -57.79 -40.38 79.73 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 122.071 0.939 . . . . 0.0 109.63 169.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -73.98 -21.27 60.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.163 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.88 -32.21 31.13 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.087 -1.008 . . . . 0.0 111.777 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 31.2 m -80.21 1.21 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.192 170.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.69 ' O ' ' HG2' ' B' ' 146' ' ' LYS . 2.1 mmt -113.73 -18.84 11.76 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.086 -1.009 . . . . 0.0 111.873 170.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -84.28 -24.01 30.1 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.307 169.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 38.5 t -84.65 -54.04 4.98 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.476 ' O ' ' HG2' ' B' ' 146' ' ' LYS . 6.1 m-85 -70.62 102.94 2.38 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 172.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.777 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 7.0 mmmt -166.82 -59.62 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 118.949 -1.1 . . . . 0.0 108.597 -163.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.777 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 0.0 OUTLIER 163.59 23.71 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.558 172.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 1.006 ' HB2' HH21 ' B' ' 150' ' ' ARG . 44.8 mt-10 -81.25 -34.64 31.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 168.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 174.35 47.63 0.05 OUTLIER Glycine 0 CA--C 1.53 0.986 0 C-N-CA 119.342 -1.409 . . . . 0.0 114.348 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' ARG . . . . . 1.006 HH21 ' HB2' ' B' ' 148' ' ' GLU . 0.5 OUTLIER -137.92 -97.26 0.19 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.175 0.987 . . . . 0.0 109.713 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 8.9 tp -60.86 -36.84 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' GLY . . . . . 0.498 ' HA3' ' HD3' ' B' ' 147' ' ' LYS . . . -80.21 -84.82 0.65 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.873 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.185 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.593 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.965 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 26.4 mmt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.965 ' HB2' ' O ' ' A' ' 1' ' ' MET . 54.6 tptt 132.29 -76.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.636 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.28 114.02 0.57 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -162.66 43.81 0.13 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.522 ' O ' ' HB3' ' B' ' 113' ' ' ARG . 6.9 p 78.0 -37.38 0.23 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -177.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -88.81 28.27 1.19 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.63 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.481 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 26.4 ttt -151.5 -47.85 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 176.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' CD ' ' H ' ' A' ' 7' ' ' MET . 22.2 Cg_exo -69.52 102.17 0.96 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.341 2.027 . . . . 0.0 111.664 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 18.0 tt0 -97.88 146.43 25.45 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.954 0.883 . . . . 0.0 110.324 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -135.92 105.67 6.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.915 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -92.36 141.65 28.31 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.04 0.924 . . . . 0.0 111.49 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 29.9 mt -119.41 -176.03 3.06 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.496 HH12 ' HA ' ' B' ' 101' ' ' MET . 90.3 mtt180 -142.12 94.03 2.61 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.283 -0.886 . . . . 0.0 109.555 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.448 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 48.2 m0 -119.55 141.58 31.17 Favored Pre-proline 0 N--CA 1.473 0.722 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.592 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -48.32 142.67 16.49 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 121.862 1.708 . . . . 0.0 111.599 173.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -59.0 -33.9 71.23 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.89 -34.64 78.61 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.687 -0.633 . . . . 0.0 112.35 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.54 -42.71 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.864 -0.522 . . . . 0.0 111.15 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.924 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 56.7 mt -65.34 -36.21 83.33 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -66.27 -29.59 69.85 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.747 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.3 tp -81.55 -31.5 32.66 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.856 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.44 -35.3 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 167.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.924 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 29.7 mmm-85 -64.99 -36.52 84.67 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.781 172.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -63.07 -55.58 24.29 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.114 -0.366 . . . . 0.0 110.814 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.1 t -55.56 -37.95 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 -33.06 74.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.77 -44.88 63.27 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.943 -0.473 . . . . 0.0 112.226 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -58.86 -51.63 69.2 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -79.31 -11.15 59.94 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.568 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.6 58.49 12.03 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.426 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 58.4 tpp -147.08 142.27 27.23 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.6 m -66.28 147.97 52.53 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.108 0.956 . . . . 0.0 111.157 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 m -64.29 -34.53 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -58.45 -52.02 67.37 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.762 -0.586 . . . . 0.0 111.453 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HA ' ' HB3' ' A' ' 38' ' ' TYR . 58.8 m -72.08 -19.28 61.84 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -71.86 -58.58 3.33 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.714 -0.616 . . . . 0.0 111.869 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.414 HD12 ' H ' ' A' ' 37' ' ' ILE . 4.3 mp -68.49 -27.85 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.9 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.41 ' HB3' ' HA ' ' A' ' 35' ' ' SER . 76.9 t80 -59.2 -35.38 73.5 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.182 169.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -77.99 -22.78 48.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.991 176.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.2 mt -81.22 -30.18 34.31 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.359 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.9 m -71.68 -28.28 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.646 169.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.433 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 11.4 mmt -82.02 -25.58 34.55 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.385 -0.822 . . . . 0.0 112.653 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -77.7 -24.54 49.22 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.335 -0.853 . . . . 0.0 111.338 170.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.9 t -80.03 -51.15 9.39 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.81 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 21.7 m-85 -69.18 99.59 1.16 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 171.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.81 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 11.0 mtpt 161.21 -41.66 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.111 -167.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 48' ' ' GLU . 2.5 tmtp? -79.89 67.17 5.6 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.934 1.35 . . . . 0.0 109.91 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 47' ' ' LYS . 12.5 tt0 161.07 -35.41 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.364 -175.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 111.43 62.42 0.48 Allowed Glycine 0 N--CA 1.467 0.709 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.09 -84.08 0.34 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 tp -61.13 -37.22 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.405 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.69 105.03 0.27 Allowed Glycine 0 N--CA 1.466 0.677 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.121 -179.846 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.914 ' O ' ' CB ' ' B' ' 102' ' ' LYS . 27.4 ttt . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.914 ' CB ' ' O ' ' B' ' 101' ' ' MET . 88.3 tttt 118.59 105.05 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.45 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.64 -65.98 0.2 Allowed Glycine 0 N--CA 1.467 0.74 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 59.8 mtt -131.32 -45.02 1.0 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 28.8 p -89.11 -106.76 0.08 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -135.05 -79.76 0.44 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' MET . . . . . 0.479 ' N ' ' HD3' ' B' ' 108' ' ' PRO . 28.1 ttt -158.8 65.6 2.93 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.079 168.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' B' ' 107' ' ' MET . 5.7 Cg_exo -95.87 92.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 121.81 1.674 . . . . 0.0 107.813 -176.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 39.8 mt-30 -82.35 133.55 35.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 122.486 1.136 . . . . 0.0 113.112 -168.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -118.25 100.43 7.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.979 -1.464 . . . . 0.0 107.436 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -86.17 138.66 31.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.919 0.866 . . . . 0.0 112.044 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.455 HD13 ' CZ2' ' B' ' 114' ' ' TRP . 38.9 mt -122.23 173.8 7.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.459 -177.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 5' ' ' SER . 98.7 mtt180 -139.7 89.91 2.36 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.413 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' TRP . . . . . 0.455 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 52.8 m0 -117.84 149.08 44.61 Favored Pre-proline 0 N--CA 1.472 0.669 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.764 -174.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.96 143.03 51.14 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 121.706 1.604 . . . . 0.0 110.756 170.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -59.07 -32.29 69.66 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.6 -40.02 92.19 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.545 -0.722 . . . . 0.0 112.227 175.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 66.5 t -66.61 -42.0 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.816 -0.552 . . . . 0.0 111.32 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.867 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 63.2 tp -67.91 -33.74 75.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -70.64 -23.03 62.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.611 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 45.9 tp -80.03 -32.27 39.56 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.916 -0.49 . . . . 0.0 111.293 172.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 91.4 t -68.87 -30.52 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.612 -0.68 . . . . 0.0 109.827 169.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ARG . . . . . 0.867 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 6.8 mmm180 -69.7 -39.49 76.88 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 122.114 -0.366 . . . . 0.0 111.161 171.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -66.54 -55.52 15.12 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.437 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 p -55.13 -40.92 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.42 83.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.83 -39.07 83.94 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -61.27 -47.97 83.54 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -75.1 -13.44 60.48 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.622 175.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.93 60.41 6.9 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.78 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 25.3 ttt -142.4 145.09 33.47 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.849 0.833 . . . . 0.0 109.153 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 89.6 p -68.62 142.11 55.21 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.776 0.798 . . . . 0.0 110.521 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 17.4 m -62.66 -37.45 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -58.1 -51.74 68.42 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.159 -0.963 . . . . 0.0 112.376 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 55.7 m -72.97 -18.69 61.34 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -72.81 -57.02 4.39 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.797 -0.564 . . . . 0.0 112.154 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' ILE . . . . . 0.449 HD12 ' H ' ' B' ' 137' ' ' ILE . 4.6 mp -68.95 -27.45 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -58.12 -37.91 75.5 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.107 0.956 . . . . 0.0 109.68 168.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -79.37 -17.01 55.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.39 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 80.9 mt -82.59 -35.87 26.7 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.949 1.249 . . . . 0.0 111.595 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 23.5 m -71.15 -14.59 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.528 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.597 ' O ' ' HG2' ' B' ' 146' ' ' LYS . 0.2 OUTLIER -101.16 -25.43 14.02 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.292 0.951 . . . . 0.0 112.719 175.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.83 -25.62 44.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.916 172.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' SER . . . . . 1.229 ' O ' ' HB3' ' B' ' 150' ' ' ARG . 75.4 m -98.19 -61.12 1.43 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 1.059 ' HA ' ' HG2' ' B' ' 150' ' ' ARG . 0.9 OUTLIER -90.78 70.2 6.58 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 123.332 1.539 . . . . 0.0 108.518 175.629 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 1.031 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 0.1 OUTLIER -90.2 -48.74 6.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.108 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 1.031 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 0.0 OUTLIER 134.26 58.09 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.659 1.218 . . . . 0.0 108.219 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -152.94 -27.7 0.15 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.74 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 144.77 69.96 0.02 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 106.434 -2.666 . . . . 0.0 106.434 -171.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' ARG . . . . . 1.229 ' HB3' ' O ' ' B' ' 144' ' ' SER . 0.0 OUTLIER -100.15 -61.06 1.42 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 122.426 1.108 . . . . 0.0 111.167 -167.38 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 4.5 tp -110.11 -53.83 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.057 -169.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.0 94.53 0.09 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.907 -179.845 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.906 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 26.2 mmt . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.906 ' HB2' ' O ' ' A' ' 1' ' ' MET . 87.9 tttt 150.7 96.55 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.116 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 139.05 82.11 0.09 OUTLIER Glycine 0 N--CA 1.468 0.778 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.123 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.9 mtt -139.32 -69.33 0.42 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.1 t -89.49 -85.23 0.21 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -133.22 -90.86 0.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.421 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 64.6 mtt -148.02 68.16 10.37 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 168.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 7' ' ' MET . 1.8 Cg_endo -101.08 82.95 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 121.556 1.504 . . . . 0.0 109.16 -173.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -91.37 151.62 20.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 122.368 1.08 . . . . 0.0 111.005 -174.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -146.69 116.84 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -97.92 119.2 36.11 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.136 -173.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.419 HD13 ' CZ2' ' A' ' 14' ' ' TRP . 44.9 mt -93.62 169.72 10.12 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.419 0.628 . . . . 0.0 109.734 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 1.145 ' HB3' ' CB ' ' B' ' 105' ' ' SER . 96.1 mtt180 -129.55 86.95 2.47 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.79 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.419 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 45.3 m0 -120.39 141.6 32.27 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.931 -172.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.27 145.09 36.71 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 121.889 1.726 . . . . 0.0 111.659 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -60.0 -34.68 73.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.93 -37.11 85.73 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.719 -0.613 . . . . 0.0 112.501 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.7 t -63.17 -41.38 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.853 -0.53 . . . . 0.0 111.125 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.909 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 76.6 mt -66.84 -32.69 74.13 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -64.84 -33.03 75.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.488 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.3 tp -77.03 -33.68 57.34 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.261 -0.575 . . . . 0.0 112.16 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.23 -35.94 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 169.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.909 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 27.2 mmm-85 -63.73 -37.02 85.79 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.812 172.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -64.1 -54.98 25.41 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.044 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.7 t -58.99 -35.87 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.49 -31.09 72.16 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -71.61 -45.96 60.61 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.89 -0.506 . . . . 0.0 112.098 173.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.32 -52.59 64.74 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -78.89 -14.36 59.27 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.513 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.82 59.64 9.83 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.264 -0.969 . . . . 0.0 111.764 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 57.7 tpp -138.16 148.13 44.56 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.069 0.938 . . . . 0.0 109.154 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.6 t -65.86 141.98 58.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.825 0.822 . . . . 0.0 110.698 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.5 m -66.44 -40.03 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -64.62 -41.8 95.93 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.279 -0.888 . . . . 0.0 112.495 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.6 m -72.35 -25.93 61.72 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 175.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -69.69 -54.5 13.57 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.825 -0.547 . . . . 0.0 111.886 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 mp -69.45 -25.25 28.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.356 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -57.34 -40.49 78.1 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.101 167.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -75.05 -20.27 59.64 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.868 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.5 mt -84.27 -33.84 23.93 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.95 1.25 . . . . 0.0 112.279 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.5 m -74.2 -13.7 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.244 170.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.696 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 28.4 mmt -99.72 -14.2 18.99 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.758 -1.214 . . . . 0.0 112.944 175.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -98.2 -18.21 18.57 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 119.871 -0.732 . . . . 0.0 112.757 172.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 1.234 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 36.2 t -100.15 -71.5 0.7 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 174.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.731 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 8.1 t80 -70.49 170.98 10.93 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 162.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.731 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -179.84 -55.13 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 O-C-N 119.521 -1.987 . . . . 0.0 109.063 177.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.471 ' HB2' ' NH2' ' A' ' 50' ' ' ARG . 73.5 mttt -119.28 -61.1 1.67 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 168.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.437 ' H ' HH21 ' A' ' 50' ' ' ARG . 8.2 pt-20 168.89 -11.68 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.243 -1.799 . . . . 0.0 110.859 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.51 37.84 3.3 Favored Glycine 0 N--CA 1.473 1.114 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.358 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 1.471 ' NH2' ' HB2' ' A' ' 47' ' ' LYS . 1.2 mpp_? -122.39 -79.21 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -173.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.6 tp -67.78 -48.35 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.417 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.92 119.07 0.54 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.601 -0.714 . . . . 0.0 109.962 179.826 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -163.95 -81.99 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.97 117.98 3.64 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 65.2 mtt -133.6 -42.54 0.84 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' SER . . . . . 1.145 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 68.5 m -141.26 -48.79 0.41 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.662 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -82.08 42.21 0.71 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.227 -0.589 . . . . 0.0 112.469 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' MET . . . . . 0.453 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 25.6 ttt -157.51 -65.24 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' B' ' 107' ' ' MET . 71.6 Cg_endo -81.27 79.54 3.23 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.568 2.179 . . . . 0.0 110.585 175.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 85.8 mt-30 -95.4 141.4 29.0 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 122.267 1.032 . . . . 0.0 110.116 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -113.11 103.99 11.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.042 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -93.67 132.59 37.86 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.802 0.811 . . . . 0.0 110.956 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.57 171.16 14.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.461 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.566 ' NH1' ' HG3' ' A' ' 2' ' ' LYS . 92.5 mtt180 -132.67 120.31 21.56 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.9 0.857 . . . . 0.0 111.518 -174.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' TRP . . . . . . . . . . . . . 49.0 m0 -126.22 147.99 61.83 Favored Pre-proline 0 N--CA 1.475 0.805 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.602 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -46.65 140.08 12.8 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 121.727 1.618 . . . . 0.0 111.182 171.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -58.43 -30.66 67.07 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -173.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.91 -42.28 97.45 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.557 -0.715 . . . . 0.0 111.7 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -64.06 -50.18 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.381 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.478 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 62.2 tp -60.31 -43.03 96.72 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 20.9 m-20 -69.13 -26.11 64.72 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.793 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 19.3 tp -77.56 -30.62 52.76 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.173 172.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 88.7 t -64.16 -32.76 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.503 -0.748 . . . . 0.0 109.768 167.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 21.3 mmt180 -66.74 -43.93 82.84 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.99 -0.444 . . . . 0.0 111.545 172.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -67.44 -52.21 42.35 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.811 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 1.8 p -57.88 -39.76 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.57 -38.04 86.05 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.62 -38.78 84.38 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.82 -45.9 90.48 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.93 -9.94 59.15 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 119.764 -0.775 . . . . 0.0 111.694 175.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 66.72 61.83 5.0 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.766 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 59.5 tpp -145.28 140.11 27.57 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.771 0.796 . . . . 0.0 109.039 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 67.9 m -68.84 140.82 55.23 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.606 0.717 . . . . 0.0 109.575 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 25.1 m -58.83 -37.52 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -173.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -61.27 -52.51 64.41 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.169 -0.957 . . . . 0.0 111.757 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 61.4 m -71.61 -18.24 62.23 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -72.47 -57.35 4.24 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.758 -0.589 . . . . 0.0 111.825 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' ILE . . . . . 0.431 HD12 ' H ' ' B' ' 137' ' ' ILE . 4.5 mp -68.59 -27.87 37.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.902 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -57.31 -37.82 73.08 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.79 169.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -79.78 -22.92 42.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.283 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.06 -37.04 39.91 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.919 1.236 . . . . 0.0 111.848 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 15.5 m -70.72 -22.14 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.836 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.536 ' O ' ' HB2' ' B' ' 146' ' ' LYS . 0.3 OUTLIER -89.51 -25.0 21.65 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.904 -1.123 . . . . 0.0 112.908 176.5 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.35 -32.36 60.83 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.712 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' SER . . . . . 0.746 ' O ' ' CB ' ' B' ' 150' ' ' ARG . 35.3 t -94.82 -64.92 1.02 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.886 ' HA ' ' CB ' ' B' ' 150' ' ' ARG . 2.7 t80 -81.56 74.67 8.55 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.855 1.312 . . . . 0.0 108.699 174.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.99 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 86.8 tttt -96.06 -38.17 10.31 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.257 -0.902 . . . . 0.0 112.035 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.99 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 4.0 tmtt? 124.02 20.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.839 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -123.87 -12.1 7.58 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 136.68 59.28 0.06 OUTLIER Glycine 0 N--CA 1.466 0.662 0 N-CA-C 106.296 -2.722 . . . . 0.0 106.296 -172.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' ARG . . . . . 0.886 ' CB ' ' HA ' ' B' ' 145' ' ' PHE . 0.0 OUTLIER -81.16 -116.85 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.523 1.154 . . . . 0.0 111.339 -169.475 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.664 HG22 ' HG3' ' B' ' 150' ' ' ARG . 6.5 tp -40.21 -44.43 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.566 -1.652 . . . . 0.0 114.868 171.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -88.29 -126.94 2.65 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.23 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.799 -178.964 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -173.59 178.92 2.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 122.092 0.949 . . . . 0.0 110.762 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.06 70.38 1.28 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.117 -1.04 . . . . 0.0 111.207 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.3 mtt -90.78 -60.67 1.85 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.6 t -85.2 -80.06 0.22 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' H ' ' HD3' ' A' ' 8' ' ' PRO . 96.3 mttt -133.93 -88.89 0.39 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 174.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 63.3 mtt -143.49 61.81 10.37 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.022 169.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HD3' ' H ' ' A' ' 6' ' ' LYS . 79.3 Cg_endo -91.2 78.63 0.51 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 121.797 1.665 . . . . 0.0 110.433 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -87.42 144.51 26.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.612 1.196 . . . . 0.0 111.165 -175.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -138.09 117.56 12.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.36 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -94.33 135.21 35.99 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.842 0.83 . . . . 0.0 110.642 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 40.0 mt -111.25 163.85 13.5 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -121.94 88.15 2.88 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.981 -173.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.418 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 49.0 m0 -122.64 146.96 49.23 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.57 -170.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.412 ' HG3' ' SD ' ' B' ' 107' ' ' MET . 41.6 Cg_exo -55.86 144.5 77.25 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 121.967 1.778 . . . . 0.0 110.871 169.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.683 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 12.3 ttp180 -58.75 -35.32 72.56 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.591 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.37 -38.29 89.61 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.07 -42.82 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.952 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.939 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 60.2 tp -64.71 -33.92 77.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.67 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 78.5 m-20 -67.8 -29.92 69.22 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.435 175.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.2 tp -77.75 -31.81 52.33 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.024 -0.423 . . . . 0.0 111.933 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.31 -30.96 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.505 -0.747 . . . . 0.0 109.428 169.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.939 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 27.9 mmm-85 -67.56 -41.95 83.41 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.046 0.451 . . . . 0.0 111.188 170.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.67 ' HG3' ' O ' ' A' ' 20' ' ' ASP . 58.5 mtpt -64.11 -55.52 21.41 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.512 HG21 ' HG3' ' B' ' 150' ' ' ARG . 2.2 p -55.42 -40.61 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.7 82.97 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.8 -38.52 83.42 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.39 -47.43 85.83 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -75.16 -11.88 60.18 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.74 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.96 60.57 6.33 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.771 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.8 ttt -147.44 148.26 31.09 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.863 0.84 . . . . 0.0 108.952 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.8 p -70.46 144.88 51.31 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.809 0.814 . . . . 0.0 110.575 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.34 -36.61 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -57.85 -53.23 60.54 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.271 -0.893 . . . . 0.0 111.548 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.5 m -72.02 -17.33 62.04 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -73.81 -55.52 6.11 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.639 -0.663 . . . . 0.0 111.979 -177.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.417 HD12 ' H ' ' A' ' 37' ' ' ILE . 4.1 mp -67.44 -28.77 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -57.52 -38.83 75.31 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.219 1.009 . . . . 0.0 109.742 168.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -76.78 -18.08 58.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.546 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.7 mt -83.46 -32.5 25.99 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.602 1.092 . . . . 0.0 111.95 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 m -74.65 -9.29 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.9 169.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.77 -18.83 13.83 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.043 0.838 . . . . 0.0 113.208 174.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -94.99 -22.72 17.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.656 173.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.877 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 32.1 t -94.88 -71.85 0.65 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 176.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.559 ' HA ' ' CG ' ' A' ' 50' ' ' ARG . 0.6 OUTLIER -71.74 140.4 49.51 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 166.082 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.026 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 26.7 ttpp -167.17 -47.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.362 -172.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.026 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 2.3 tmtt? 137.28 54.22 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.136 0.969 . . . . 0.0 108.774 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -148.53 -36.51 0.19 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.202 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.74 84.76 0.6 Allowed Glycine 0 N--CA 1.468 0.795 0 N-CA-C 104.866 -3.293 . . . . 0.0 104.866 -169.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.877 ' HB3' ' O ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -115.95 -98.74 0.44 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.536 1.16 . . . . 0.0 109.503 -162.044 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.506 ' H ' ' HB2' ' A' ' 50' ' ' ARG . 7.0 tp -46.59 -48.12 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 113.562 -1.654 . . . . 0.0 113.728 170.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.84 80.46 0.05 OUTLIER Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.602 -0.714 . . . . 0.0 109.156 -179.583 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.722 ' O ' ' HB2' ' B' ' 102' ' ' LYS . 2.0 mpt? . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.722 ' HB2' ' O ' ' B' ' 101' ' ' MET . 31.6 mmmt 85.73 -76.63 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.291 0.567 . . . . 0.0 109.92 -178.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 179.71 80.06 0.06 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 66.0 mtt -79.44 -58.41 3.22 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.178 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 35.9 t -75.67 -76.57 0.15 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 173.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -140.78 -44.89 0.39 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 169.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' MET . . . . . 0.412 ' SD ' ' HG3' ' A' ' 15' ' ' PRO . 67.4 mtt -106.85 159.26 30.54 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 168.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.683 ' HG2' ' HB2' ' A' ' 16' ' ' ARG . 76.3 Cg_exo -48.07 129.46 18.49 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.64 2.227 . . . . 0.0 116.18 -176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 24.9 mt-30 -80.54 164.25 23.1 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.582 1.182 . . . . 0.0 111.125 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -137.55 111.51 8.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -103.04 130.41 50.15 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.687 0.756 . . . . 0.0 111.065 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.98 177.88 7.54 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.282 175.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -135.54 121.03 19.29 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.32 -0.862 . . . . 0.0 111.813 -174.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -126.58 141.67 40.86 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.809 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -45.26 139.76 8.65 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 121.907 1.738 . . . . 0.0 111.859 173.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -25.2 63.85 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -173.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -65.04 -44.79 87.94 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.386 -0.821 . . . . 0.0 111.017 173.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 81.4 t -66.14 -49.29 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.688 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.488 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 63.9 tp -62.11 -43.82 98.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 71.5 m-20 -70.2 -24.84 63.18 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.881 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 25.2 tp -77.04 -32.04 56.66 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.009 170.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.83 -34.31 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 O-C-N 121.494 -0.753 . . . . 0.0 109.848 167.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 21.7 mmt180 -65.2 -39.22 92.54 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.119 -0.363 . . . . 0.0 111.791 171.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -66.32 -49.0 68.48 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.987 -0.446 . . . . 0.0 111.615 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 89.0 t -56.17 -39.05 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.17 74.91 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.65 -42.12 74.68 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 174.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.99 -49.41 77.56 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -75.23 -12.1 60.21 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 119.699 -0.801 . . . . 0.0 111.589 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 63.65 57.27 15.11 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.436 -0.887 . . . . 0.0 112.186 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 15.2 tpt -147.46 148.53 31.34 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 90.2 p -65.34 149.6 49.71 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 122.169 0.985 . . . . 0.0 111.647 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.55 -37.73 79.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.62 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -60.46 -45.15 94.76 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.521 -0.737 . . . . 0.0 112.271 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 59.6 m -71.11 -26.83 63.2 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -66.68 -60.46 2.68 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.652 -0.655 . . . . 0.0 112.103 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.59 -27.4 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.126 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -58.63 -37.23 75.47 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.957 169.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -77.3 -18.12 57.79 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.481 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 65.2 mt -81.86 -29.01 32.69 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.765 1.166 . . . . 0.0 112.666 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.43 -28.92 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.709 169.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.7 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 0.9 OUTLIER -75.65 -28.27 58.7 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.627 -0.671 . . . . 0.0 112.23 172.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -72.03 -26.15 62.08 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.143 -0.973 . . . . 0.0 111.581 170.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 58.7 m -76.91 -56.63 4.42 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.578 ' HD1' ' HB3' ' B' ' 150' ' ' ARG . 15.0 m-85 -64.55 103.08 0.62 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 175.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.7 ' HG3' ' O ' ' B' ' 142' ' ' MET . 2.1 mtpt 173.09 -58.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 117.08 -1.848 . . . . 0.0 112.702 -160.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 1.246 ' HB3' ' NH2' ' B' ' 150' ' ' ARG . 4.4 tmtp? -73.66 1.99 9.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.093 175.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 66.97 13.26 9.4 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -92.05 17.37 57.1 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 119.088 -1.529 . . . . 0.0 111.311 169.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' ARG . . . . . 1.246 ' NH2' ' HB3' ' B' ' 147' ' ' LYS . 0.7 OUTLIER -128.31 -81.27 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -168.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 7.6 tp -63.67 -46.87 93.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.823 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -112.31 -137.47 7.05 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.917 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.692 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' A' ' 6' ' ' LYS . 97.8 mttt -105.05 115.6 30.55 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.04 -77.4 1.35 Allowed Glycine 0 N--CA 1.467 0.757 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.1 mtt -85.86 -58.39 2.67 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.7 t -113.61 -102.48 0.41 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 96.8 mttt -120.7 -88.64 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.436 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 63.0 mtt -146.17 62.91 8.54 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.923 168.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 7' ' ' MET . 13.3 Cg_exo -77.91 99.1 1.25 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 CA-C-N 122.114 1.791 . . . . 0.0 107.953 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 14.5 tt0 -89.66 142.92 27.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 122.409 1.1 . . . . 0.0 112.331 -168.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -131.85 101.72 5.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.043 -175.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -88.15 121.11 30.17 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.877 0.846 . . . . 0.0 110.879 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 30.3 mt -101.42 169.84 8.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 176.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.84 ' HB3' ' O ' ' B' ' 105' ' ' SER . 93.5 mtt180 -129.95 90.8 3.02 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.903 -176.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.44 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 49.1 m0 -119.48 146.77 41.96 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.948 -173.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.59 145.34 48.33 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 121.802 1.668 . . . . 0.0 111.122 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -59.63 -33.41 71.47 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.99 -34.04 75.77 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.627 -0.671 . . . . 0.0 112.332 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.3 t -63.99 -40.5 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.828 -0.545 . . . . 0.0 110.945 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.899 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 69.1 mt -66.2 -33.99 77.01 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -65.56 -29.23 69.82 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.638 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tt -80.24 -33.49 37.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.382 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.66 -33.48 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 168.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.899 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 28.7 mmm-85 -67.93 -40.49 83.32 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.36 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.14 -57.47 7.57 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.085 -0.384 . . . . 0.0 111.372 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.2 p -53.97 -39.66 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.73 -37.06 85.95 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.15 -40.69 82.33 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.98 -49.56 77.18 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -78.32 -12.35 60.0 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.598 175.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.7 61.88 5.52 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.051 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.5 ttt -143.56 146.44 33.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.77 0.795 . . . . 0.0 109.033 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.5 p -70.66 143.69 51.32 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.824 0.821 . . . . 0.0 110.648 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -65.05 -37.14 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -61.84 -47.17 86.26 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.358 -0.839 . . . . 0.0 112.572 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.7 m -73.87 -18.6 60.9 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -73.23 -55.58 6.25 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.805 -0.559 . . . . 0.0 111.961 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -69.76 -27.13 32.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -58.26 -38.67 77.37 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.052 0.929 . . . . 0.0 109.5 168.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -77.83 -16.48 58.28 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.405 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.4 mt -80.83 -37.56 29.81 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.837 1.199 . . . . 0.0 111.566 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.4 m -73.67 -9.52 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.145 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -107.64 -15.81 14.5 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.12 -19.69 17.06 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.483 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.976 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 34.6 t -96.51 -70.3 0.72 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.634 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.6 OUTLIER -73.71 141.79 46.37 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 166.307 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.115 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 37.2 ttpt -167.9 -47.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 120.962 -1.086 . . . . 0.0 111.228 -172.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.115 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 2.3 tmtt? 135.85 54.48 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.048 0.928 . . . . 0.0 108.535 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -149.97 -35.72 0.16 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.463 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.0 84.76 0.59 Allowed Glycine 0 N--CA 1.468 0.789 0 N-CA-C 104.996 -3.241 . . . . 0.0 104.996 -169.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.976 ' HB3' ' O ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -115.58 -97.46 0.45 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.63 1.205 . . . . 0.0 109.765 -161.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.463 ' H ' ' HB2' ' A' ' 50' ' ' ARG . 6.8 tp -46.51 -49.12 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 113.376 -1.738 . . . . 0.0 113.992 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 170.79 94.09 0.09 OUTLIER Glycine 0 CA--C 1.524 0.645 0 C-N-CA 119.859 -1.163 . . . . 0.0 110.216 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.736 179.795 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.905 ' O ' ' CB ' ' B' ' 102' ' ' LYS . 66.4 mtt . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.905 ' CB ' ' O ' ' B' ' 101' ' ' MET . 88.5 tttt 119.83 98.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.229 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.88 101.29 1.22 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 67.0 mtt -145.1 108.52 4.62 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.84 ' O ' ' HB3' ' A' ' 13' ' ' ARG . 43.9 m 78.49 -63.35 0.3 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.364 -175.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' LYS . . . . . 0.419 ' HG3' ' HG2' ' B' ' 107' ' ' MET . 63.2 pttt -61.94 -39.51 92.34 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -176.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' MET . . . . . 0.453 ' HB2' ' HD3' ' B' ' 108' ' ' PRO . 26.4 mmt -95.69 -45.9 0.26 Allowed Pre-proline 0 N--CA 1.474 0.735 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' B' ' 107' ' ' MET . 33.9 Cg_exo -65.46 98.6 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.594 2.196 . . . . 0.0 112.6 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 78.9 mt-30 -99.86 160.5 14.26 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 122.468 1.127 . . . . 0.0 111.565 -176.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -131.13 101.77 5.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -90.52 120.96 32.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.245 -170.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 37.6 mt -111.68 175.17 5.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.825 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -142.14 96.58 2.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.65 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' TRP . . . . . 0.423 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 51.0 m0 -120.62 143.74 37.02 Favored Pre-proline 0 N--CA 1.474 0.76 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.028 -174.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -49.19 139.81 26.65 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 121.778 1.652 . . . . 0.0 111.396 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.02 -29.56 67.35 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.24 -43.54 91.08 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.626 -0.672 . . . . 0.0 111.623 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.14 -47.93 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.598 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.459 ' O ' ' HG3' ' B' ' 123' ' ' ARG . 59.1 tp -61.27 -46.08 91.81 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -69.4 -24.07 63.8 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 25.5 tp -74.89 -32.06 61.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.531 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.44 -28.88 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.64 -0.662 . . . . 0.0 110.41 167.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' B' ' 119' ' ' LEU . 94.3 mtt180 -74.04 -34.97 64.27 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.919 -0.488 . . . . 0.0 111.99 172.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -63.27 -52.85 60.38 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.046 -0.409 . . . . 0.0 110.629 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 97.9 t -55.88 -38.65 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.32 -34.79 77.3 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.34 -40.41 70.74 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.62 -47.63 84.55 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -75.99 -8.58 57.28 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.745 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.51 59.5 8.2 Favored Glycine 0 N--CA 1.47 0.935 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.951 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 24.7 ttt -151.74 149.09 28.67 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 89.7 p -70.18 151.27 45.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.975 0.893 . . . . 0.0 111.032 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 16.1 m -64.0 -36.98 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -58.75 -52.04 67.39 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.778 -0.576 . . . . 0.0 111.551 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 57.8 m -71.11 -21.52 62.2 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -70.49 -60.16 2.42 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.716 -0.615 . . . . 0.0 111.832 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' ILE . . . . . 0.439 HD12 ' H ' ' B' ' 137' ' ' ILE . 4.4 mp -69.31 -26.71 32.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.953 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -59.85 -35.85 75.64 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.046 169.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -77.87 -20.47 52.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.831 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 84.3 mt -79.8 -35.08 39.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.566 1.076 . . . . 0.0 112.167 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 32.9 m -70.06 -24.29 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.375 170.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 32.1 mmt -86.21 -27.87 24.22 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.502 -0.749 . . . . 0.0 112.383 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.92 -28.85 63.76 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.093 170.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 63.8 m -79.68 -47.82 14.73 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.43 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.654 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 14.0 m-30 -78.21 94.23 4.73 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.654 ' HG3' ' O ' ' B' ' 145' ' ' PHE . 1.4 mtpt 157.89 -20.99 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.163 -1.015 . . . . 0.0 113.255 -167.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.804 ' HB3' ' NH2' ' B' ' 150' ' ' ARG . 8.1 tmtt? -56.55 -29.68 62.24 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.973 0.892 . . . . 0.0 112.046 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.37 -26.23 4.3 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.142 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 113.58 62.37 0.42 Allowed Glycine 0 N--CA 1.467 0.724 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 -172.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' ARG . . . . . 0.804 ' NH2' ' HB3' ' B' ' 147' ' ' LYS . 0.1 OUTLIER -87.28 -80.24 0.26 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.827 0.823 . . . . 0.0 109.081 -176.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 8.2 tp -58.09 -45.41 88.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.203 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 165.91 86.95 0.06 OUTLIER Glycine 0 CA--C 1.524 0.638 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.452 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.145 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -140.66 92.51 2.52 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 175.54 84.15 0.06 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.873 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.483 ' HB2' ' H ' ' A' ' 9' ' ' GLN . 66.9 mtt -134.08 -69.58 0.53 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.7 t -95.95 -111.9 0.13 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.617 ' HG3' ' H ' ' A' ' 7' ' ' MET . 19.3 ptpt -107.35 -55.17 2.38 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 166.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.617 ' H ' ' HG3' ' A' ' 6' ' ' LYS . 65.9 mtt -95.78 146.02 30.57 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 166.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 1.023 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 35.1 Cg_exo -41.5 123.18 2.05 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.14 2.56 . . . . 0.0 116.538 -176.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.483 ' H ' ' HB2' ' A' ' 4' ' ' MET . 25.4 tt0 -79.0 148.68 32.45 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.717 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -133.72 110.73 10.03 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -174.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -89.98 141.9 28.22 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.052 0.929 . . . . 0.0 112.011 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 56.4 mt -123.63 168.11 13.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.785 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -130.61 84.8 2.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.477 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.432 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 43.8 m0 -120.0 143.36 35.21 Favored Pre-proline 0 N--CA 1.474 0.749 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.643 -171.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.72 147.83 48.08 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.005 1.803 . . . . 0.0 111.428 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.666 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 12.6 ttp180 -59.83 -38.78 83.02 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.16 -35.14 79.32 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.8 t -65.61 -38.62 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.627 -0.671 . . . . 0.0 111.274 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.413 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 74.2 mt -62.49 -46.09 90.05 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.059 172.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -51.57 -29.94 19.07 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.0 tp -81.3 -36.45 29.81 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.92 -34.34 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 121.774 -0.579 . . . . 0.0 110.946 173.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 46.5 mtm180 -68.84 -39.81 79.74 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.088 -0.382 . . . . 0.0 110.422 170.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -61.05 -57.72 11.39 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.56 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 p -57.49 -38.86 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.83 85.01 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.14 -36.95 82.97 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -62.45 -45.31 93.66 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -75.41 -11.82 60.12 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.622 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.8 62.09 4.79 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.008 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.6 ttt -146.9 144.64 29.41 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.845 0.831 . . . . 0.0 109.412 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.8 t -70.4 143.44 51.87 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.709 0.766 . . . . 0.0 110.187 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.0 m -61.47 -39.87 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 114.995 1.479 . . . . 0.0 114.995 -173.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -59.88 -49.1 79.02 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.915 -1.116 . . . . 0.0 112.385 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.9 m -73.63 -17.12 61.2 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -73.67 -57.1 4.22 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.723 -0.61 . . . . 0.0 111.912 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 37' ' ' ILE . 4.6 mp -67.15 -29.27 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -57.31 -38.93 74.78 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.827 0.823 . . . . 0.0 109.821 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -78.68 -19.24 52.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.456 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.4 mt -78.45 -40.3 36.06 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.748 1.158 . . . . 0.0 111.375 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.94 -11.3 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.765 174.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.554 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 26.0 mmt -105.62 -13.72 15.5 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.116 -0.99 . . . . 0.0 112.923 176.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -93.87 -26.31 16.96 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.959 171.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 1.001 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 36.9 t -94.18 -70.15 0.72 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.916 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 3.5 t80 -74.14 156.4 37.4 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 167.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.052 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER 167.28 -51.55 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 120.717 -1.239 . . . . 0.0 110.06 -177.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.052 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 2.2 tmtt? 134.51 59.19 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -151.55 -43.74 0.11 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.786 -169.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.31 65.85 0.02 OUTLIER Glycine 0 N--CA 1.467 0.712 0 N-CA-C 106.669 -2.572 . . . . 0.0 106.669 -171.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 1.001 ' HB3' ' O ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -108.31 -122.46 0.25 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.532 1.158 . . . . 0.0 109.834 -167.759 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.4 tp -46.28 -45.34 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 113.629 -1.623 . . . . 0.0 113.922 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 177.41 91.51 0.08 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.191 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.899 -179.915 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.33 -138.99 0.24 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.694 0.759 . . . . 0.0 110.275 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.49 80.92 1.33 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.129 -1.034 . . . . 0.0 110.61 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 66.5 mtt -91.12 -62.53 1.43 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.992 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 32.2 t -85.72 -102.61 0.06 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' LYS . . . . . 0.438 ' HG3' ' H ' ' B' ' 107' ' ' MET . 51.6 pttt -118.47 -54.77 2.26 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 168.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' MET . . . . . 0.438 ' H ' ' HG3' ' B' ' 106' ' ' LYS . 23.8 mmt -93.32 152.34 41.03 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 165.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.666 ' HG2' ' HB2' ' A' ' 16' ' ' ARG . 66.9 Cg_exo -45.95 127.76 10.71 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.787 2.325 . . . . 0.0 115.964 -176.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 28.3 tt0 -81.23 153.36 27.2 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.257 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -139.74 108.33 5.89 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -95.32 131.69 41.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.224 -173.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.446 HD13 ' CZ2' ' B' ' 114' ' ' TRP . 61.9 mt -111.7 175.36 5.46 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.68 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -133.34 86.52 2.3 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.792 0.806 . . . . 0.0 109.468 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' TRP . . . . . 0.446 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 47.1 m0 -117.41 143.87 32.9 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.497 -172.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.38 142.75 68.53 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 121.923 1.749 . . . . 0.0 111.022 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 1.023 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . 6.6 ttp180 -60.32 -31.76 70.59 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.803 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.31 -40.3 93.59 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.592 -0.693 . . . . 0.0 112.125 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 64.5 t -66.37 -44.64 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.025 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.88 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 59.9 tp -67.22 -32.95 74.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 18.6 m-20 -69.95 -28.65 65.73 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.357 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 16.7 tp -78.13 -31.33 49.8 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.604 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 72.0 t -64.03 -34.14 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 167.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ARG . . . . . 0.88 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 28.0 mmm-85 -64.94 -37.26 87.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 171.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.38 -55.64 22.79 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.044 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 92.0 t -54.55 -39.29 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.38 -34.21 76.26 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.29 -41.54 69.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 175.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -60.39 -49.67 76.65 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -76.94 -12.72 59.99 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.631 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 63.72 58.79 9.97 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.006 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 26.1 ttt -146.46 148.15 31.96 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 91.9 p -67.78 147.3 52.78 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.039 0.923 . . . . 0.0 111.084 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 16.2 m -64.86 -36.44 77.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -61.02 -47.65 85.43 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.403 -0.811 . . . . 0.0 112.113 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 57.3 m -71.64 -21.56 61.81 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -70.89 -58.96 3.08 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.847 -0.533 . . . . 0.0 112.089 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' ILE . . . . . 0.426 HD12 ' H ' ' B' ' 137' ' ' ILE . 4.5 mp -69.24 -26.62 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 176.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -59.12 -36.59 75.46 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.779 0.8 . . . . 0.0 109.886 169.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -78.55 -20.64 50.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.988 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.65 -30.09 32.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.435 1.016 . . . . 0.0 112.422 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 31.3 m -72.41 -28.64 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.448 169.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.511 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 0.9 OUTLIER -78.1 -30.5 49.54 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.903 0.774 . . . . 0.0 112.313 175.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -73.1 -28.65 62.4 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.418 -0.801 . . . . 0.0 111.354 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 70.0 m -75.63 -37.79 59.45 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.677 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.626 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 23.5 m-85 -81.06 79.3 7.76 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.626 ' HG3' ' O ' ' B' ' 145' ' ' PHE . 10.7 mtpt 177.8 -30.38 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.39 -168.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -84.79 35.94 0.59 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 118.961 -1.095 . . . . 0.0 112.418 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -155.69 -17.05 0.11 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.216 174.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.65 65.68 1.95 Allowed Glycine 0 N--CA 1.468 0.791 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -170.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' ARG . . . . . 0.46 ' HB2' ' H ' ' B' ' 151' ' ' ILE . 43.8 mtt180 -101.51 -82.22 0.47 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.573 1.178 . . . . 0.0 109.285 -168.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.46 ' H ' ' HB2' ' B' ' 150' ' ' ARG . 7.7 tp -59.54 -39.89 80.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 113.577 -1.647 . . . . 0.0 113.183 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -85.67 -96.56 0.76 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.225 -0.988 . . . . 0.0 110.875 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.404 -179.597 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -174.8 125.32 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.351 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.09 -55.84 0.03 OUTLIER Glycine 0 CA--C 1.526 0.767 0 C-N-CA 119.943 -1.122 . . . . 0.0 110.947 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.7 mtt -140.06 -59.69 0.54 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.652 ' HB2' ' CB ' ' B' ' 113' ' ' ARG . 79.1 p -160.23 90.35 0.89 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 122.117 0.96 . . . . 0.0 109.371 174.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -129.43 -24.33 2.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.431 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.552 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 26.8 ttt -156.77 -43.66 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.552 ' CD ' ' H ' ' A' ' 7' ' ' MET . 52.1 Cg_exo -63.02 99.81 0.23 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.508 2.139 . . . . 0.0 113.404 -176.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 18.2 tt0 -102.58 155.99 17.91 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.492 -175.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -136.46 107.4 6.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -94.61 124.96 38.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.25 -169.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 46.5 mt -115.38 169.9 8.8 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.795 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -142.52 102.16 4.02 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.281 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.464 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 54.5 m0 -122.29 143.47 39.39 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.215 -173.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.17 139.43 11.97 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 121.916 1.744 . . . . 0.0 111.544 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -57.93 -31.26 66.64 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -173.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.15 -43.11 96.2 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.582 -0.699 . . . . 0.0 111.896 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.06 -49.83 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.122 0.487 . . . . 0.0 111.409 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.973 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 63.1 tp -63.36 -35.87 81.81 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.8 -28.62 63.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.31 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.4 tp -79.24 -31.27 43.5 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.878 173.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.46 -35.63 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 O-C-N 121.462 -0.774 . . . . 0.0 109.017 168.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.973 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 29.3 mmm-85 -64.06 -39.07 93.27 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 171.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -64.11 -53.95 41.53 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.191 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.2 t -56.32 -36.87 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.94 -35.78 81.23 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.52 -0.738 . . . . 0.0 112.931 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -71.57 -40.91 69.62 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -61.92 -47.35 85.3 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -74.19 -12.94 60.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.612 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.32 57.49 13.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.036 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 53.7 tpp -147.51 148.14 30.89 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.983 0.897 . . . . 0.0 108.703 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.7 m -65.71 149.84 49.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 122.31 1.053 . . . . 0.0 111.555 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -63.75 -36.44 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -59.08 -53.98 52.26 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.856 -0.528 . . . . 0.0 111.698 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.8 m -70.45 -22.49 62.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -69.43 -59.6 2.88 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.796 -0.565 . . . . 0.0 112.128 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.1 mp -70.83 -27.0 28.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.728 -0.389 . . . . 0.0 109.981 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -56.52 -37.81 70.97 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.612 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -79.21 -24.56 43.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.591 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 47.5 mt -79.23 -37.75 37.29 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 118.669 -1.213 . . . . 0.0 112.213 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 m -69.09 -28.65 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.583 172.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -85.41 -26.34 26.46 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.356 -0.84 . . . . 0.0 113.261 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -75.86 -35.48 59.9 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.867 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.1 t -87.72 -68.01 0.79 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.882 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -73.11 114.02 10.8 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 176.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.031 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 39.7 ttpt -169.26 -46.71 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.062 0.934 . . . . 0.0 110.047 -169.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.031 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 2.3 tmtt? 143.66 53.47 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -155.93 -35.61 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.244 -173.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.88 -60.77 0.04 OUTLIER Glycine 0 N--CA 1.465 0.57 0 N-CA-C 108.171 -1.971 . . . . 0.0 108.171 -172.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.882 ' HG2' ' HA ' ' A' ' 45' ' ' PHE . 89.6 mtt180 73.57 -86.57 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 168.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.623 HG22 ' HB3' ' A' ' 50' ' ' ARG . 2.4 tp -146.84 -54.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 112.872 -1.967 . . . . 0.0 110.005 -159.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.51 -92.44 1.17 Allowed Glycine 0 N--CA 1.467 0.735 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.622 179.433 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -89.46 167.75 12.74 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 122.126 0.965 . . . . 0.0 111.059 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -167.06 -78.48 0.04 OUTLIER Glycine 0 N--CA 1.466 0.666 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.203 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 66.1 mtt -82.46 -59.08 2.65 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.944 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 40.9 t -96.05 -84.76 0.34 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' LYS . . . . . 0.495 ' H ' ' HD3' ' B' ' 108' ' ' PRO . 60.4 pttt 178.48 54.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' MET . . . . . 0.557 ' O ' ' SD ' ' B' ' 107' ' ' MET . 0.0 OUTLIER 54.21 63.54 7.4 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -173.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.495 ' HD3' ' H ' ' B' ' 106' ' ' LYS . 41.1 Cg_endo -98.76 76.06 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 121.703 1.602 . . . . 0.0 110.084 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 14.6 tt0 -84.67 146.46 27.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.193 0.997 . . . . 0.0 111.389 -173.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -133.31 109.5 9.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -95.38 118.84 32.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.203 -169.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.451 HD13 ' CZ2' ' B' ' 114' ' ' TRP . 56.8 mt -107.33 169.5 8.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.628 0.728 . . . . 0.0 109.892 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.652 ' CB ' ' HB2' ' A' ' 5' ' ' SER . 95.4 mtt180 -139.62 94.92 2.84 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.766 0.793 . . . . 0.0 109.045 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' TRP . . . . . 0.451 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 50.6 m0 -116.28 149.4 43.51 Favored Pre-proline 0 N--CA 1.474 0.737 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.945 -173.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.52 142.04 40.33 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 121.799 1.666 . . . . 0.0 110.978 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -59.1 -35.81 74.06 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.79 -38.03 89.62 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.725 -0.609 . . . . 0.0 112.385 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 78.2 t -63.46 -38.73 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.346 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.43 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 57.6 mt -62.2 -45.61 92.59 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 119.971 -0.692 . . . . 0.0 112.834 173.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -57.63 -31.45 66.28 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 24.8 tp -76.54 -35.54 58.2 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.611 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 79.6 t -63.2 -32.72 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.855 -0.528 . . . . 0.0 110.501 168.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 10.9 mmt180 -68.32 -36.83 79.89 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.99 -0.443 . . . . 0.0 110.724 172.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -64.19 -55.84 18.91 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.037 -0.415 . . . . 0.0 110.714 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.38 -37.48 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.65 -32.31 73.76 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.49 -42.85 64.41 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 174.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.16 -50.54 73.66 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -78.56 -13.47 59.81 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.448 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.02 58.88 11.45 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.104 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 21.7 ttt -138.49 144.51 40.05 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.896 0.855 . . . . 0.0 109.065 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 66.3 m -68.44 155.33 40.08 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.129 0.966 . . . . 0.0 111.068 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 17.5 m -63.38 -39.43 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -62.33 -50.65 70.79 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.548 -0.72 . . . . 0.0 112.4 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 59.9 m -71.52 -29.55 64.91 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -66.34 -58.71 4.72 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.77 -0.581 . . . . 0.0 112.257 -177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 3.6 mp -70.43 -23.35 24.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.417 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -57.97 -40.27 80.19 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.052 167.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -73.25 -22.2 60.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.679 -0.809 . . . . 0.0 112.591 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 68.0 mt -83.66 -32.11 25.8 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.831 1.196 . . . . 0.0 112.685 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 17.4 m -75.0 -12.01 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.482 169.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.816 ' O ' ' HG2' ' B' ' 146' ' ' LYS . 27.2 mmt -99.63 -18.17 17.44 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.269 -0.894 . . . . 0.0 112.791 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -89.39 -24.5 21.92 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.301 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' SER . . . . . 1.121 ' O ' ' HB3' ' B' ' 150' ' ' ARG . 66.1 m -95.82 -72.31 0.64 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.782 ' O ' ' HB2' ' B' ' 146' ' ' LYS . 2.3 t80 -71.8 158.72 35.57 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 165.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.816 ' HG2' ' O ' ' B' ' 142' ' ' MET . 0.0 OUTLIER 170.87 -51.31 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 120.207 -1.558 . . . . 0.0 109.843 -175.257 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.703 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 21.5 mmmt 128.78 64.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -176.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -151.47 -25.34 0.2 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.129 -175.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 108.39 79.39 1.15 Allowed Glycine 0 N--CA 1.469 0.883 0 N-CA-C 105.108 -3.197 . . . . 0.0 105.108 -169.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' ARG . . . . . 1.121 ' HB3' ' O ' ' B' ' 144' ' ' SER . 0.0 OUTLIER -110.41 -99.8 0.4 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 122.546 1.165 . . . . 0.0 109.915 -162.261 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 6.6 tp -47.59 -49.26 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 113.448 -1.705 . . . . 0.0 113.799 172.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.31 82.23 0.05 OUTLIER Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.79 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.802 ' NZ ' HH22 ' B' ' 123' ' ' ARG . 99.6 mttt -97.82 -140.37 0.3 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.636 0.732 . . . . 0.0 110.222 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 147.41 96.16 0.17 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.6 mtt -122.07 -65.46 1.12 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.5 t -83.47 -81.61 0.16 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -136.74 -63.8 0.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 170.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.8 mtt -87.31 155.88 54.3 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 165.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.892 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 64.2 Cg_exo -47.19 127.11 12.47 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.522 2.148 . . . . 0.0 116.065 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 28.6 tt0 -82.34 154.6 25.19 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.096 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -135.76 107.8 7.17 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -173.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -98.79 130.3 45.23 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.783 -171.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.456 HD13 ' CZ2' ' A' ' 14' ' ' TRP . 31.6 mt -115.28 174.46 5.98 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.623 0.725 . . . . 0.0 110.584 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.611 ' HB3' ' HA ' ' B' ' 106' ' ' LYS . 96.6 mtt180 -138.89 94.23 2.8 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.481 0.658 . . . . 0.0 109.422 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.456 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 53.6 m0 -119.98 150.02 50.07 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.741 -175.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.18 143.47 63.43 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 121.733 1.622 . . . . 0.0 110.931 170.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.27 -30.56 66.69 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.93 -39.23 79.74 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.52 -0.737 . . . . 0.0 111.995 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.2 t -67.26 -42.7 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.16 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.936 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 60.0 tp -66.65 -35.78 80.99 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -71.9 -21.52 61.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.774 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.1 tp -80.15 -34.54 37.6 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.859 -0.526 . . . . 0.0 111.257 171.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.52 -32.95 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.528 -0.733 . . . . 0.0 109.403 170.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.936 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 27.4 mmm-85 -65.84 -38.64 89.42 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.773 0.321 . . . . 0.0 111.57 170.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -62.87 -56.76 14.42 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 122.252 -0.28 . . . . 0.0 111.031 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG21 ' CE1' ' B' ' 145' ' ' PHE . 98.9 t -56.68 -36.84 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.21 -33.38 75.36 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.84 -41.58 64.65 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -60.83 -49.19 78.47 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -77.63 -6.68 54.64 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.194 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.65 59.77 8.77 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.491 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.5 ttt -146.97 147.25 30.54 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.4 m -68.47 145.29 54.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.027 0.918 . . . . 0.0 110.514 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.7 m -61.81 -36.63 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -57.59 -52.48 65.22 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.431 -0.793 . . . . 0.0 111.582 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.2 m -72.14 -19.76 61.72 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -73.03 -57.44 4.03 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.636 -0.665 . . . . 0.0 111.982 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.464 HD12 ' H ' ' A' ' 37' ' ' ILE . 4.5 mp -69.66 -26.64 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -58.11 -39.46 78.7 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.038 0.923 . . . . 0.0 109.538 168.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -73.68 -20.69 60.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.981 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.55 -34.0 41.39 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.043 -1.036 . . . . 0.0 111.673 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 m -78.47 2.23 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.48 170.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.71 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 1.9 mmt -113.88 -19.62 11.4 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.159 -0.963 . . . . 0.0 111.806 169.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -84.87 -22.92 29.19 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.884 171.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.2 m -87.59 -48.21 8.08 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -72.93 95.62 2.0 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.718 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 8.4 mmmt -156.64 19.05 0.33 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 118.621 -1.232 . . . . 0.0 113.832 -165.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.718 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 5.4 tmtt? 91.45 -12.83 0.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 1.314 ' HB2' ' NH2' ' A' ' 50' ' ' ARG . 2.2 mp0 -58.53 -37.13 75.0 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.63 -0.669 . . . . 0.0 110.267 169.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.23 36.65 0.05 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 119.615 -1.278 . . . . 0.0 114.089 172.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 1.314 ' NH2' ' HB2' ' A' ' 48' ' ' GLU . 0.2 OUTLIER -121.36 -93.04 0.53 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.038 0.919 . . . . 0.0 109.096 -176.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.8 tp -62.98 -40.17 87.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.5 -157.96 34.17 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.226 -0.987 . . . . 0.0 111.324 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.848 179.727 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -167.97 114.37 0.7 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.89 99.29 1.57 Allowed Glycine 0 N--CA 1.466 0.653 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 26.3 mmt -131.26 -42.98 1.06 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 75.0 m -154.48 -46.16 0.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.864 0.364 . . . . 0.0 110.087 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' LYS . . . . . 0.611 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 98.1 mttt -66.2 -35.67 81.07 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -176.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' MET . . . . . 0.473 ' HB2' ' HD3' ' B' ' 108' ' ' PRO . 64.4 mtt -72.63 -49.29 8.49 Favored Pre-proline 0 N--CA 1.472 0.651 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.473 ' HD3' ' HB2' ' B' ' 107' ' ' MET . 23.4 Cg_exo -67.47 98.08 0.46 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.381 2.054 . . . . 0.0 111.214 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 19.3 tt0 -99.1 147.97 24.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.936 0.874 . . . . 0.0 110.218 -174.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -133.58 108.91 8.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.756 -173.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -90.87 140.11 30.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.044 0.926 . . . . 0.0 111.956 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 55.7 mt -125.14 164.65 19.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.683 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -127.31 87.88 2.71 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.78 0.8 . . . . 0.0 109.563 -173.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' TRP . . . . . 0.439 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 47.5 m0 -120.0 146.07 41.29 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.972 -170.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.99 142.96 75.19 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 121.924 1.75 . . . . 0.0 110.922 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.892 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . 7.6 ttp180 -60.21 -32.0 70.69 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.639 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.04 -38.96 89.71 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.619 -0.676 . . . . 0.0 112.304 175.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 95.4 t -66.98 -42.64 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.789 -0.569 . . . . 0.0 111.184 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' B' ' 123' ' ' ARG . 57.5 tp -65.89 -39.93 91.09 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 176.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -66.57 -22.0 66.14 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.33 -34.62 65.77 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.235 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.37 -28.61 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.738 -0.601 . . . . 0.0 110.723 168.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ARG . . . . . 0.802 HH22 ' NZ ' ' A' ' 2' ' ' LYS . 94.4 mtt180 -74.92 -34.99 62.21 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.849 -0.532 . . . . 0.0 111.762 173.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -63.32 -54.04 43.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.447 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.431 HG21 ' HG3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -60.39 -37.58 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.592 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.43 -30.4 71.53 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.67 -47.19 55.89 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.863 -0.523 . . . . 0.0 111.907 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -56.61 -52.97 62.82 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 -80.24 -13.97 58.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.566 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.54 60.29 8.44 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.946 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 25.8 ttt -137.13 144.17 42.87 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.938 0.875 . . . . 0.0 109.239 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 66.7 m -70.76 141.44 51.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.863 0.84 . . . . 0.0 110.37 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 19.3 m -64.82 -35.59 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -59.55 -52.56 65.02 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.328 -0.858 . . . . 0.0 111.623 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 61.5 m -70.57 -18.41 62.91 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -73.16 -56.19 5.45 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.635 -0.665 . . . . 0.0 112.239 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' ILE . . . . . 0.411 HD12 ' H ' ' B' ' 137' ' ' ILE . 4.4 mp -69.8 -26.37 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -57.76 -36.44 72.12 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.849 0.833 . . . . 0.0 109.853 168.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -78.99 -21.82 46.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.135 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 82.9 mt -78.89 -29.55 44.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.892 1.223 . . . . 0.0 112.344 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 29.6 m -73.57 -29.07 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.994 171.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.93 -23.61 33.41 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.378 -0.826 . . . . 0.0 112.632 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.67 -29.71 56.48 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.21 -0.931 . . . . 0.0 110.947 170.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 36.4 t -75.11 -44.7 45.71 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.147 -0.345 . . . . 0.0 110.392 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.662 ' HD1' ' CB ' ' B' ' 150' ' ' ARG . 9.9 m-30 -79.14 102.09 8.28 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.894 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 0.0 OUTLIER -174.7 -56.58 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 118.185 -1.406 . . . . 0.0 110.9 -159.646 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.894 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 2.3 tmtp? 158.02 61.37 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -148.35 -48.66 0.16 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.284 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' GLY . . . . . 0.637 ' H ' ' HG3' ' B' ' 150' ' ' ARG . . . 163.19 89.45 0.07 OUTLIER Glycine 0 N--CA 1.467 0.738 0 N-CA-C 106.675 -2.57 . . . . 0.0 106.675 -174.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' ARG . . . . . 0.662 ' CB ' ' HD1' ' B' ' 145' ' ' PHE . 0.1 OUTLIER -159.27 -129.68 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.298 -164.014 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.424 ' H ' ' HB2' ' B' ' 150' ' ' ARG . 0.0 OUTLIER -47.76 -43.56 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.84 72.54 0.1 Allowed Glycine 0 N--CA 1.467 0.736 0 C-N-CA 119.374 -1.393 . . . . 0.0 111.526 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.589 -0.719 . . . . 0.0 109.862 179.93 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.894 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 66.5 mtt . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.894 ' CB ' ' O ' ' A' ' 1' ' ' MET . 63.3 tttp 120.6 105.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.241 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.67 -76.99 0.02 OUTLIER Glycine 0 N--CA 1.465 0.621 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.314 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.7 mtt -99.24 -67.87 0.83 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.662 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.1 t -92.31 -91.32 0.17 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -127.51 -64.37 0.99 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 169.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.1 mtt -86.01 148.91 49.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 165.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.936 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 52.2 Cg_exo -44.72 127.31 7.93 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.773 2.315 . . . . 0.0 116.437 -175.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 28.2 tt0 -81.41 155.58 25.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.596 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -139.72 109.52 6.34 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -174.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -95.84 133.39 40.05 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.307 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.452 HD13 ' CZ2' ' A' ' 14' ' ' TRP . 51.8 mt -114.69 174.69 5.84 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.661 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -133.2 87.68 2.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.853 0.835 . . . . 0.0 109.441 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.452 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 47.5 m0 -117.49 142.95 31.22 Favored Pre-proline 0 N--CA 1.473 0.714 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.341 -172.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.14 142.02 67.75 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 121.831 1.687 . . . . 0.0 111.045 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.986 ' HB3' ' HG2' ' B' ' 108' ' ' PRO . 0.3 OUTLIER -59.18 -29.75 67.69 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.734 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -67.56 -40.21 84.92 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.58 -0.7 . . . . 0.0 111.822 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.64 -45.3 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.953 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.867 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 54.8 tp -67.1 -34.72 78.24 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 68.0 m-20 -71.88 -25.47 61.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.589 176.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.8 tp -80.0 -30.7 39.69 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.346 172.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.0 t -64.77 -32.99 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 166.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.867 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 32.2 mmm-85 -64.9 -38.37 90.74 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.838 0.351 . . . . 0.0 111.821 171.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -63.59 -53.25 54.55 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.176 -0.327 . . . . 0.0 110.885 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.407 HG13 HG21 ' B' ' 151' ' ' ILE . 71.0 t -55.84 -40.56 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 176.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.4 -31.92 71.85 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -72.2 -41.73 66.62 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 174.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.96 -49.65 76.6 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -76.3 -8.75 57.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.137 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.65 56.68 21.64 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.864 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.5 tpt -150.83 148.03 27.98 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.4 t -65.12 147.87 52.7 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.123 0.964 . . . . 0.0 111.459 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.1 m -63.6 -34.88 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -58.8 -50.51 73.68 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.649 -0.657 . . . . 0.0 111.483 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -72.57 -19.63 61.46 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -71.98 -58.36 3.51 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.66 -0.65 . . . . 0.0 111.82 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.84 -29.84 46.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -57.63 -37.06 72.68 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.018 170.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -74.28 -27.83 60.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.739 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.7 mt -76.32 -26.45 55.8 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 119.015 -1.074 . . . . 0.0 112.301 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.5 t -84.16 -3.52 7.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.659 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.741 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 1.8 mmt -114.23 -12.93 12.4 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.05 -1.031 . . . . 0.0 111.674 168.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -86.2 -27.17 24.68 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.529 171.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.0 t -83.55 -51.18 7.54 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.45 97.28 2.05 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.94 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 7.4 mmmt -160.72 -57.19 0.05 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.183 -1.007 . . . . 0.0 108.994 -164.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.94 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 157.9 22.85 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.6 173.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 1.236 ' HB2' ' NH2' ' A' ' 50' ' ' ARG . 42.4 mt-10 -83.19 -34.2 25.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 169.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.4 34.16 0.05 OUTLIER Glycine 0 CA--C 1.531 1.086 0 C-N-CA 119.707 -1.235 . . . . 0.0 114.263 174.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 1.236 ' NH2' ' HB2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -118.51 -91.56 0.55 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.137 0.969 . . . . 0.0 108.945 -177.36 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.77 -42.41 96.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA3' ' HD3' ' A' ' 47' ' ' LYS . . . -96.02 -137.18 9.14 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.97 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.151 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.991 ' O ' ' HB2' ' B' ' 102' ' ' LYS . 66.0 mtt . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.991 ' HB2' ' O ' ' B' ' 101' ' ' MET . 88.2 tttt 149.9 -79.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.893 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.54 89.43 2.11 Favored Glycine 0 N--CA 1.467 0.704 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.405 ' HB2' ' H ' ' B' ' 109' ' ' GLN . 67.1 mtt -91.27 -55.69 3.43 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.382 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 29.5 t -91.09 -109.01 0.09 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -110.56 -65.37 1.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 168.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' MET . . . . . . . . . . . . . 67.5 mtt -83.12 136.93 43.23 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 164.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.986 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 34.8 Cg_exo -41.46 124.85 2.53 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 123.044 2.496 . . . . 0.0 116.849 -174.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 25.8 tt0 -77.52 149.07 34.97 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.887 -177.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -133.47 110.65 10.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.631 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -90.42 141.93 28.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.047 0.927 . . . . 0.0 111.881 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.469 HD13 ' CZ2' ' B' ' 114' ' ' TRP . 50.5 mt -123.91 165.73 16.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.002 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -129.36 88.67 2.73 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.86 0.838 . . . . 0.0 109.575 -173.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 114' ' ' TRP . . . . . 0.469 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 48.9 m0 -121.58 147.48 47.96 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.91 -171.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.95 143.94 70.19 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 121.914 1.742 . . . . 0.0 111.083 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.936 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . 9.9 ttp180 -59.9 -33.34 71.72 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.44 -38.77 90.86 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.602 -0.686 . . . . 0.0 112.32 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.59 -42.1 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.82 -0.55 . . . . 0.0 111.069 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.835 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 57.5 tp -68.4 -33.21 73.82 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 176.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -69.36 -24.52 63.9 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.949 -0.469 . . . . 0.0 111.624 175.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 48.2 tp -78.44 -33.76 48.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.218 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.23 -35.08 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 121.633 -0.667 . . . . 0.0 109.738 169.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 123' ' ' ARG . . . . . 0.835 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 7.0 mmm180 -66.75 -37.48 84.71 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.732 0.301 . . . . 0.0 111.555 172.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -65.3 -56.5 12.36 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.15 -0.344 . . . . 0.0 111.136 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -57.69 -38.5 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.511 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.67 80.57 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.74 -42.51 77.45 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -59.64 -50.19 74.82 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -78.41 -12.73 60.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.588 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 63.93 62.28 5.37 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.85 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 59.7 tpp -139.59 144.34 37.71 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.933 0.873 . . . . 0.0 108.94 -176.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 66.4 m -70.84 140.53 51.18 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.893 0.854 . . . . 0.0 110.468 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 17.6 m -65.19 -35.72 76.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -59.34 -52.79 64.12 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.345 -0.847 . . . . 0.0 111.722 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 60.9 m -71.47 -17.77 62.34 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -72.57 -56.62 5.07 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.645 -0.659 . . . . 0.0 112.077 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' ILE . . . . . 0.421 HD12 ' H ' ' B' ' 137' ' ' ILE . 4.4 mp -69.94 -26.77 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -58.02 -37.37 74.19 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.106 0.955 . . . . 0.0 109.601 168.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -79.85 -16.27 55.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.416 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 87.0 mt -81.88 -35.72 28.96 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.066 1.303 . . . . 0.0 111.881 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.11 -19.84 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.438 170.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 142' ' ' MET . . . . . 0.499 ' O ' ' HB2' ' B' ' 146' ' ' LYS . 0.5 OUTLIER -95.78 -26.34 15.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.146 0.885 . . . . 0.0 112.979 177.056 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.94 -31.16 56.42 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.262 -0.899 . . . . 0.0 111.719 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 74.9 m -90.17 -63.3 1.3 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.912 ' HA ' ' CB ' ' B' ' 150' ' ' ARG . 0.3 OUTLIER -88.29 80.62 7.48 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.789 1.28 . . . . 0.0 108.266 176.469 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 1.104 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 36.9 ttpt -107.58 -42.62 4.72 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.537 -173.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 1.104 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 0.0 OUTLIER 126.84 55.79 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 122.809 1.29 . . . . 0.0 108.699 -176.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -156.32 -23.16 0.1 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.916 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 145.09 58.85 0.02 OUTLIER Glycine 0 N--CA 1.465 0.58 0 N-CA-C 106.102 -2.799 . . . . 0.0 106.102 -169.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' ARG . . . . . 0.912 ' CB ' ' HA ' ' B' ' 145' ' ' PHE . 0.0 OUTLIER -81.64 -117.95 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.8 -1.2 . . . . 0.0 110.365 -169.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.627 HG22 ' CG ' ' B' ' 150' ' ' ARG . 4.7 tp -43.91 -48.23 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 113.597 -1.638 . . . . 0.0 113.656 169.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.79 88.34 0.07 OUTLIER Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.258 -179.391 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.901 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 66.1 mtt . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.901 ' CB ' ' O ' ' A' ' 1' ' ' MET . 55.1 tptt 117.47 109.32 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.169 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.55 104.11 0.17 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.4 mtt -131.6 -42.8 1.03 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . 1.099 ' CB ' ' HB3' ' B' ' 113' ' ' ARG . 68.9 m -137.63 -42.77 0.54 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.742 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -82.77 39.36 0.62 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.463 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 26.0 ttt -154.61 -65.82 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 7' ' ' MET . 71.4 Cg_endo -80.73 77.01 4.22 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.412 2.075 . . . . 0.0 111.092 176.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 42.3 mt-30 -93.9 142.17 27.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.924 0.869 . . . . 0.0 109.323 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -116.79 98.82 6.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.052 -173.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -85.21 138.4 32.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.034 0.921 . . . . 0.0 111.731 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.461 HD13 ' CZ2' ' A' ' 14' ' ' TRP . 28.8 mt -123.99 173.6 8.14 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.786 -174.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.829 ' HB3' ' HB3' ' B' ' 105' ' ' SER . 88.9 mtt180 -138.06 93.04 2.72 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.624 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.461 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 52.5 m0 -119.65 139.41 27.91 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.937 -173.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.02 139.79 19.87 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.109 1.873 . . . . 0.0 111.528 171.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -26.09 61.23 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -174.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.22 -44.18 80.18 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.348 -0.845 . . . . 0.0 111.546 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.86 -44.47 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.541 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.775 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 64.4 tp -67.4 -35.63 79.68 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -74.92 -18.16 60.45 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.931 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.7 tt -82.7 -31.06 28.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.288 169.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.6 t -65.1 -34.4 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.939 -1.101 . . . . 0.0 109.348 168.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.775 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 28.0 mmm-85 -68.31 -39.28 82.06 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.167 -0.333 . . . . 0.0 111.472 171.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.04 -57.47 7.67 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.126 -0.359 . . . . 0.0 111.56 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 p -52.68 -39.97 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.07 -36.24 83.35 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.45 -41.16 76.63 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -58.82 -50.25 74.68 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -79.44 -12.69 59.89 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.545 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.84 62.43 5.51 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.644 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -145.46 135.51 23.76 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -174.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.0 p -62.54 142.84 57.78 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.961 0.886 . . . . 0.0 112.772 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.6 m -67.98 -37.3 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -58.76 -50.98 71.91 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.367 -0.833 . . . . 0.0 111.634 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' A' ' 38' ' ' TYR . 62.2 m -70.99 -21.27 62.32 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -70.75 -58.48 3.59 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.487 -0.758 . . . . 0.0 112.318 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.465 HD12 ' H ' ' A' ' 37' ' ' ILE . 4.4 mp -67.6 -27.46 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.816 176.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.408 ' HB3' ' HA ' ' A' ' 35' ' ' SER . 42.7 t80 -57.21 -38.1 73.21 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.865 168.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -76.95 -18.11 58.46 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.767 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.4 mt -82.02 -33.26 30.13 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.787 1.176 . . . . 0.0 112.439 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.36 -25.62 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.044 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.43 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 1.3 mmt -77.69 -33.57 53.16 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.73 -0.606 . . . . 0.0 111.946 174.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.66 -28.55 64.88 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.392 -0.818 . . . . 0.0 111.363 172.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 66.7 m -76.35 -37.21 57.63 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.918 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.67 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 22.3 m-85 -81.65 78.95 8.33 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 172.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.67 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 14.5 mtpt 179.2 -23.56 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.374 -0.93 . . . . 0.0 113.127 -168.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 2.0 tmtt? -83.25 37.88 0.58 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 118.808 -1.157 . . . . 0.0 111.631 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -164.15 -23.2 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.633 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.07 69.6 1.38 Allowed Glycine 0 N--CA 1.468 0.777 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 -170.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -102.0 -70.33 0.75 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.558 1.171 . . . . 0.0 110.064 -168.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.451 ' H ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -72.07 -50.2 38.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.839 178.056 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 170.99 87.55 0.07 OUTLIER Glycine 0 N--CA 1.466 0.649 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.145 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.791 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.957 ' O ' ' HB2' ' B' ' 102' ' ' LYS . 15.9 tpt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.957 ' HB2' ' O ' ' B' ' 101' ' ' MET . 88.6 tttt 135.93 94.05 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.283 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.9 93.5 0.09 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 67.0 mtt -128.35 -53.06 1.28 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 105' ' ' SER . . . . . 0.829 ' HB3' ' HB3' ' A' ' 13' ' ' ARG . 73.0 m -119.38 -48.51 2.41 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.591 177.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -54.29 -40.7 68.12 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' MET . . . . . 0.488 ' HB2' ' HD3' ' B' ' 108' ' ' PRO . 26.3 mmt -91.12 -48.18 0.35 Allowed Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 118.438 -0.792 . . . . 0.0 113.018 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' B' ' 107' ' ' MET . 32.7 Cg_exo -70.94 84.44 0.84 Allowed 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.441 2.094 . . . . 0.0 112.709 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 17.7 tt0 -102.23 149.78 23.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.957 0.884 . . . . 0.0 110.0 -176.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -140.59 102.04 4.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.815 -173.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -92.14 141.63 28.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.06 0.933 . . . . 0.0 111.313 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.456 HD13 ' CZ2' ' B' ' 114' ' ' TRP . 30.0 mt -114.24 179.96 3.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.556 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 1.099 ' HB3' ' CB ' ' A' ' 5' ' ' SER . 95.5 mtt180 -135.2 88.99 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.645 -177.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' TRP . . . . . 0.456 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 51.2 m0 -121.76 136.8 26.42 Favored Pre-proline 0 N--CA 1.473 0.704 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.098 -172.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.19 145.06 36.11 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 121.952 1.768 . . . . 0.0 111.382 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.83 -28.95 64.56 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -175.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.16 -41.77 85.43 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.462 -0.774 . . . . 0.0 111.925 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.22 -43.65 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.496 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' B' ' 123' ' ' ARG . 64.4 tp -62.81 -43.47 98.71 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 120' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' B' ' 124' ' ' LYS . 76.1 m-20 -69.17 -21.19 64.0 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 50.1 tp -75.29 -31.69 60.77 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.731 -0.606 . . . . 0.0 110.305 168.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.97 -27.15 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.668 -0.645 . . . . 0.0 110.702 168.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' B' ' 119' ' ' LEU . 89.6 mtt180 -77.44 -35.84 53.58 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.748 -0.595 . . . . 0.0 111.322 171.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' B' ' 120' ' ' ASP . 69.8 mmtt -63.06 -54.13 42.87 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.264 -0.273 . . . . 0.0 110.92 176.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.6 -39.13 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.84 -33.11 74.55 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.02 -40.92 71.47 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.85 -49.54 77.31 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -76.55 -14.74 59.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.457 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.3 59.14 9.9 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.949 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 57.7 tpp -142.29 151.45 42.02 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.96 0.886 . . . . 0.0 108.962 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 63.8 m -62.97 136.46 57.85 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.815 0.817 . . . . 0.0 110.811 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 4.3 p -70.43 -37.87 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.001 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -62.87 -41.88 99.55 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.434 -0.791 . . . . 0.0 112.335 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 54.4 m -72.52 -19.34 61.54 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -72.36 -54.92 8.04 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.832 -0.543 . . . . 0.0 112.051 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 137' ' ' ILE . . . . . 0.44 HD12 ' H ' ' B' ' 137' ' ' ILE . 4.2 mp -68.86 -28.83 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 175.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -57.92 -35.81 71.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.203 169.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -77.75 -22.18 50.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.123 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 72.3 mt -78.83 -35.39 44.11 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.593 1.088 . . . . 0.0 112.27 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.99 -27.88 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.966 170.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 1.6 mmt -81.02 -28.04 35.6 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.492 -0.755 . . . . 0.0 112.447 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.28 -29.91 61.86 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 119.626 -0.829 . . . . 0.0 111.169 171.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 66.9 m -75.01 -40.9 60.36 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.678 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.787 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 19.3 m-30 -79.92 86.59 5.42 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 173.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.787 ' HG3' ' O ' ' B' ' 145' ' ' PHE . 13.4 mtpt 164.94 -35.43 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.581 -165.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' B' ' 147' ' ' LYS . 0.2 OUTLIER -79.45 62.45 3.78 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.773 1.273 . . . . 0.0 109.741 177.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' B' ' 147' ' ' LYS . 21.7 tt0 165.81 -38.06 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.684 -173.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.93 70.8 1.21 Allowed Glycine 0 N--CA 1.467 0.733 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 -171.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 150' ' ' ARG . . . . . 0.48 ' HB2' ' H ' ' B' ' 151' ' ' ILE . 47.1 mtt180 -104.33 -83.74 0.49 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.388 1.089 . . . . 0.0 108.925 -169.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.48 ' H ' ' HB2' ' B' ' 150' ' ' ARG . 7.3 tp -57.93 -39.0 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 113.878 -1.51 . . . . 0.0 113.208 173.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -154.92 101.98 0.21 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.148 -179.686 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.937 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 26.4 mmt . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.937 ' HB2' ' O ' ' A' ' 1' ' ' MET . 65.5 tttm 153.41 109.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.358 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -160.67 -70.78 0.02 OUTLIER Glycine 0 N--CA 1.466 0.655 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.378 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.415 ' HB2' ' H ' ' A' ' 9' ' ' GLN . 67.8 mtt -109.91 -61.37 1.66 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.89 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -90.17 -122.22 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.59 ' HG3' ' H ' ' A' ' 7' ' ' MET . 42.6 pttt -99.41 -57.23 2.2 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.59 ' H ' ' HG3' ' A' ' 6' ' ' LYS . 1.8 mpt? -93.52 139.09 22.76 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 165.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.719 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 46.9 Cg_exo -41.25 125.18 2.44 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.067 2.512 . . . . 0.0 116.561 -174.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 23.8 tt0 -77.57 153.71 33.06 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.683 -176.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -138.65 109.43 6.67 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -174.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -96.6 130.28 43.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.766 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.446 HD13 ' CZ2' ' A' ' 14' ' ' TRP . 38.5 mt -113.81 169.86 8.69 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.634 0.731 . . . . 0.0 110.056 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -130.38 91.26 3.07 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.695 0.76 . . . . 0.0 109.284 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.446 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 49.2 m0 -125.79 151.36 70.88 Favored Pre-proline 0 N--CA 1.475 0.79 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.509 -170.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.45 150.49 67.85 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.038 1.825 . . . . 0.0 111.819 168.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.699 ' HB3' ' HG2' ' B' ' 108' ' ' PRO . 4.0 ptm180 -59.06 -40.33 84.81 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -64.07 -31.32 72.47 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 177.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.74 -53.21 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.206 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.13 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 3.1 pp -81.2 -1.62 45.48 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -79.95 -28.09 39.71 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.786 -1.196 . . . . 0.0 110.0 167.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' B' ' 150' ' ' ARG . 50.6 tp -77.74 -35.09 52.2 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.841 -0.537 . . . . 0.0 111.908 174.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 19' ' ' LEU . 1.4 p -67.18 -30.59 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.337 -0.852 . . . . 0.0 110.247 169.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 1.13 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 5.9 mmm180 -66.05 -41.01 91.39 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.281 170.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -65.91 -57.36 8.04 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.133 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.83 -39.54 71.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.04 -35.79 82.28 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.15 -37.69 84.23 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 175.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.65 -46.8 88.22 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -76.89 -13.76 59.95 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.557 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.27 62.13 5.15 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.231 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.4 ttt -141.94 145.77 34.9 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.999 0.904 . . . . 0.0 109.653 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.8 m -69.98 142.6 52.81 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.756 0.789 . . . . 0.0 110.303 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -62.43 -39.12 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -58.26 -51.81 68.2 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.063 -1.023 . . . . 0.0 112.709 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 64.5 m -72.16 -22.97 61.22 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 175.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -71.38 -55.38 8.09 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.512 -0.743 . . . . 0.0 112.537 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mp -67.3 -26.66 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -56.72 -39.35 73.74 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.583 168.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -76.62 -20.4 56.77 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.2 mt -82.99 -35.26 26.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.282 1.401 . . . . 0.0 112.265 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 m -70.1 -26.95 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.871 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -87.79 -25.53 23.31 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -83.19 -25.86 31.39 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.13 174.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.8 t -92.85 -70.52 0.69 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.946 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -70.44 135.54 48.78 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 171.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.083 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 40.1 ttpt 177.56 -50.64 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.118 0.961 . . . . 0.0 109.929 -171.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.083 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 2.6 tmtp? 142.46 54.73 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -153.52 -36.74 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.457 -170.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 50' ' ' ARG . . . -176.64 -58.1 0.06 OUTLIER Glycine 0 N--CA 1.464 0.559 0 N-CA-C 107.582 -2.207 . . . . 0.0 107.582 -173.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.946 ' HG2' ' HA ' ' A' ' 45' ' ' PHE . 96.3 mtt180 72.52 -87.73 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 168.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.678 HG22 ' HB3' ' A' ' 50' ' ' ARG . 2.9 tp -145.48 -51.86 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 112.726 -2.034 . . . . 0.0 110.777 -159.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.7 100.04 0.16 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.527 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.802 179.045 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.907 ' O ' ' CB ' ' B' ' 102' ' ' LYS . 67.0 mtt . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.907 ' CB ' ' O ' ' B' ' 101' ' ' MET . 87.9 tttt 113.65 -76.32 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.047 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 158.5 84.83 0.05 OUTLIER Glycine 0 N--CA 1.466 0.684 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 66.9 mtt -92.75 -62.27 1.42 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.525 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 29.0 m -64.88 -55.66 18.05 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.083 0.944 . . . . 0.0 110.786 174.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -173.55 -49.95 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' MET . . . . . . . . . . . . . 67.7 mtt -106.81 156.17 37.74 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 167.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.699 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 41.5 Cg_exo -41.64 122.18 1.84 Allowed 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.969 2.446 . . . . 0.0 116.461 -177.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -81.86 152.72 26.73 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.043 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -136.75 110.68 8.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.522 0.677 . . . . 0.0 109.699 -172.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -92.73 140.59 29.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.96 0.886 . . . . 0.0 111.806 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.453 HD13 ' CZ2' ' B' ' 114' ' ' TRP . 58.6 mt -124.0 172.79 8.7 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.918 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -132.95 88.79 2.54 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.815 0.817 . . . . 0.0 109.342 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 114' ' ' TRP . . . . . 0.453 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 48.4 m0 -118.22 141.8 30.11 Favored Pre-proline 0 N--CA 1.472 0.652 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.579 -172.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.52 143.88 65.46 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 121.899 1.732 . . . . 0.0 111.022 171.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.719 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . 7.8 ttp180 -58.7 -32.04 68.8 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.1 -40.85 95.13 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.542 -0.724 . . . . 0.0 112.27 176.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.63 -46.02 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.802 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.967 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 56.0 tp -65.13 -32.07 73.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -69.08 -32.46 71.92 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.179 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 42.6 tp -76.31 -32.01 58.5 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.682 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 79.8 t -64.99 -36.14 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.565 -0.709 . . . . 0.0 109.166 169.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' ARG . . . . . 0.967 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 24.6 mmm-85 -64.97 -38.93 92.58 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.817 172.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -62.5 -51.38 67.65 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.232 -0.292 . . . . 0.0 111.775 177.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 99.5 t -59.31 -38.55 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 120.404 -0.518 . . . . 0.0 112.163 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.36 72.39 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.68 -40.28 66.4 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.27 -49.45 77.58 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -78.44 -10.91 59.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.856 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.37 59.2 11.08 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.702 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 131' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' B' ' 132' ' ' SER . 0.0 OUTLIER -145.65 147.71 32.29 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -176.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.464 ' N ' ' SD ' ' B' ' 131' ' ' MET . 56.2 m -61.04 150.78 32.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.441 1.115 . . . . 0.0 112.317 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 17.7 m -67.81 -37.79 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -175.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -60.74 -47.84 84.47 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.477 -0.765 . . . . 0.0 112.559 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 64.6 m -70.72 -26.58 63.46 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -65.83 -59.78 3.53 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.755 -0.591 . . . . 0.0 112.293 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.88 -24.16 26.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.375 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -58.64 -38.31 77.83 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.411 168.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -76.63 -19.55 57.68 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.675 -0.81 . . . . 0.0 112.684 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 71.1 mt -82.81 -32.25 27.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.798 1.181 . . . . 0.0 112.536 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.84 -28.08 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 119.521 -0.871 . . . . 0.0 109.913 169.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 142' ' ' MET . . . . . 1.028 ' O ' ' HG2' ' B' ' 146' ' ' LYS . 9.1 mmt -78.99 -33.33 45.12 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.612 -0.68 . . . . 0.0 112.131 174.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 143' ' ' GLU . . . . . 0.488 ' HA ' ' HG3' ' B' ' 146' ' ' LYS . 38.1 mt-10 -72.3 -22.9 61.13 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.294 -0.879 . . . . 0.0 112.152 174.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 68.5 m -85.21 -39.81 17.38 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.118 -0.364 . . . . 0.0 110.69 173.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 0.665 ' O ' ' HB2' ' B' ' 146' ' ' LYS . 12.4 m-30 -72.2 -99.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 172.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 1.028 ' HG2' ' O ' ' B' ' 142' ' ' MET . 3.0 mmmt 81.63 -134.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.484 -0.887 . . . . 0.0 109.584 166.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -109.8 45.87 1.06 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 122.889 1.328 . . . . 0.0 109.853 170.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 1.423 ' HB2' ' NH2' ' B' ' 150' ' ' ARG . 37.5 mm-40 -86.23 -29.69 22.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.825 167.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 148.0 40.22 0.04 OUTLIER Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.286 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' ARG . . . . . 1.423 ' NH2' ' HB2' ' B' ' 148' ' ' GLU . 0.1 OUTLIER -126.84 -93.46 0.47 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.572 0.701 . . . . 0.0 110.488 -172.171 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 10.6 tp -67.54 -39.34 82.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -172.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.8 -80.7 1.19 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.905 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.464 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.921 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 28.0 ttt . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.921 ' HB2' ' O ' ' A' ' 1' ' ' MET . 88.5 tttt 139.29 103.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.125 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.57 42.08 6.24 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.905 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.6 mtt -144.12 -55.51 0.36 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.582 ' HB3' ' HB3' ' B' ' 113' ' ' ARG . 61.9 m -146.39 40.36 1.11 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.42 0.629 . . . . 0.0 110.109 172.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 38.1 ttpt -76.66 -31.78 57.53 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.587 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 61.1 mtt -142.07 -42.53 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -177.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.587 ' CD ' ' H ' ' A' ' 7' ' ' MET . 70.1 Cg_exo -60.83 98.89 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.48 2.12 . . . . 0.0 114.622 -174.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -108.04 156.63 19.04 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.801 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -146.26 120.98 9.85 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -91.52 128.89 37.52 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.755 0.788 . . . . 0.0 110.785 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 28.7 mt -102.47 165.49 11.07 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.603 ' HD3' ' HA ' ' B' ' 106' ' ' LYS . 94.6 mtt180 -133.98 94.74 3.31 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.824 -175.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.41 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 53.3 m0 -124.06 149.3 59.85 Favored Pre-proline 0 N--CA 1.474 0.736 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.142 -173.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.7 144.38 65.24 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 121.815 1.677 . . . . 0.0 111.181 170.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.58 -29.39 66.38 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.5 -40.83 80.72 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.52 -0.738 . . . . 0.0 111.798 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.06 -47.29 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.942 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 64.6 tp -59.79 -43.72 94.3 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -69.7 -24.24 63.55 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 120.097 -0.641 . . . . 0.0 112.076 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.6 tp -76.42 -33.58 58.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.035 170.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.38 -33.67 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.59 -0.694 . . . . 0.0 109.934 169.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 21.9 mmt180 -66.41 -36.71 83.51 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.143 -0.348 . . . . 0.0 111.659 171.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -63.61 -56.28 17.05 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.026 -0.421 . . . . 0.0 110.769 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.5 t -56.32 -37.33 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.81 -34.97 79.11 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.54 -40.24 70.17 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 175.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.27 -48.39 81.63 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -76.46 -12.35 60.03 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.56 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.89 60.38 8.17 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.676 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.3 tpt -141.43 149.1 40.57 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 122.056 0.931 . . . . 0.0 108.879 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.4 t -64.38 141.77 58.65 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 122.104 0.954 . . . . 0.0 110.811 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -63.22 -37.9 80.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -63.08 -47.98 80.58 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.551 -0.718 . . . . 0.0 111.957 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.8 m -70.43 -26.03 63.48 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -67.19 -58.01 5.65 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.663 -0.648 . . . . 0.0 112.146 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -69.84 -25.44 28.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.249 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -57.05 -39.04 74.1 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.474 168.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -76.91 -22.73 52.94 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.732 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.5 mt -81.13 -36.05 30.79 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.056 1.298 . . . . 0.0 112.615 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.4 m -67.95 -30.31 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.139 169.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.69 ' CE ' ' HA ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -82.23 -16.97 47.69 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.018 -1.051 . . . . 0.0 113.707 178.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.17 -28.07 21.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.389 173.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 1.04 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 33.1 t -93.6 -72.4 0.61 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.97 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 5.6 t80 -66.53 164.76 15.89 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 165.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.001 ' O ' ' CB ' ' A' ' 47' ' ' LYS . 25.5 ttpt 161.17 52.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 119.752 -1.843 . . . . 0.0 111.439 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.479 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 45.3 tptt 117.92 -16.74 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 117.769 -1.573 . . . . 0.0 110.536 -168.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 49.6 mt-10 79.76 7.87 1.69 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -105.28 36.82 4.15 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 169.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 1.479 ' NH2' ' HB3' ' A' ' 47' ' ' LYS . 1.3 mpp_? -127.36 -84.21 0.6 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -169.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.0 tp -63.26 -35.52 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.285 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.07 96.46 0.16 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.031 179.966 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -165.6 123.98 1.6 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.02 122.67 0.63 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 66.9 mtt -126.83 -38.01 2.08 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 61.7 m -157.91 -51.08 0.07 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 106' ' ' LYS . . . . . 0.603 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 98.3 mttt -65.71 -40.96 92.77 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' MET . . . . . 0.431 ' HB2' ' HD3' ' B' ' 108' ' ' PRO . 61.6 mtt -73.09 -48.18 7.77 Favored Pre-proline 0 N--CA 1.473 0.679 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -177.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' B' ' 107' ' ' MET . 31.3 Cg_exo -66.71 94.73 0.33 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.346 2.031 . . . . 0.0 111.503 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 79.9 mt-30 -100.17 160.87 13.99 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.648 1.213 . . . . 0.0 111.355 -176.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -137.5 101.49 4.51 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -90.64 125.39 35.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.53 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.83 176.55 7.95 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.741 176.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 5' ' ' SER . 99.8 mtt180 -131.91 113.57 13.61 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.504 0.669 . . . . 0.0 110.9 -171.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -123.53 154.65 66.37 Favored Pre-proline 0 N--CA 1.474 0.737 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.623 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.58 144.33 52.68 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 121.676 1.584 . . . . 0.0 110.443 170.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -59.99 -30.09 68.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.923 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.15 -40.4 94.3 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.577 -0.702 . . . . 0.0 112.003 174.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 82.3 t -66.51 -43.85 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.862 -0.524 . . . . 0.0 111.608 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 1.012 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 65.4 tp -67.85 -37.13 81.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.0 -20.91 60.18 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.778 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 25.8 tp -85.46 -32.26 22.38 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.927 -0.483 . . . . 0.0 111.795 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' B' ' 119' ' ' LEU . 28.1 m -69.91 -25.99 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.07 167.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 123' ' ' ARG . . . . . 1.012 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 27.6 mmm-85 -67.35 -42.68 83.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.983 170.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -65.27 -52.37 54.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.894 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.57 -40.33 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.75 -35.81 80.99 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.01 -38.78 86.59 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -61.36 -47.65 84.88 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.232 0.539 . . . . 0.0 112.454 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -75.72 -11.91 60.09 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.734 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 65.35 61.83 5.38 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.856 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 57.4 tpp -141.94 144.1 33.58 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.945 0.879 . . . . 0.0 109.104 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 64.3 m -69.02 142.01 54.71 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.876 0.846 . . . . 0.0 110.183 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 18.2 m -64.88 -37.51 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -60.6 -48.85 79.96 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.286 -0.884 . . . . 0.0 112.377 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 60.9 m -71.21 -23.66 62.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 175.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -70.58 -55.06 9.71 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.648 -0.658 . . . . 0.0 112.208 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.03 -26.31 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.107 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -56.33 -39.8 73.4 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.502 168.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -74.81 -24.2 58.6 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.882 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 60.7 mt -82.34 -34.13 28.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.071 1.305 . . . . 0.0 112.537 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 20.8 m -70.32 -26.67 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.832 171.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -86.22 -29.6 23.03 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.397 -0.815 . . . . 0.0 112.907 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.04 -27.95 48.89 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.195 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 37.2 t -91.84 -72.13 0.6 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 145' ' ' PHE . . . . . 1.156 ' HA ' ' CB ' ' B' ' 150' ' ' ARG . 0.1 OUTLIER -68.58 112.77 5.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.727 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 1.109 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 37.8 ttpt -154.07 -43.17 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.838 0.828 . . . . 0.0 111.143 -171.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 1.109 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 0.0 OUTLIER 132.35 53.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.877 1.322 . . . . 0.0 108.736 178.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -156.09 -21.18 0.1 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.891 -177.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 145.17 57.44 0.02 OUTLIER Glycine 0 N--CA 1.466 0.644 0 N-CA-C 106.132 -2.787 . . . . 0.0 106.132 -169.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 150' ' ' ARG . . . . . 1.156 ' CB ' ' HA ' ' B' ' 145' ' ' PHE . 0.0 OUTLIER -76.16 -40.78 51.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -170.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 151' ' ' ILE . . . . . 0.793 HG22 ' HG2' ' B' ' 150' ' ' ARG . 3.4 tp -156.63 -49.11 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -168.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.88 97.7 0.13 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.886 -179.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.715 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 15.5 tpt . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.715 ' HB3' ' O ' ' A' ' 1' ' ' MET . 40.4 ttmt 84.22 112.26 0.06 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.19 0.519 . . . . 0.0 109.957 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 94.3 95.26 1.6 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.194 -1.003 . . . . 0.0 110.915 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.5 mtt -135.8 -52.75 0.75 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.4 m -146.51 -56.04 0.27 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.057 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 1.004 ' HA ' ' HB3' ' B' ' 113' ' ' ARG . 98.6 mttt -85.85 56.72 4.1 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.472 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 44.8 mtt -137.26 -60.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 171.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 7' ' ' MET . 31.5 Cg_exo -61.11 103.96 0.26 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.511 2.141 . . . . 0.0 111.493 170.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 82.6 mt-30 -94.7 143.66 26.26 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.656 1.217 . . . . 0.0 111.573 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -116.25 96.95 5.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.727 -1.579 . . . . 0.0 106.945 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -99.24 131.92 44.92 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.807 0.813 . . . . 0.0 111.044 -175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.53 -173.93 3.56 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.242 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -137.63 118.41 14.12 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.162 -0.962 . . . . 0.0 111.646 -175.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -125.36 146.68 55.08 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.389 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -47.12 143.37 10.32 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 121.875 1.717 . . . . 0.0 111.506 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -58.35 -36.91 74.17 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -172.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.53 -36.59 84.28 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.719 -0.613 . . . . 0.0 112.518 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.3 t -62.98 -44.01 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.878 -0.514 . . . . 0.0 111.582 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.433 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 56.5 mt -58.22 -49.55 76.7 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.43 -0.508 . . . . 0.0 112.254 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -56.44 -25.86 51.84 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 tt -78.11 -39.29 41.8 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.577 173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.7 t -60.69 -38.34 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 121.452 -0.78 . . . . 0.0 110.989 170.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 95.8 mtt180 -72.06 -30.84 65.54 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.492 175.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -66.5 -54.08 27.92 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.26 174.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.8 t -59.89 -34.86 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.09 -32.97 74.72 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -72.47 -41.21 66.29 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.85 -48.82 80.06 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.729 0.641 . . . . 0.0 112.729 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -75.35 -13.77 60.43 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.524 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.45 58.3 11.89 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.031 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.9 ttt -145.33 147.63 32.53 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.93 0.871 . . . . 0.0 108.898 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.5 t -67.19 143.72 56.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.9 0.857 . . . . 0.0 110.368 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -61.46 -37.7 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -55.58 -53.73 52.77 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.274 -0.891 . . . . 0.0 111.84 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.4 m -71.46 -22.1 61.87 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -71.21 -57.17 4.75 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.5 -0.75 . . . . 0.0 112.163 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 37' ' ' ILE . 4.2 mp -66.38 -28.37 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -56.73 -41.09 76.9 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.642 169.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -74.92 -16.31 60.66 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.44 -36.15 20.82 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.078 1.308 . . . . 0.0 111.748 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.6 m -73.83 -7.95 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.954 172.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.638 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -108.97 -25.13 10.88 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.978 0.808 . . . . 0.0 112.208 174.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -83.56 -16.01 47.05 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.968 172.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.1 t -108.15 -50.52 3.03 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 175.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.427 ' O ' ' CG ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -103.4 69.09 0.98 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 123.143 1.449 . . . . 0.0 107.623 175.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.049 ' HB2' ' NH2' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -84.89 -43.46 14.07 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 120.98 -1.075 . . . . 0.0 111.291 -176.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.706 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 27.5 mmmt 118.44 33.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.127 0.965 . . . . 0.0 110.438 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -94.47 -30.32 14.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.744 167.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.56 65.29 0.1 OUTLIER Glycine 0 N--CA 1.467 0.739 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 1.049 ' NH2' ' HB2' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -112.38 -87.81 0.54 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -177.126 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.6 tp -60.8 -37.88 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.6 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.16 -88.34 0.75 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.26 -0.971 . . . . 0.0 110.919 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.149 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 16.0 tpt . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' B' ' 102' ' ' LYS . 22.9 pttp -171.88 109.44 0.26 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.139 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.11 62.22 0.01 OUTLIER Glycine 0 N--CA 1.466 0.684 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 16.4 tpt -101.25 -64.32 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 27.3 t -85.5 -71.81 0.51 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . 0.515 ' H ' ' HD3' ' B' ' 108' ' ' PRO . 58.2 mtmt -145.11 -86.96 0.11 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 174.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' MET . . . . . . . . . . . . . 65.3 mtt -143.08 63.28 12.86 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 169.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.515 ' HD3' ' H ' ' B' ' 106' ' ' LYS . 54.4 Cg_endo -93.11 79.3 0.26 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 121.797 1.665 . . . . 0.0 110.39 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -86.98 144.66 26.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 122.53 1.157 . . . . 0.0 111.571 -173.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -140.68 110.06 6.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.307 -174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -93.84 130.61 39.81 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.811 0.815 . . . . 0.0 111.135 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 34.8 mt -104.7 171.4 7.35 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 1.004 ' HB3' ' HA ' ' A' ' 6' ' ' LYS . 97.2 mtt180 -134.09 94.1 3.19 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.812 0.815 . . . . 0.0 109.596 -176.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' TRP . . . . . 0.42 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 54.7 m0 -121.29 151.1 55.49 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.87 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -55.61 144.06 76.5 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 121.673 1.582 . . . . 0.0 110.586 170.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.91 -30.29 67.71 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.96 -38.54 82.89 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.63 -0.669 . . . . 0.0 112.092 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.59 -44.44 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.204 0.526 . . . . 0.0 111.015 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.407 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 58.4 tp -67.7 -34.01 76.03 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . 0.699 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 68.0 m-20 -70.61 -25.85 63.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.564 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 15.2 tp -78.17 -32.59 50.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.228 172.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.78 -39.19 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 167.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . 0.699 ' HB2' ' O ' ' B' ' 120' ' ' ASP . 2.9 mmp_? -54.34 -48.91 70.86 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.108 0.48 . . . . 0.0 111.797 169.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -56.92 -57.51 12.19 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.277 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 92.2 t -55.93 -39.04 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.82 -30.97 72.0 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -73.19 -44.77 59.29 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.795 -0.565 . . . . 0.0 112.192 174.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.93 -51.83 67.99 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -79.36 -12.75 59.91 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.467 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.96 59.85 8.97 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.268 -0.967 . . . . 0.0 111.932 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 59.2 tpp -141.38 146.18 36.29 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 65.2 m -67.66 142.0 56.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.038 0.923 . . . . 0.0 110.982 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 14.0 m -64.82 -33.38 63.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -58.8 -53.34 59.53 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.807 -0.558 . . . . 0.0 111.43 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 59.0 m -71.98 -19.5 61.87 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -71.83 -57.29 4.46 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.743 -0.598 . . . . 0.0 111.756 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 2.6 mp -69.7 -25.85 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -58.59 -37.71 76.37 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.882 0.849 . . . . 0.0 109.694 168.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' B' ' 139' ' ' GLN . 2.4 tp60 -78.61 -21.4 48.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.111 177.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 84.9 mt -81.57 -31.67 32.5 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.562 1.074 . . . . 0.0 112.189 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.21 -25.61 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.926 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.495 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 30.6 mmt -84.48 -28.81 26.51 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.383 -0.823 . . . . 0.0 112.539 175.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -74.08 -24.79 59.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.654 171.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 67.3 m -84.83 -43.32 14.28 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.154 -0.341 . . . . 0.0 110.301 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.776 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 18.1 m-30 -77.27 95.92 4.46 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.776 ' HG3' ' O ' ' B' ' 145' ' ' PHE . 10.9 mtpt 165.69 -36.94 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.817 -166.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' B' ' 148' ' ' GLU . 13.6 tptm -81.16 63.63 5.58 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 123.201 1.477 . . . . 0.0 109.797 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 147' ' ' LYS . 26.6 tt0 169.7 -32.85 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 112.804 -1.998 . . . . 0.0 108.786 -174.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 89.01 68.28 1.26 Allowed Glycine 0 N--CA 1.466 0.691 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . 0.435 ' HB2' ' H ' ' B' ' 151' ' ' ILE . 48.1 mtt180 -105.49 -84.21 0.5 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.277 1.037 . . . . 0.0 108.821 -169.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.435 ' H ' ' HB2' ' B' ' 150' ' ' ARG . 6.9 tp -58.93 -43.34 88.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 114.11 -1.405 . . . . 0.0 112.769 174.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -90.59 -112.16 1.57 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.726 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.491 -179.409 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.62 ' HG3' ' CE ' ' A' ' 4' ' ' MET . 27.9 ttt . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -169.37 103.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.76 78.38 1.41 Allowed Glycine 0 N--CA 1.468 0.804 0 C-N-CA 120.245 -0.978 . . . . 0.0 111.025 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.62 ' CE ' ' HG3' ' A' ' 1' ' ' MET . 26.4 mmt -93.73 -50.36 5.42 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.426 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.448 ' HB2' HE21 ' A' ' 9' ' ' GLN . 33.5 t -77.59 -95.17 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.43 ' HG3' ' H ' ' A' ' 7' ' ' MET . 53.6 pttt -126.83 -54.33 1.41 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 168.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.43 ' H ' ' HG3' ' A' ' 6' ' ' LYS . 24.4 mmt -90.58 149.68 41.18 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 165.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.987 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 69.4 Cg_exo -46.4 128.9 12.91 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 122.659 2.239 . . . . 0.0 115.739 -176.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.448 HE21 ' HB2' ' A' ' 5' ' ' SER . 24.2 tt0 -83.19 149.43 26.84 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.628 -176.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -133.44 113.12 12.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.369 -172.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -96.6 142.29 28.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.813 0.816 . . . . 0.0 111.987 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.459 HD13 ' CZ2' ' A' ' 14' ' ' TRP . 41.2 mt -122.52 171.58 9.0 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.573 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.406 ' HB3' ' HA ' ' B' ' 106' ' ' LYS . 97.7 mtt180 -137.28 93.15 2.78 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.504 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.459 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 53.7 m0 -119.2 153.75 53.38 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.476 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.77 142.05 74.9 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 121.55 1.5 . . . . 0.0 110.479 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -58.79 -33.32 70.19 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.39 -39.75 89.23 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.65 -0.656 . . . . 0.0 112.167 175.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.9 t -64.46 -46.65 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.92 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 56.2 tp -61.66 -40.78 96.14 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 91.7 m-20 -68.94 -26.81 65.26 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.876 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.3 tp -75.68 -31.48 59.76 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.175 171.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -64.21 -36.06 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.523 -0.736 . . . . 0.0 109.74 168.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 21.5 mmt180 -64.15 -38.72 92.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.875 0.369 . . . . 0.0 111.746 170.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 20' ' ' ASP . 68.5 mmtt -61.35 -54.35 44.91 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.2 t -58.21 -38.03 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.11 -32.5 73.9 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.93 -41.76 67.47 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.98 -50.27 74.41 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -76.69 -13.08 60.07 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.513 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.63 59.63 8.99 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.668 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.2 tpt -140.41 147.16 39.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.004 0.907 . . . . 0.0 108.75 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 63.0 m -66.77 144.94 56.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.118 0.961 . . . . 0.0 110.999 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -62.88 -36.76 77.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -60.59 -52.96 62.95 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.838 -0.539 . . . . 0.0 112.081 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.1 m -71.44 -20.66 62.07 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -69.8 -59.69 2.78 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.785 -0.572 . . . . 0.0 111.74 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.1 mp -70.19 -25.84 28.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.264 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -59.26 -38.72 80.76 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 122.102 0.953 . . . . 0.0 109.441 169.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.445 HE21 ' HA ' ' A' ' 39' ' ' GLN . 1.2 tp60 -77.89 -17.13 57.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.267 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.1 mt -83.83 -35.54 24.15 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.756 1.162 . . . . 0.0 111.828 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.8 m -71.68 -11.97 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.31 169.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.829 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -97.29 -28.87 13.86 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.375 0.989 . . . . 0.0 112.352 172.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.55 -15.47 59.24 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.417 -0.802 . . . . 0.0 112.332 172.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.4 m -118.87 -9.05 10.19 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.431 ' O ' ' CG ' ' A' ' 45' ' ' PHE . 1.6 t80 -152.26 67.35 0.84 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.829 ' HB2' ' O ' ' A' ' 42' ' ' MET . 0.1 OUTLIER -91.02 -45.43 8.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.505 -174.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 6.0 mmmm 126.67 33.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.766 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -95.93 -28.55 14.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.143 166.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.78 78.94 0.45 Allowed Glycine 0 N--CA 1.467 0.708 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.633 HH21 ' HB3' ' A' ' 46' ' ' LYS . 74.9 mtt-85 -123.71 -85.78 0.65 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.632 1.206 . . . . 0.0 109.052 -171.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.462 ' H ' ' HB2' ' A' ' 50' ' ' ARG . 9.2 tp -62.81 -45.55 98.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 113.542 -1.663 . . . . 0.0 112.912 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 156.95 99.09 0.15 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.091 -179.554 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.885 ' O ' ' HB2' ' B' ' 102' ' ' LYS . 15.6 tpt . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.885 ' HB2' ' O ' ' B' ' 101' ' ' MET . 88.3 tttt 133.5 108.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.382 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.96 87.46 1.23 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.115 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 26.2 mmt -139.02 -50.92 0.53 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 89.7 p -160.55 -33.89 0.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.972 175.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 97.7 mttt -87.02 35.66 0.7 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' MET . . . . . 0.495 ' H ' ' CD ' ' B' ' 108' ' ' PRO . 25.6 mmt -132.57 -49.47 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 118.69 -0.671 . . . . 0.0 111.663 173.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.495 ' CD ' ' H ' ' B' ' 107' ' ' MET . 18.5 Cg_exo -68.98 103.18 0.99 Allowed 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.521 2.147 . . . . 0.0 110.582 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -99.06 147.7 24.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.93 0.871 . . . . 0.0 110.548 -174.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -133.61 108.57 8.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.849 -174.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -91.4 141.65 28.52 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.962 0.887 . . . . 0.0 112.003 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 53.0 mt -125.87 168.82 13.34 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.261 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -127.26 85.53 2.38 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.829 0.823 . . . . 0.0 109.67 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' TRP . . . . . 0.419 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 44.7 m0 -119.32 142.49 32.52 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.628 -171.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.94 145.15 53.17 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 121.972 1.781 . . . . 0.0 111.661 172.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.987 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . 11.9 ttp180 -61.37 -34.96 76.19 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.87 -35.9 81.53 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.2 -42.76 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.982 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.911 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 80.7 mt -67.37 -32.06 72.72 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -65.31 -33.49 76.1 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.502 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 19.2 tp -77.72 -32.33 52.82 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.077 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.1 -36.34 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . 0.911 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 25.5 mmm-85 -65.24 -35.3 80.61 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.984 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.64 -55.77 20.96 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.723 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 93.0 t -57.99 -36.18 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.77 73.09 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -72.06 -44.61 63.05 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.847 -0.533 . . . . 0.0 112.186 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -57.48 -51.77 68.11 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -80.46 -13.13 59.38 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.499 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.79 61.11 7.09 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.922 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 58.8 tpp -142.77 143.52 32.24 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.866 0.841 . . . . 0.0 109.011 -176.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 64.8 m -68.63 148.48 50.39 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 122.07 0.938 . . . . 0.0 110.929 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 16.5 m -64.04 -35.53 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -59.87 -53.55 56.56 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.62 -0.675 . . . . 0.0 111.681 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 60.0 m -70.73 -23.98 62.54 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -68.46 -57.77 5.34 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.528 -0.733 . . . . 0.0 112.286 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 3.9 mp -68.82 -26.42 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.211 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -56.29 -39.82 73.31 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.496 168.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -76.03 -22.98 55.13 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.821 -0.751 . . . . 0.0 112.917 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 58.9 mt -82.8 -34.38 26.99 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.124 1.329 . . . . 0.0 112.471 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 18.4 m -70.56 -24.86 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.964 172.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.64 -31.77 18.39 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.315 -0.866 . . . . 0.0 112.6 177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -77.58 -23.62 49.94 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.418 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . 0.843 ' C ' ' HB3' ' B' ' 150' ' ' ARG . 35.5 t -97.57 -66.67 0.89 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 1.176 ' HA ' ' CG ' ' B' ' 150' ' ' ARG . 0.1 OUTLIER -75.24 98.99 3.9 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 122.927 1.346 . . . . 0.0 107.892 174.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 1.103 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 27.9 ttpp -138.15 -42.52 0.51 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.535 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 1.103 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 2.5 tmtt? 138.64 48.18 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.889 0.852 . . . . 0.0 109.2 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -151.54 -30.63 0.17 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.276 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 157.05 64.24 0.01 OUTLIER Glycine 0 N--CA 1.466 0.66 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -173.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . 1.176 ' CG ' ' HA ' ' B' ' 145' ' ' PHE . 0.0 OUTLIER -90.52 -55.07 3.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.19 0.995 . . . . 0.0 111.249 -172.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 3.6 tp -120.65 -53.64 3.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.602 -168.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -178.64 98.01 0.11 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 119.884 -1.15 . . . . 0.0 110.25 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.569 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.96 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 61.5 tpp . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.96 ' HB2' ' O ' ' A' ' 1' ' ' MET . 88.6 tttt 143.87 99.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.203 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.3 98.17 0.12 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.1 mtt -140.26 -39.3 0.44 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.855 ' O ' ' HB3' ' B' ' 113' ' ' ARG . 90.0 p -159.92 -40.59 0.05 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.568 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -86.38 30.06 0.73 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.475 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 55.4 tpp -149.68 -48.64 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 118.736 -0.65 . . . . 0.0 112.534 173.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 7' ' ' MET . 15.9 Cg_exo -73.03 96.13 0.85 Allowed 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.248 1.965 . . . . 0.0 111.053 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 78.0 mt-30 -99.91 144.81 28.53 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.541 1.162 . . . . 0.0 111.126 -176.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -120.77 105.66 10.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.148 -1.387 . . . . 0.0 107.689 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -90.26 135.1 33.88 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.872 0.844 . . . . 0.0 111.279 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.91 171.08 14.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.33 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -129.91 106.54 8.73 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.093 -170.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 53.7 m0 -118.62 152.82 51.76 Favored Pre-proline 0 N--CA 1.474 0.755 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.228 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.26 146.23 32.38 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 121.776 1.651 . . . . 0.0 110.758 171.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.55 -33.48 72.73 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -174.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.75 -32.03 73.06 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.625 -0.672 . . . . 0.0 112.314 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.84 -43.38 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.13 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.9 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 59.6 mt -62.39 -40.49 96.66 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -69.81 -24.16 63.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.52 -0.472 . . . . 0.0 112.171 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.7 tp -80.17 -35.09 36.97 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.889 -0.507 . . . . 0.0 111.291 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.86 -33.74 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 170.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.9 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 29.5 mmm-85 -67.61 -40.04 84.72 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 122.18 -0.325 . . . . 0.0 111.255 171.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -63.67 -52.79 59.12 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.755 HG21 ' HG2' ' B' ' 150' ' ' ARG . 0.5 OUTLIER -60.03 -40.11 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.97 -34.34 77.31 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.4 -40.2 81.4 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -60.29 -49.19 78.58 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -76.38 -13.34 60.13 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.625 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.14 61.99 5.3 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.718 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.8 ttt -137.85 148.57 45.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.993 0.901 . . . . 0.0 109.118 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -67.91 135.79 53.0 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.021 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.85 -39.69 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -174.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -59.7 -48.76 80.39 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.435 -0.791 . . . . 0.0 112.039 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.8 m -72.16 -15.75 61.97 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -73.9 -55.77 5.77 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.683 -0.635 . . . . 0.0 111.849 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.498 HD12 ' H ' ' A' ' 37' ' ' ILE . 4.5 mp -65.82 -30.67 50.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -57.0 -37.83 72.22 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.125 170.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.42 HE21 ' HA ' ' A' ' 39' ' ' GLN . 2.2 tp60 -77.04 -23.09 52.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.201 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.2 mt -79.39 -37.22 37.75 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.773 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.3 m -73.32 -13.89 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.281 171.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.53 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 29.4 mmt -97.44 -14.79 20.95 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.531 -1.356 . . . . 0.0 112.869 175.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -94.64 -25.55 16.72 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 119.539 -0.865 . . . . 0.0 112.313 171.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 1.14 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 74.4 m -93.72 -71.94 0.63 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 175.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.967 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 14.7 t80 -71.07 178.35 3.29 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 164.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.967 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER 169.61 -58.83 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 O-C-N 119.923 -1.735 . . . . 0.0 108.8 177.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.854 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 4.5 tmtp? -132.5 23.23 4.37 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.23 169.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 73.86 9.2 4.8 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.43 46.73 1.08 Allowed Glycine 0 N--CA 1.47 0.964 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 171.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 1.14 ' HB3' ' O ' ' A' ' 44' ' ' SER . 1.9 mpp_? -131.57 -84.95 0.5 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -169.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.2 tp -66.66 -42.91 90.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.903 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 152.71 124.01 1.02 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.273 -179.642 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.883 ' O ' ' CB ' ' B' ' 102' ' ' LYS . 66.0 mtt . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.883 ' CB ' ' O ' ' B' ' 101' ' ' MET . 88.4 tttt 115.96 106.93 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.384 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 151.62 43.89 0.02 OUTLIER Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.237 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -173.71 36.56 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 88.7 p 48.57 69.03 0.6 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -77.89 -58.17 3.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 167.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' MET . . . . . 0.549 ' N ' ' HD3' ' B' ' 108' ' ' PRO . 24.5 ttt -162.07 46.05 0.17 Allowed Pre-proline 0 CA--C 1.552 1.046 0 CA-C-O 117.898 -1.049 . . . . 0.0 112.926 168.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' B' ' 107' ' ' MET . 17.2 Cg_exo -74.43 102.59 1.57 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 124.274 2.562 . . . . 0.0 109.646 174.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -95.51 154.19 17.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.083 0.944 . . . . 0.0 111.174 -172.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -148.76 115.13 5.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -92.1 126.91 37.37 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.38 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 31.4 mt -97.76 173.65 7.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.965 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.855 ' HB3' ' O ' ' A' ' 5' ' ' SER . 98.7 mtt180 -134.07 85.57 2.21 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.705 -175.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' TRP . . . . . 0.419 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 45.2 m0 -119.45 150.6 50.06 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.125 -172.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.02 145.35 64.02 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 121.747 1.631 . . . . 0.0 111.009 172.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -60.86 -36.58 79.52 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 119.776 -0.769 . . . . 0.0 112.849 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.9 -33.72 76.69 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.38 -42.13 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.904 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.909 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 64.4 mt -65.2 -34.74 79.09 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 75.6 m-20 -65.76 -34.72 78.84 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.516 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 28.2 tp -80.16 -29.46 38.77 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 120.394 -0.523 . . . . 0.0 112.176 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 67.8 t -64.94 -33.25 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 166.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . 0.909 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 30.2 mmm-85 -62.98 -41.34 99.54 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 122.14 -0.35 . . . . 0.0 111.514 171.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.98 -48.69 51.9 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.272 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.84 -43.42 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.88 -42.57 81.03 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -69.4 -33.35 72.88 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -68.46 -41.13 80.65 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.047 -0.408 . . . . 0.0 111.749 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -72.04 -8.33 53.95 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.389 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.54 63.67 3.28 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.782 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 18.7 ttt -153.58 145.55 23.63 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.729 0.776 . . . . 0.0 109.281 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 66.4 m -73.35 144.81 46.35 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.61 0.719 . . . . 0.0 109.837 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 14.0 m -65.18 -38.04 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -64.0 -45.52 88.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.306 -0.871 . . . . 0.0 111.416 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 57.0 m -71.94 -19.24 61.93 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -73.15 -55.42 6.49 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.695 -0.628 . . . . 0.0 111.619 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 3.7 mp -68.16 -27.44 37.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.996 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -57.79 -40.38 79.73 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 122.071 0.939 . . . . 0.0 109.63 169.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -73.98 -21.27 60.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.163 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.88 -32.21 31.13 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.087 -1.008 . . . . 0.0 111.777 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 31.2 m -80.21 1.21 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.192 170.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.69 ' O ' ' HG2' ' B' ' 146' ' ' LYS . 2.1 mmt -113.73 -18.84 11.76 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.086 -1.009 . . . . 0.0 111.873 170.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -84.28 -24.01 30.1 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 119.519 -0.872 . . . . 0.0 111.307 169.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 38.5 t -84.65 -54.04 4.98 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.476 ' O ' ' HG2' ' B' ' 146' ' ' LYS . 6.1 m-85 -70.62 102.94 2.38 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 172.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.777 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 7.0 mmmt -166.82 -59.62 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 118.949 -1.1 . . . . 0.0 108.597 -163.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.777 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 0.0 OUTLIER 163.59 23.71 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.558 172.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 1.006 ' HB2' HH21 ' B' ' 150' ' ' ARG . 44.8 mt-10 -81.25 -34.64 31.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 168.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 174.35 47.63 0.05 OUTLIER Glycine 0 CA--C 1.53 0.986 0 C-N-CA 119.342 -1.409 . . . . 0.0 114.348 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . 1.006 HH21 ' HB2' ' B' ' 148' ' ' GLU . 0.5 OUTLIER -137.92 -97.26 0.19 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.175 0.987 . . . . 0.0 109.713 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 8.9 tp -60.86 -36.84 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . 0.498 ' HA3' ' HD3' ' B' ' 147' ' ' LYS . . . -80.21 -84.82 0.65 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.873 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.185 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.593 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.965 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 26.4 mmt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.965 ' HB2' ' O ' ' A' ' 1' ' ' MET . 54.6 tptt 132.29 -76.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.636 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.28 114.02 0.57 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -162.66 43.81 0.13 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.522 ' O ' ' HB3' ' B' ' 113' ' ' ARG . 6.9 p 78.0 -37.38 0.23 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -177.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -88.81 28.27 1.19 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.63 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.481 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 26.4 ttt -151.5 -47.85 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 176.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' CD ' ' H ' ' A' ' 7' ' ' MET . 22.2 Cg_exo -69.52 102.17 0.96 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.341 2.027 . . . . 0.0 111.664 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 18.0 tt0 -97.88 146.43 25.45 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.954 0.883 . . . . 0.0 110.324 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -135.92 105.67 6.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.915 -173.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -92.36 141.65 28.31 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.04 0.924 . . . . 0.0 111.49 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 29.9 mt -119.41 -176.03 3.06 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.496 HH12 ' HA ' ' B' ' 101' ' ' MET . 90.3 mtt180 -142.12 94.03 2.61 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.283 -0.886 . . . . 0.0 109.555 177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.448 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 48.2 m0 -119.55 141.58 31.17 Favored Pre-proline 0 N--CA 1.473 0.722 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.592 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -48.32 142.67 16.49 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 121.862 1.708 . . . . 0.0 111.599 173.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -59.0 -33.9 71.23 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.89 -34.64 78.61 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.687 -0.633 . . . . 0.0 112.35 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.54 -42.71 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.864 -0.522 . . . . 0.0 111.15 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.924 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 56.7 mt -65.34 -36.21 83.33 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -66.27 -29.59 69.85 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.747 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.3 tp -81.55 -31.5 32.66 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.856 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.44 -35.3 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 167.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.924 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 29.7 mmm-85 -64.99 -36.52 84.67 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.781 172.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -63.07 -55.58 24.29 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.114 -0.366 . . . . 0.0 110.814 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.1 t -55.56 -37.95 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.73 -33.06 74.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.77 -44.88 63.27 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.943 -0.473 . . . . 0.0 112.226 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -58.86 -51.63 69.2 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -79.31 -11.15 59.94 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 119.634 -0.826 . . . . 0.0 111.568 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.6 58.49 12.03 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.426 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 58.4 tpp -147.08 142.27 27.23 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.6 m -66.28 147.97 52.53 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.108 0.956 . . . . 0.0 111.157 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 m -64.29 -34.53 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -58.45 -52.02 67.37 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.762 -0.586 . . . . 0.0 111.453 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.41 ' HA ' ' HB3' ' A' ' 38' ' ' TYR . 58.8 m -72.08 -19.28 61.84 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -71.86 -58.58 3.33 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.714 -0.616 . . . . 0.0 111.869 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.414 HD12 ' H ' ' A' ' 37' ' ' ILE . 4.3 mp -68.49 -27.85 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.9 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.41 ' HB3' ' HA ' ' A' ' 35' ' ' SER . 76.9 t80 -59.2 -35.38 73.5 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.182 169.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.415 HE21 ' HA ' ' A' ' 39' ' ' GLN . 2.5 tp60 -77.99 -22.78 48.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.991 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 72.2 mt -81.22 -30.18 34.31 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.359 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.9 m -71.68 -28.28 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 119.579 -0.848 . . . . 0.0 109.646 169.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.433 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 11.4 mmt -82.02 -25.58 34.55 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.385 -0.822 . . . . 0.0 112.653 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -77.7 -24.54 49.22 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.335 -0.853 . . . . 0.0 111.338 170.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.9 t -80.03 -51.15 9.39 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.81 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 21.7 m-85 -69.18 99.59 1.16 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 171.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.81 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 11.0 mtpt 161.21 -41.66 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.111 -167.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 48' ' ' GLU . 2.5 tmtp? -79.89 67.17 5.6 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.934 1.35 . . . . 0.0 109.91 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 47' ' ' LYS . 12.5 tt0 161.07 -35.41 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.364 -175.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 111.43 62.42 0.48 Allowed Glycine 0 N--CA 1.467 0.709 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.09 -84.08 0.34 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 tp -61.13 -37.22 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.405 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.69 105.03 0.27 Allowed Glycine 0 N--CA 1.466 0.677 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.121 -179.846 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.914 ' O ' ' CB ' ' B' ' 102' ' ' LYS . 27.4 ttt . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.914 ' CB ' ' O ' ' B' ' 101' ' ' MET . 88.3 tttt 118.59 105.05 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.45 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.64 -65.98 0.2 Allowed Glycine 0 N--CA 1.467 0.74 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 59.8 mtt -131.32 -45.02 1.0 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 28.8 p -89.11 -106.76 0.08 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -135.05 -79.76 0.44 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' MET . . . . . 0.479 ' N ' ' HD3' ' B' ' 108' ' ' PRO . 28.1 ttt -158.8 65.6 2.93 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.079 168.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' B' ' 107' ' ' MET . 5.7 Cg_exo -95.87 92.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 121.81 1.674 . . . . 0.0 107.813 -176.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 39.8 mt-30 -82.35 133.55 35.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 122.486 1.136 . . . . 0.0 113.112 -168.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -118.25 100.43 7.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.979 -1.464 . . . . 0.0 107.436 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -86.17 138.66 31.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.919 0.866 . . . . 0.0 112.044 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.455 HD13 ' CZ2' ' B' ' 114' ' ' TRP . 38.9 mt -122.23 173.8 7.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.459 -177.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 5' ' ' SER . 98.7 mtt180 -139.7 89.91 2.36 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.413 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' TRP . . . . . 0.455 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 52.8 m0 -117.84 149.08 44.61 Favored Pre-proline 0 N--CA 1.472 0.669 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.764 -174.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.96 143.03 51.14 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 121.706 1.604 . . . . 0.0 110.756 170.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -59.07 -32.29 69.66 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.6 -40.02 92.19 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.545 -0.722 . . . . 0.0 112.227 175.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 66.5 t -66.61 -42.0 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 121.816 -0.552 . . . . 0.0 111.32 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.867 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 63.2 tp -67.91 -33.74 75.28 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -70.64 -23.03 62.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.611 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 45.9 tp -80.03 -32.27 39.56 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.916 -0.49 . . . . 0.0 111.293 172.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 91.4 t -68.87 -30.52 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.612 -0.68 . . . . 0.0 109.827 169.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . 0.867 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 6.8 mmm180 -69.7 -39.49 76.88 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 122.114 -0.366 . . . . 0.0 111.161 171.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -66.54 -55.52 15.12 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.437 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 p -55.13 -40.92 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.42 83.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.83 -39.07 83.94 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -61.27 -47.97 83.54 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -75.1 -13.44 60.48 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.622 175.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.93 60.41 6.9 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.78 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 25.3 ttt -142.4 145.09 33.47 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.849 0.833 . . . . 0.0 109.153 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 89.6 p -68.62 142.11 55.21 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.776 0.798 . . . . 0.0 110.521 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 17.4 m -62.66 -37.45 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -58.1 -51.74 68.42 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.159 -0.963 . . . . 0.0 112.376 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 55.7 m -72.97 -18.69 61.34 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -72.81 -57.02 4.39 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.797 -0.564 . . . . 0.0 112.154 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' ILE . . . . . 0.449 HD12 ' H ' ' B' ' 137' ' ' ILE . 4.6 mp -68.95 -27.45 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -58.12 -37.91 75.5 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.107 0.956 . . . . 0.0 109.68 168.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -79.37 -17.01 55.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.39 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 80.9 mt -82.59 -35.87 26.7 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.949 1.249 . . . . 0.0 111.595 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 23.5 m -71.15 -14.59 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.528 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.597 ' O ' ' HG2' ' B' ' 146' ' ' LYS . 0.2 OUTLIER -101.16 -25.43 14.02 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.292 0.951 . . . . 0.0 112.719 175.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.83 -25.62 44.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.916 172.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . 1.229 ' O ' ' HB3' ' B' ' 150' ' ' ARG . 75.4 m -98.19 -61.12 1.43 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 1.059 ' HA ' ' HG2' ' B' ' 150' ' ' ARG . 0.9 OUTLIER -90.78 70.2 6.58 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 123.332 1.539 . . . . 0.0 108.518 175.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 1.031 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 0.1 OUTLIER -90.2 -48.74 6.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.108 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 1.031 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 0.0 OUTLIER 134.26 58.09 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 122.659 1.218 . . . . 0.0 108.219 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -152.94 -27.7 0.15 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.74 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 144.77 69.96 0.02 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 106.434 -2.666 . . . . 0.0 106.434 -171.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . 1.229 ' HB3' ' O ' ' B' ' 144' ' ' SER . 0.0 OUTLIER -100.15 -61.06 1.42 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 122.426 1.108 . . . . 0.0 111.167 -167.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 4.5 tp -110.11 -53.83 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.057 -169.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 175.0 94.53 0.09 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.907 -179.845 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.906 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 26.2 mmt . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.906 ' HB2' ' O ' ' A' ' 1' ' ' MET . 87.9 tttt 150.7 96.55 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.116 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 139.05 82.11 0.09 OUTLIER Glycine 0 N--CA 1.468 0.778 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.123 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.9 mtt -139.32 -69.33 0.42 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.1 t -89.49 -85.23 0.21 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -133.22 -90.86 0.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.421 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 64.6 mtt -148.02 68.16 10.37 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 168.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 7' ' ' MET . 1.8 Cg_endo -101.08 82.95 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 121.556 1.504 . . . . 0.0 109.16 -173.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -91.37 151.62 20.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 122.368 1.08 . . . . 0.0 111.005 -174.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -146.69 116.84 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -97.92 119.2 36.11 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.136 -173.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.419 HD13 ' CZ2' ' A' ' 14' ' ' TRP . 44.9 mt -93.62 169.72 10.12 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.419 0.628 . . . . 0.0 109.734 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 1.145 ' HB3' ' CB ' ' B' ' 105' ' ' SER . 96.1 mtt180 -129.55 86.95 2.47 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.79 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.419 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 45.3 m0 -120.39 141.6 32.27 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.931 -172.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.27 145.09 36.71 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 121.889 1.726 . . . . 0.0 111.659 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -60.0 -34.68 73.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.93 -37.11 85.73 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.719 -0.613 . . . . 0.0 112.501 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.7 t -63.17 -41.38 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.853 -0.53 . . . . 0.0 111.125 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.909 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 76.6 mt -66.84 -32.69 74.13 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -64.84 -33.03 75.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.488 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.3 tp -77.03 -33.68 57.34 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.261 -0.575 . . . . 0.0 112.16 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.23 -35.94 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 169.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.909 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 27.2 mmm-85 -63.73 -37.02 85.79 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.812 172.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -64.1 -54.98 25.41 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.044 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.7 t -58.99 -35.87 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 177.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.49 -31.09 72.16 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -71.61 -45.96 60.61 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.89 -0.506 . . . . 0.0 112.098 173.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.32 -52.59 64.74 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -78.89 -14.36 59.27 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.513 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.82 59.64 9.83 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.264 -0.969 . . . . 0.0 111.764 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 57.7 tpp -138.16 148.13 44.56 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.069 0.938 . . . . 0.0 109.154 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.6 t -65.86 141.98 58.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.825 0.822 . . . . 0.0 110.698 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.5 m -66.44 -40.03 85.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -64.62 -41.8 95.93 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.279 -0.888 . . . . 0.0 112.495 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.6 m -72.35 -25.93 61.72 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 175.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -69.69 -54.5 13.57 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.825 -0.547 . . . . 0.0 111.886 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 mp -69.45 -25.25 28.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.356 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -57.34 -40.49 78.1 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.101 167.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -75.05 -20.27 59.64 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.868 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.5 mt -84.27 -33.84 23.93 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.95 1.25 . . . . 0.0 112.279 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.5 m -74.2 -13.7 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.244 170.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.696 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 28.4 mmt -99.72 -14.2 18.99 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.758 -1.214 . . . . 0.0 112.944 175.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -98.2 -18.21 18.57 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 119.871 -0.732 . . . . 0.0 112.757 172.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 1.234 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 36.2 t -100.15 -71.5 0.7 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 174.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.731 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 8.1 t80 -70.49 170.98 10.93 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 162.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.731 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -179.84 -55.13 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 O-C-N 119.521 -1.987 . . . . 0.0 109.063 177.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.471 ' HB2' ' NH2' ' A' ' 50' ' ' ARG . 73.5 mttt -119.28 -61.1 1.67 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 168.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.437 ' H ' HH21 ' A' ' 50' ' ' ARG . 8.2 pt-20 168.89 -11.68 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.243 -1.799 . . . . 0.0 110.859 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.51 37.84 3.3 Favored Glycine 0 N--CA 1.473 1.114 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.358 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 1.471 ' NH2' ' HB2' ' A' ' 47' ' ' LYS . 1.2 mpp_? -122.39 -79.21 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -173.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.6 tp -67.78 -48.35 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.417 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.92 119.07 0.54 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.601 -0.714 . . . . 0.0 109.962 179.826 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -163.95 -81.99 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.97 117.98 3.64 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 65.2 mtt -133.6 -42.54 0.84 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 1.145 ' CB ' ' HB3' ' A' ' 13' ' ' ARG . 68.5 m -141.26 -48.79 0.41 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.662 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -82.08 42.21 0.71 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.227 -0.589 . . . . 0.0 112.469 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' MET . . . . . 0.453 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 25.6 ttt -157.51 -65.24 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' B' ' 107' ' ' MET . 71.6 Cg_endo -81.27 79.54 3.23 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.568 2.179 . . . . 0.0 110.585 175.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 85.8 mt-30 -95.4 141.4 29.0 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 122.267 1.032 . . . . 0.0 110.116 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -113.11 103.99 11.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.042 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -93.67 132.59 37.86 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.802 0.811 . . . . 0.0 110.956 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.57 171.16 14.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.461 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.566 ' NH1' ' HG3' ' A' ' 2' ' ' LYS . 92.5 mtt180 -132.67 120.31 21.56 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.9 0.857 . . . . 0.0 111.518 -174.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' TRP . . . . . . . . . . . . . 49.0 m0 -126.22 147.99 61.83 Favored Pre-proline 0 N--CA 1.475 0.805 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.602 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -46.65 140.08 12.8 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 121.727 1.618 . . . . 0.0 111.182 171.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -58.43 -30.66 67.07 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -173.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.91 -42.28 97.45 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.557 -0.715 . . . . 0.0 111.7 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -64.06 -50.18 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.381 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.478 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 62.2 tp -60.31 -43.03 96.72 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 20.9 m-20 -69.13 -26.11 64.72 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.793 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 19.3 tp -77.56 -30.62 52.76 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.173 172.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 88.7 t -64.16 -32.76 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 O-C-N 121.503 -0.748 . . . . 0.0 109.768 167.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 21.3 mmt180 -66.74 -43.93 82.84 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.99 -0.444 . . . . 0.0 111.545 172.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -67.44 -52.21 42.35 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.811 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 1.8 p -57.88 -39.76 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.57 -38.04 86.05 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.62 -38.78 84.38 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.82 -45.9 90.48 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.93 -9.94 59.15 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 119.764 -0.775 . . . . 0.0 111.694 175.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 66.72 61.83 5.0 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.766 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 59.5 tpp -145.28 140.11 27.57 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.771 0.796 . . . . 0.0 109.039 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 67.9 m -68.84 140.82 55.23 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.606 0.717 . . . . 0.0 109.575 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 25.1 m -58.83 -37.52 67.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -173.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -61.27 -52.51 64.41 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.169 -0.957 . . . . 0.0 111.757 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 61.4 m -71.61 -18.24 62.23 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -72.47 -57.35 4.24 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.758 -0.589 . . . . 0.0 111.825 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' ILE . . . . . 0.431 HD12 ' H ' ' B' ' 137' ' ' ILE . 4.5 mp -68.59 -27.87 37.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.902 175.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -57.31 -37.82 73.08 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.79 169.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -79.78 -22.92 42.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.283 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.06 -37.04 39.91 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.919 1.236 . . . . 0.0 111.848 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 15.5 m -70.72 -22.14 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.836 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.536 ' O ' ' HB2' ' B' ' 146' ' ' LYS . 0.3 OUTLIER -89.51 -25.0 21.65 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.904 -1.123 . . . . 0.0 112.908 176.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.35 -32.36 60.83 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.712 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . 0.746 ' O ' ' CB ' ' B' ' 150' ' ' ARG . 35.3 t -94.82 -64.92 1.02 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.886 ' HA ' ' CB ' ' B' ' 150' ' ' ARG . 2.7 t80 -81.56 74.67 8.55 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.855 1.312 . . . . 0.0 108.699 174.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.99 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 86.8 tttt -96.06 -38.17 10.31 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.257 -0.902 . . . . 0.0 112.035 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.99 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 4.0 tmtt? 124.02 20.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.839 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -123.87 -12.1 7.58 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 136.68 59.28 0.06 OUTLIER Glycine 0 N--CA 1.466 0.662 0 N-CA-C 106.296 -2.722 . . . . 0.0 106.296 -172.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . 0.886 ' CB ' ' HA ' ' B' ' 145' ' ' PHE . 0.0 OUTLIER -81.16 -116.85 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.523 1.154 . . . . 0.0 111.339 -169.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.664 HG22 ' HG3' ' B' ' 150' ' ' ARG . 6.5 tp -40.21 -44.43 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.566 -1.652 . . . . 0.0 114.868 171.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -88.29 -126.94 2.65 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.23 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.799 -178.964 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -173.59 178.92 2.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 122.092 0.949 . . . . 0.0 110.762 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.06 70.38 1.28 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.117 -1.04 . . . . 0.0 111.207 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.3 mtt -90.78 -60.67 1.85 Allowed 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.6 t -85.2 -80.06 0.22 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' H ' ' HD3' ' A' ' 8' ' ' PRO . 96.3 mttt -133.93 -88.89 0.39 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 174.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 63.3 mtt -143.49 61.81 10.37 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.022 169.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HD3' ' H ' ' A' ' 6' ' ' LYS . 79.3 Cg_endo -91.2 78.63 0.51 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 121.797 1.665 . . . . 0.0 110.433 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -87.42 144.51 26.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.612 1.196 . . . . 0.0 111.165 -175.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -138.09 117.56 12.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.36 -175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -94.33 135.21 35.99 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.842 0.83 . . . . 0.0 110.642 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 40.0 mt -111.25 163.85 13.5 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -121.94 88.15 2.88 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.981 -173.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.418 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 49.0 m0 -122.64 146.96 49.23 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.57 -170.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.412 ' HG3' ' SD ' ' B' ' 107' ' ' MET . 41.6 Cg_exo -55.86 144.5 77.25 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 121.967 1.778 . . . . 0.0 110.871 169.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.683 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 12.3 ttp180 -58.75 -35.32 72.56 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.591 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.37 -38.29 89.61 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.07 -42.82 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.952 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.939 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 60.2 tp -64.71 -33.92 77.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.67 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 78.5 m-20 -67.8 -29.92 69.22 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.435 175.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.2 tp -77.75 -31.81 52.33 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 122.024 -0.423 . . . . 0.0 111.933 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.31 -30.96 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.505 -0.747 . . . . 0.0 109.428 169.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.939 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 27.9 mmm-85 -67.56 -41.95 83.41 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.046 0.451 . . . . 0.0 111.188 170.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.67 ' HG3' ' O ' ' A' ' 20' ' ' ASP . 58.5 mtpt -64.11 -55.52 21.41 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.512 HG21 ' HG3' ' B' ' 150' ' ' ARG . 2.2 p -55.42 -40.61 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.7 82.97 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.8 -38.52 83.42 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.39 -47.43 85.83 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -75.16 -11.88 60.18 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.74 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.96 60.57 6.33 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.771 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.8 ttt -147.44 148.26 31.09 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.863 0.84 . . . . 0.0 108.952 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.8 p -70.46 144.88 51.31 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.809 0.814 . . . . 0.0 110.575 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.34 -36.61 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -57.85 -53.23 60.54 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.271 -0.893 . . . . 0.0 111.548 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.5 m -72.02 -17.33 62.04 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -73.81 -55.52 6.11 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.639 -0.663 . . . . 0.0 111.979 -177.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.417 HD12 ' H ' ' A' ' 37' ' ' ILE . 4.1 mp -67.44 -28.77 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -57.52 -38.83 75.31 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.219 1.009 . . . . 0.0 109.742 168.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.406 HE21 ' HA ' ' A' ' 39' ' ' GLN . 3.2 tp60 -76.78 -18.08 58.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.546 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.7 mt -83.46 -32.5 25.99 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.602 1.092 . . . . 0.0 111.95 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 m -74.65 -9.29 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.9 169.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.77 -18.83 13.83 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.043 0.838 . . . . 0.0 113.208 174.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -94.99 -22.72 17.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.656 173.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.877 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 32.1 t -94.88 -71.85 0.65 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 176.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.559 ' HA ' ' CG ' ' A' ' 50' ' ' ARG . 0.6 OUTLIER -71.74 140.4 49.51 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 166.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.026 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 26.7 ttpp -167.17 -47.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.362 -172.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.026 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 2.3 tmtt? 137.28 54.22 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.136 0.969 . . . . 0.0 108.774 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -148.53 -36.51 0.19 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.202 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.74 84.76 0.6 Allowed Glycine 0 N--CA 1.468 0.795 0 N-CA-C 104.866 -3.293 . . . . 0.0 104.866 -169.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.877 ' HB3' ' O ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -115.95 -98.74 0.44 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.536 1.16 . . . . 0.0 109.503 -162.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.506 ' H ' ' HB2' ' A' ' 50' ' ' ARG . 7.0 tp -46.59 -48.12 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 113.562 -1.654 . . . . 0.0 113.728 170.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.84 80.46 0.05 OUTLIER Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.602 -0.714 . . . . 0.0 109.156 -179.583 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.722 ' O ' ' HB2' ' B' ' 102' ' ' LYS . 2.0 mpt? . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.722 ' HB2' ' O ' ' B' ' 101' ' ' MET . 31.6 mmmt 85.73 -76.63 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.291 0.567 . . . . 0.0 109.92 -178.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 179.71 80.06 0.06 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 66.0 mtt -79.44 -58.41 3.22 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.178 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.628 ' HB2' HE21 ' B' ' 109' ' ' GLN . 35.9 t -75.67 -76.57 0.15 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 173.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -140.78 -44.89 0.39 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 169.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' MET . . . . . 0.412 ' SD ' ' HG3' ' A' ' 15' ' ' PRO . 67.4 mtt -106.85 159.26 30.54 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 168.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.683 ' HG2' ' HB2' ' A' ' 16' ' ' ARG . 76.3 Cg_exo -48.07 129.46 18.49 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.64 2.227 . . . . 0.0 116.18 -176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.628 HE21 ' HB2' ' B' ' 105' ' ' SER . 81.3 mt-30 -80.54 164.25 23.1 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.582 1.182 . . . . 0.0 111.125 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -137.55 111.51 8.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -103.04 130.41 50.15 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.687 0.756 . . . . 0.0 111.065 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.98 177.88 7.54 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.282 175.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -135.54 121.03 19.29 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.32 -0.862 . . . . 0.0 111.813 -174.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -126.58 141.67 40.86 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.809 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -45.26 139.76 8.65 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 121.907 1.738 . . . . 0.0 111.859 173.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -25.2 63.85 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -173.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -65.04 -44.79 87.94 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.386 -0.821 . . . . 0.0 111.017 173.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 81.4 t -66.14 -49.29 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.688 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.488 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 63.9 tp -62.11 -43.82 98.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 71.5 m-20 -70.2 -24.84 63.18 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 119.961 -0.695 . . . . 0.0 111.881 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 25.2 tp -77.04 -32.04 56.66 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.009 170.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.83 -34.31 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 O-C-N 121.494 -0.753 . . . . 0.0 109.848 167.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 21.7 mmt180 -65.2 -39.22 92.54 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.119 -0.363 . . . . 0.0 111.791 171.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -66.32 -49.0 68.48 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.987 -0.446 . . . . 0.0 111.615 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 89.0 t -56.17 -39.05 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.17 74.91 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.65 -42.12 74.68 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 174.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.99 -49.41 77.56 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -75.23 -12.1 60.21 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 119.699 -0.801 . . . . 0.0 111.589 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 63.65 57.27 15.11 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.436 -0.887 . . . . 0.0 112.186 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 15.2 tpt -147.46 148.53 31.34 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 90.2 p -65.34 149.6 49.71 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 122.169 0.985 . . . . 0.0 111.647 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.55 -37.73 79.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.62 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -60.46 -45.15 94.76 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.521 -0.737 . . . . 0.0 112.271 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 59.6 m -71.11 -26.83 63.2 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 176.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -66.68 -60.46 2.68 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.652 -0.655 . . . . 0.0 112.103 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.59 -27.4 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.126 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -58.63 -37.23 75.47 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.957 169.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -77.3 -18.12 57.79 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.481 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 65.2 mt -81.86 -29.01 32.69 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.765 1.166 . . . . 0.0 112.666 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.43 -28.92 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.709 169.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.7 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 0.9 OUTLIER -75.65 -28.27 58.7 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.627 -0.671 . . . . 0.0 112.23 172.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -72.03 -26.15 62.08 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.143 -0.973 . . . . 0.0 111.581 170.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 58.7 m -76.91 -56.63 4.42 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.578 ' HD1' ' HB3' ' B' ' 150' ' ' ARG . 15.0 m-85 -64.55 103.08 0.62 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 175.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.7 ' HG3' ' O ' ' B' ' 142' ' ' MET . 2.1 mtpt 173.09 -58.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 117.08 -1.848 . . . . 0.0 112.702 -160.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 1.246 ' HB3' ' NH2' ' B' ' 150' ' ' ARG . 4.4 tmtp? -73.66 1.99 9.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.093 175.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 66.97 13.26 9.4 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . -92.05 17.37 57.1 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 119.088 -1.529 . . . . 0.0 111.311 169.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . 1.246 ' NH2' ' HB3' ' B' ' 147' ' ' LYS . 0.7 OUTLIER -128.31 -81.27 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -168.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 7.6 tp -63.67 -46.87 93.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.823 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -112.31 -137.47 7.05 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.917 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.692 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' A' ' 6' ' ' LYS . 97.8 mttt -105.05 115.6 30.55 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.04 -77.4 1.35 Allowed Glycine 0 N--CA 1.467 0.757 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.1 mtt -85.86 -58.39 2.67 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.7 t -113.61 -102.48 0.41 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 96.8 mttt -120.7 -88.64 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.436 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 63.0 mtt -146.17 62.91 8.54 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.923 168.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 7' ' ' MET . 13.3 Cg_exo -77.91 99.1 1.25 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 CA-C-N 122.114 1.791 . . . . 0.0 107.953 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 14.5 tt0 -89.66 142.92 27.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 122.409 1.1 . . . . 0.0 112.331 -168.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -131.85 101.72 5.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.043 -175.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -88.15 121.11 30.17 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.877 0.846 . . . . 0.0 110.879 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 30.3 mt -101.42 169.84 8.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 176.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.84 ' HB3' ' O ' ' B' ' 105' ' ' SER . 93.5 mtt180 -129.95 90.8 3.02 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.903 -176.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.44 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 49.1 m0 -119.48 146.77 41.96 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.948 -173.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.59 145.34 48.33 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 121.802 1.668 . . . . 0.0 111.122 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -59.63 -33.41 71.47 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.99 -34.04 75.77 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.627 -0.671 . . . . 0.0 112.332 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.3 t -63.99 -40.5 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.828 -0.545 . . . . 0.0 110.945 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.899 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 69.1 mt -66.2 -33.99 77.01 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -65.56 -29.23 69.82 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.638 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tt -80.24 -33.49 37.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.382 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.66 -33.48 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 168.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.899 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 28.7 mmm-85 -67.93 -40.49 83.32 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.36 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.14 -57.47 7.57 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.085 -0.384 . . . . 0.0 111.372 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.2 p -53.97 -39.66 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.73 -37.06 85.95 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.15 -40.69 82.33 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.98 -49.56 77.18 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -78.32 -12.35 60.0 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.598 175.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.7 61.88 5.52 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.051 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.5 ttt -143.56 146.44 33.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.77 0.795 . . . . 0.0 109.033 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.5 p -70.66 143.69 51.32 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.824 0.821 . . . . 0.0 110.648 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -65.05 -37.14 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -61.84 -47.17 86.26 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.358 -0.839 . . . . 0.0 112.572 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.7 m -73.87 -18.6 60.9 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -73.23 -55.58 6.25 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.805 -0.559 . . . . 0.0 111.961 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -69.76 -27.13 32.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -58.26 -38.67 77.37 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.052 0.929 . . . . 0.0 109.5 168.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -77.83 -16.48 58.28 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.405 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.4 mt -80.83 -37.56 29.81 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.837 1.199 . . . . 0.0 111.566 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.4 m -73.67 -9.52 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.145 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -107.64 -15.81 14.5 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.12 -19.69 17.06 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.483 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.976 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 34.6 t -96.51 -70.3 0.72 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.634 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.6 OUTLIER -73.71 141.79 46.37 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 166.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.115 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 37.2 ttpt -167.9 -47.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 120.962 -1.086 . . . . 0.0 111.228 -172.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.115 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 2.3 tmtt? 135.85 54.48 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.048 0.928 . . . . 0.0 108.535 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -149.97 -35.72 0.16 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.463 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.0 84.76 0.59 Allowed Glycine 0 N--CA 1.468 0.789 0 N-CA-C 104.996 -3.241 . . . . 0.0 104.996 -169.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.976 ' HB3' ' O ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -115.58 -97.46 0.45 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.63 1.205 . . . . 0.0 109.765 -161.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.463 ' H ' ' HB2' ' A' ' 50' ' ' ARG . 6.8 tp -46.51 -49.12 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 113.376 -1.738 . . . . 0.0 113.992 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 170.79 94.09 0.09 OUTLIER Glycine 0 CA--C 1.524 0.645 0 C-N-CA 119.859 -1.163 . . . . 0.0 110.216 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.736 179.795 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.905 ' O ' ' CB ' ' B' ' 102' ' ' LYS . 66.4 mtt . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.905 ' CB ' ' O ' ' B' ' 101' ' ' MET . 88.5 tttt 119.83 98.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.229 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.88 101.29 1.22 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 67.0 mtt -145.1 108.52 4.62 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.84 ' O ' ' HB3' ' A' ' 13' ' ' ARG . 43.9 m 78.49 -63.35 0.3 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.364 -175.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . 0.419 ' HG3' ' HG2' ' B' ' 107' ' ' MET . 63.2 pttt -61.94 -39.51 92.34 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -176.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' MET . . . . . 0.453 ' HB2' ' HD3' ' B' ' 108' ' ' PRO . 26.4 mmt -95.69 -45.9 0.26 Allowed Pre-proline 0 N--CA 1.474 0.735 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' B' ' 107' ' ' MET . 33.9 Cg_exo -65.46 98.6 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.594 2.196 . . . . 0.0 112.6 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 78.9 mt-30 -99.86 160.5 14.26 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 122.468 1.127 . . . . 0.0 111.565 -176.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -131.13 101.77 5.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -90.52 120.96 32.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.245 -170.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 37.6 mt -111.68 175.17 5.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.825 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -142.14 96.58 2.98 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.65 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' TRP . . . . . 0.423 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 51.0 m0 -120.62 143.74 37.02 Favored Pre-proline 0 N--CA 1.474 0.76 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.028 -174.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -49.19 139.81 26.65 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 121.778 1.652 . . . . 0.0 111.396 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.02 -29.56 67.35 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -175.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.24 -43.54 91.08 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.626 -0.672 . . . . 0.0 111.623 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.14 -47.93 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.598 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.459 ' O ' ' HG3' ' B' ' 123' ' ' ARG . 59.1 tp -61.27 -46.08 91.81 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -69.4 -24.07 63.8 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 25.5 tp -74.89 -32.06 61.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.531 169.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.44 -28.88 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.64 -0.662 . . . . 0.0 110.41 167.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' B' ' 119' ' ' LEU . 94.3 mtt180 -74.04 -34.97 64.27 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.919 -0.488 . . . . 0.0 111.99 172.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -63.27 -52.85 60.38 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.046 -0.409 . . . . 0.0 110.629 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 97.9 t -55.88 -38.65 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.32 -34.79 77.3 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.34 -40.41 70.74 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.62 -47.63 84.55 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -75.99 -8.58 57.28 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.745 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.51 59.5 8.2 Favored Glycine 0 N--CA 1.47 0.935 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.951 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 24.7 ttt -151.74 149.09 28.67 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 89.7 p -70.18 151.27 45.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.975 0.893 . . . . 0.0 111.032 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 16.1 m -64.0 -36.98 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -58.75 -52.04 67.39 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.778 -0.576 . . . . 0.0 111.551 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 57.8 m -71.11 -21.52 62.2 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -70.49 -60.16 2.42 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.716 -0.615 . . . . 0.0 111.832 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' ILE . . . . . 0.439 HD12 ' H ' ' B' ' 137' ' ' ILE . 4.4 mp -69.31 -26.71 32.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.953 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -59.85 -35.85 75.64 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.046 169.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -77.87 -20.47 52.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.831 177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 84.3 mt -79.8 -35.08 39.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.566 1.076 . . . . 0.0 112.167 175.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 32.9 m -70.06 -24.29 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.375 170.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 32.1 mmt -86.21 -27.87 24.22 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.502 -0.749 . . . . 0.0 112.383 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.92 -28.85 63.76 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.093 170.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 63.8 m -79.68 -47.82 14.73 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.43 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.654 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 14.0 m-30 -78.21 94.23 4.73 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.654 ' HG3' ' O ' ' B' ' 145' ' ' PHE . 1.4 mtpt 157.89 -20.99 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.163 -1.015 . . . . 0.0 113.255 -167.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.804 ' HB3' ' NH2' ' B' ' 150' ' ' ARG . 8.1 tmtt? -56.55 -29.68 62.24 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.973 0.892 . . . . 0.0 112.046 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.37 -26.23 4.3 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.142 -175.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 113.58 62.37 0.42 Allowed Glycine 0 N--CA 1.467 0.724 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 -172.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . 0.804 ' NH2' ' HB3' ' B' ' 147' ' ' LYS . 0.1 OUTLIER -87.28 -80.24 0.26 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.827 0.823 . . . . 0.0 109.081 -176.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 8.2 tp -58.09 -45.41 88.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.203 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 165.91 86.95 0.06 OUTLIER Glycine 0 CA--C 1.524 0.638 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.452 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.145 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -140.66 92.51 2.52 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 175.54 84.15 0.06 OUTLIER Glycine 0 CA--C 1.524 0.621 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.873 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.483 ' HB2' ' H ' ' A' ' 9' ' ' GLN . 66.9 mtt -134.08 -69.58 0.53 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.7 t -95.95 -111.9 0.13 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.617 ' HG3' ' H ' ' A' ' 7' ' ' MET . 19.3 ptpt -107.35 -55.17 2.38 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 166.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.617 ' H ' ' HG3' ' A' ' 6' ' ' LYS . 65.9 mtt -95.78 146.02 30.57 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 166.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 1.023 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 35.1 Cg_exo -41.5 123.18 2.05 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.14 2.56 . . . . 0.0 116.538 -176.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.483 ' H ' ' HB2' ' A' ' 4' ' ' MET . 28.4 tt0 -79.0 148.68 32.45 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.717 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -133.72 110.73 10.03 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -174.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -89.98 141.9 28.22 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.052 0.929 . . . . 0.0 112.011 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 56.4 mt -123.63 168.11 13.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.785 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -130.61 84.8 2.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.477 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.432 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 43.8 m0 -120.0 143.36 35.21 Favored Pre-proline 0 N--CA 1.474 0.749 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.643 -171.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.72 147.83 48.08 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.005 1.803 . . . . 0.0 111.428 171.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.666 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 12.6 ttp180 -59.83 -38.78 83.02 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.16 -35.14 79.32 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.8 t -65.61 -38.62 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.627 -0.671 . . . . 0.0 111.274 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.413 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 74.2 mt -62.49 -46.09 90.05 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.059 172.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -51.57 -29.94 19.07 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.0 tp -81.3 -36.45 29.81 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.92 -34.34 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 121.774 -0.579 . . . . 0.0 110.946 173.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 19' ' ' LEU . 46.5 mtm180 -68.84 -39.81 79.74 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.088 -0.382 . . . . 0.0 110.422 170.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -61.05 -57.72 11.39 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.56 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 p -57.49 -38.86 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.83 85.01 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.14 -36.95 82.97 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -62.45 -45.31 93.66 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -75.41 -11.82 60.12 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.622 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.8 62.09 4.79 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.008 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.6 ttt -146.9 144.64 29.41 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.845 0.831 . . . . 0.0 109.412 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.8 t -70.4 143.44 51.87 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.709 0.766 . . . . 0.0 110.187 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.0 m -61.47 -39.87 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 114.995 1.479 . . . . 0.0 114.995 -173.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -59.88 -49.1 79.02 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.915 -1.116 . . . . 0.0 112.385 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.9 m -73.63 -17.12 61.2 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -73.67 -57.1 4.22 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.723 -0.61 . . . . 0.0 111.912 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 37' ' ' ILE . 4.6 mp -67.15 -29.27 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -57.31 -38.93 74.78 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.827 0.823 . . . . 0.0 109.821 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -78.68 -19.24 52.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.456 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.4 mt -78.45 -40.3 36.06 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.748 1.158 . . . . 0.0 111.375 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.94 -11.3 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.765 174.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.554 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 26.0 mmt -105.62 -13.72 15.5 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.116 -0.99 . . . . 0.0 112.923 176.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -93.87 -26.31 16.96 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.959 171.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 1.001 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 36.9 t -94.18 -70.15 0.72 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 176.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.916 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 3.5 t80 -74.14 156.4 37.4 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 167.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.052 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER 167.28 -51.55 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 120.717 -1.239 . . . . 0.0 110.06 -177.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.052 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 2.2 tmtt? 134.51 59.19 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -151.55 -43.74 0.11 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.786 -169.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.31 65.85 0.02 OUTLIER Glycine 0 N--CA 1.467 0.712 0 N-CA-C 106.669 -2.572 . . . . 0.0 106.669 -171.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 1.001 ' HB3' ' O ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -108.31 -122.46 0.25 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.532 1.158 . . . . 0.0 109.834 -167.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.4 tp -46.28 -45.34 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 113.629 -1.623 . . . . 0.0 113.922 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 177.41 91.51 0.08 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.191 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.899 -179.915 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.33 -138.99 0.24 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.694 0.759 . . . . 0.0 110.275 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.49 80.92 1.33 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.129 -1.034 . . . . 0.0 110.61 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 66.5 mtt -91.12 -62.53 1.43 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.992 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.411 ' HB2' HE21 ' B' ' 109' ' ' GLN . 32.2 t -85.72 -102.61 0.06 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . 0.438 ' HG3' ' H ' ' B' ' 107' ' ' MET . 51.6 pttt -118.47 -54.77 2.26 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 168.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' MET . . . . . 0.438 ' H ' ' HG3' ' B' ' 106' ' ' LYS . 23.8 mmt -93.32 152.34 41.03 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 165.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.666 ' HG2' ' HB2' ' A' ' 16' ' ' ARG . 66.9 Cg_exo -45.95 127.76 10.71 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.787 2.325 . . . . 0.0 115.964 -176.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 24.8 tt0 -81.23 153.36 27.2 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.257 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -139.74 108.33 5.89 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -95.32 131.69 41.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.224 -173.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.446 HD13 ' CZ2' ' B' ' 114' ' ' TRP . 61.9 mt -111.7 175.36 5.46 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.68 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -133.34 86.52 2.3 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.792 0.806 . . . . 0.0 109.468 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' TRP . . . . . 0.446 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 47.1 m0 -117.41 143.87 32.9 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.497 -172.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.38 142.75 68.53 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 121.923 1.749 . . . . 0.0 111.022 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 1.023 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . 6.6 ttp180 -60.32 -31.76 70.59 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.803 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.31 -40.3 93.59 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.592 -0.693 . . . . 0.0 112.125 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 64.5 t -66.37 -44.64 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.025 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.88 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 59.9 tp -67.22 -32.95 74.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' B' ' 123' ' ' ARG . 18.6 m-20 -69.95 -28.65 65.73 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.357 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 16.7 tp -78.13 -31.33 49.8 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.604 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 72.0 t -64.03 -34.14 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 167.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . 0.88 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 28.0 mmm-85 -64.94 -37.26 87.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 171.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.38 -55.64 22.79 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.044 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 92.0 t -54.55 -39.29 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.38 -34.21 76.26 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.29 -41.54 69.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 175.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -60.39 -49.67 76.65 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -76.94 -12.72 59.99 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.631 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 63.72 58.79 9.97 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.006 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 26.1 ttt -146.46 148.15 31.96 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 91.9 p -67.78 147.3 52.78 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.039 0.923 . . . . 0.0 111.084 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 16.2 m -64.86 -36.44 77.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -61.02 -47.65 85.43 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.403 -0.811 . . . . 0.0 112.113 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 57.3 m -71.64 -21.56 61.81 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -70.89 -58.96 3.08 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.847 -0.533 . . . . 0.0 112.089 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' ILE . . . . . 0.426 HD12 ' H ' ' B' ' 137' ' ' ILE . 4.5 mp -69.24 -26.62 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 176.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -59.12 -36.59 75.46 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.779 0.8 . . . . 0.0 109.886 169.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' GLN . . . . . 0.42 HE21 ' HA ' ' B' ' 139' ' ' GLN . 1.6 tp60 -78.55 -20.64 50.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.988 177.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.65 -30.09 32.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.435 1.016 . . . . 0.0 112.422 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 31.3 m -72.41 -28.64 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.448 169.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.511 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 0.9 OUTLIER -78.1 -30.5 49.54 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.903 0.774 . . . . 0.0 112.313 175.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -73.1 -28.65 62.4 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.418 -0.801 . . . . 0.0 111.354 171.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 70.0 m -75.63 -37.79 59.45 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.677 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.626 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 23.5 m-85 -81.06 79.3 7.76 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.626 ' HG3' ' O ' ' B' ' 145' ' ' PHE . 10.7 mtpt 177.8 -30.38 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.39 -168.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -84.79 35.94 0.59 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 118.961 -1.095 . . . . 0.0 112.418 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -155.69 -17.05 0.11 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.216 174.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.65 65.68 1.95 Allowed Glycine 0 N--CA 1.468 0.791 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -170.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . 0.46 ' HB2' ' H ' ' B' ' 151' ' ' ILE . 43.8 mtt180 -101.51 -82.22 0.47 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.573 1.178 . . . . 0.0 109.285 -168.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.46 ' H ' ' HB2' ' B' ' 150' ' ' ARG . 7.7 tp -59.54 -39.89 80.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 113.577 -1.647 . . . . 0.0 113.183 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -85.67 -96.56 0.76 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.225 -0.988 . . . . 0.0 110.875 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.404 -179.597 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -174.8 125.32 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.351 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.09 -55.84 0.03 OUTLIER Glycine 0 CA--C 1.526 0.767 0 C-N-CA 119.943 -1.122 . . . . 0.0 110.947 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.7 mtt -140.06 -59.69 0.54 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.652 ' HB2' ' CB ' ' B' ' 113' ' ' ARG . 79.1 p -160.23 90.35 0.89 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 122.117 0.96 . . . . 0.0 109.371 174.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -129.43 -24.33 2.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.431 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.552 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 26.8 ttt -156.77 -43.66 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.552 ' CD ' ' H ' ' A' ' 7' ' ' MET . 52.1 Cg_exo -63.02 99.81 0.23 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.508 2.139 . . . . 0.0 113.404 -176.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 18.2 tt0 -102.58 155.99 17.91 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.492 -175.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -136.46 107.4 6.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -94.61 124.96 38.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.25 -169.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 46.5 mt -115.38 169.9 8.8 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.795 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -142.52 102.16 4.02 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.281 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.464 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 54.5 m0 -122.29 143.47 39.39 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.215 -173.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -46.17 139.43 11.97 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 121.916 1.744 . . . . 0.0 111.544 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -57.93 -31.26 66.64 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -173.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.15 -43.11 96.2 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.582 -0.699 . . . . 0.0 111.896 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.06 -49.83 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.122 0.487 . . . . 0.0 111.409 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.973 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 63.1 tp -63.36 -35.87 81.81 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.8 -28.62 63.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.31 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.4 tp -79.24 -31.27 43.5 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.878 173.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.46 -35.63 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 O-C-N 121.462 -0.774 . . . . 0.0 109.017 168.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.973 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 29.3 mmm-85 -64.06 -39.07 93.27 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 171.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -64.11 -53.95 41.53 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.191 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.2 t -56.32 -36.87 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.94 -35.78 81.23 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.52 -0.738 . . . . 0.0 112.931 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -71.57 -40.91 69.62 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -61.92 -47.35 85.3 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -74.19 -12.94 60.72 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.612 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.32 57.49 13.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.036 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 53.7 tpp -147.51 148.14 30.89 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.983 0.897 . . . . 0.0 108.703 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.7 m -65.71 149.84 49.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 122.31 1.053 . . . . 0.0 111.555 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -63.75 -36.44 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -59.08 -53.98 52.26 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.856 -0.528 . . . . 0.0 111.698 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.8 m -70.45 -22.49 62.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -69.43 -59.6 2.88 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.796 -0.565 . . . . 0.0 112.128 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.1 mp -70.83 -27.0 28.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.728 -0.389 . . . . 0.0 109.981 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -56.52 -37.81 70.97 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.612 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.425 HE21 ' HA ' ' A' ' 39' ' ' GLN . 2.4 tp60 -79.21 -24.56 43.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.591 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 47.5 mt -79.23 -37.75 37.29 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 118.669 -1.213 . . . . 0.0 112.213 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 m -69.09 -28.65 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.583 172.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -85.41 -26.34 26.46 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.356 -0.84 . . . . 0.0 113.261 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -75.86 -35.48 59.9 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.867 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.1 t -87.72 -68.01 0.79 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.882 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -73.11 114.02 10.8 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 176.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.031 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 39.7 ttpt -169.26 -46.71 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.062 0.934 . . . . 0.0 110.047 -169.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.031 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 2.3 tmtt? 143.66 53.47 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -155.93 -35.61 0.09 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.244 -173.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.88 -60.77 0.04 OUTLIER Glycine 0 N--CA 1.465 0.57 0 N-CA-C 108.171 -1.971 . . . . 0.0 108.171 -172.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.882 ' HG2' ' HA ' ' A' ' 45' ' ' PHE . 89.6 mtt180 73.57 -86.57 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 168.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.623 HG22 ' HB3' ' A' ' 50' ' ' ARG . 2.4 tp -146.84 -54.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 112.872 -1.967 . . . . 0.0 110.005 -159.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.51 -92.44 1.17 Allowed Glycine 0 N--CA 1.467 0.735 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.622 179.433 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -89.46 167.75 12.74 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 122.126 0.965 . . . . 0.0 111.059 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -167.06 -78.48 0.04 OUTLIER Glycine 0 N--CA 1.466 0.666 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.203 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 66.1 mtt -82.46 -59.08 2.65 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.944 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 40.9 t -96.05 -84.76 0.34 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . 0.495 ' H ' ' HD3' ' B' ' 108' ' ' PRO . 60.4 pttt 178.48 54.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' MET . . . . . 0.557 ' O ' ' SD ' ' B' ' 107' ' ' MET . 0.0 OUTLIER 54.21 63.54 7.4 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -173.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.495 ' HD3' ' H ' ' B' ' 106' ' ' LYS . 41.1 Cg_endo -98.76 76.06 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 121.703 1.602 . . . . 0.0 110.084 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 14.6 tt0 -84.67 146.46 27.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.193 0.997 . . . . 0.0 111.389 -173.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -133.31 109.5 9.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -95.38 118.84 32.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.203 -169.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.451 HD13 ' CZ2' ' B' ' 114' ' ' TRP . 56.8 mt -107.33 169.5 8.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.628 0.728 . . . . 0.0 109.892 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.652 ' CB ' ' HB2' ' A' ' 5' ' ' SER . 95.4 mtt180 -139.62 94.92 2.84 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.766 0.793 . . . . 0.0 109.045 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' TRP . . . . . 0.451 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 50.6 m0 -116.28 149.4 43.51 Favored Pre-proline 0 N--CA 1.474 0.737 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.945 -173.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.52 142.04 40.33 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 121.799 1.666 . . . . 0.0 110.978 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -59.1 -35.81 74.06 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.79 -38.03 89.62 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.725 -0.609 . . . . 0.0 112.385 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 78.2 t -63.46 -38.73 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.346 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.43 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 57.6 mt -62.2 -45.61 92.59 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 119.971 -0.692 . . . . 0.0 112.834 173.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -57.63 -31.45 66.28 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 24.8 tp -76.54 -35.54 58.2 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.611 173.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 79.6 t -63.2 -32.72 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.855 -0.528 . . . . 0.0 110.501 168.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 10.9 mmt180 -68.32 -36.83 79.89 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.99 -0.443 . . . . 0.0 110.724 172.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -64.19 -55.84 18.91 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.037 -0.415 . . . . 0.0 110.714 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.38 -37.48 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.65 -32.31 73.76 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.49 -42.85 64.41 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 174.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.16 -50.54 73.66 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -78.56 -13.47 59.81 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.448 175.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.02 58.88 11.45 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.104 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 21.7 ttt -138.49 144.51 40.05 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.896 0.855 . . . . 0.0 109.065 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 66.3 m -68.44 155.33 40.08 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.129 0.966 . . . . 0.0 111.068 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 17.5 m -63.38 -39.43 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -62.33 -50.65 70.79 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.548 -0.72 . . . . 0.0 112.4 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 59.9 m -71.52 -29.55 64.91 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -66.34 -58.71 4.72 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.77 -0.581 . . . . 0.0 112.257 -177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 3.6 mp -70.43 -23.35 24.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.417 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -57.97 -40.27 80.19 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.052 167.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -73.25 -22.2 60.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.679 -0.809 . . . . 0.0 112.591 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 68.0 mt -83.66 -32.11 25.8 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.831 1.196 . . . . 0.0 112.685 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 17.4 m -75.0 -12.01 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.482 169.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.816 ' O ' ' HG2' ' B' ' 146' ' ' LYS . 27.2 mmt -99.63 -18.17 17.44 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.269 -0.894 . . . . 0.0 112.791 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -89.39 -24.5 21.92 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.301 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . 1.121 ' O ' ' HB3' ' B' ' 150' ' ' ARG . 66.1 m -95.82 -72.31 0.64 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.782 ' O ' ' HB2' ' B' ' 146' ' ' LYS . 2.3 t80 -71.8 158.72 35.57 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 165.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.816 ' HG2' ' O ' ' B' ' 142' ' ' MET . 0.0 OUTLIER 170.87 -51.31 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 120.207 -1.558 . . . . 0.0 109.843 -175.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.703 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 21.5 mmmt 128.78 64.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -176.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -151.47 -25.34 0.2 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.129 -175.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 108.39 79.39 1.15 Allowed Glycine 0 N--CA 1.469 0.883 0 N-CA-C 105.108 -3.197 . . . . 0.0 105.108 -169.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . 1.121 ' HB3' ' O ' ' B' ' 144' ' ' SER . 0.0 OUTLIER -110.41 -99.8 0.4 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 122.546 1.165 . . . . 0.0 109.915 -162.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 6.6 tp -47.59 -49.26 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 113.448 -1.705 . . . . 0.0 113.799 172.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.31 82.23 0.05 OUTLIER Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.79 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.802 ' NZ ' HH22 ' B' ' 123' ' ' ARG . 99.6 mttt -97.82 -140.37 0.3 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.636 0.732 . . . . 0.0 110.222 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 147.41 96.16 0.17 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.6 mtt -122.07 -65.46 1.12 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.542 ' HB2' HE21 ' A' ' 9' ' ' GLN . 35.5 t -83.47 -81.61 0.16 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 174.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -136.74 -63.8 0.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 170.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.8 mtt -87.31 155.88 54.3 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 165.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.892 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 64.2 Cg_exo -47.19 127.11 12.47 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.522 2.148 . . . . 0.0 116.065 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.542 HE21 ' HB2' ' A' ' 5' ' ' SER . 26.3 tt0 -82.34 154.6 25.19 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.096 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -135.76 107.8 7.17 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -173.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -98.79 130.3 45.23 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.783 -171.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.456 HD13 ' CZ2' ' A' ' 14' ' ' TRP . 31.6 mt -115.28 174.46 5.98 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.623 0.725 . . . . 0.0 110.584 -175.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.611 ' HB3' ' HA ' ' B' ' 106' ' ' LYS . 96.6 mtt180 -138.89 94.23 2.8 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.481 0.658 . . . . 0.0 109.422 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.456 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 53.6 m0 -119.98 150.02 50.07 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.741 -175.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.18 143.47 63.43 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 121.733 1.622 . . . . 0.0 110.931 170.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.27 -30.56 66.69 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -68.93 -39.23 79.74 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.52 -0.737 . . . . 0.0 111.995 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.2 t -67.26 -42.7 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.16 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.936 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 60.0 tp -66.65 -35.78 80.99 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -71.9 -21.52 61.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.774 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.1 tp -80.15 -34.54 37.6 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.859 -0.526 . . . . 0.0 111.257 171.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.52 -32.95 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.528 -0.733 . . . . 0.0 109.403 170.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.936 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 27.4 mmm-85 -65.84 -38.64 89.42 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.773 0.321 . . . . 0.0 111.57 170.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -62.87 -56.76 14.42 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 122.252 -0.28 . . . . 0.0 111.031 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG21 ' CE1' ' B' ' 145' ' ' PHE . 98.9 t -56.68 -36.84 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.21 -33.38 75.36 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.84 -41.58 64.65 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -60.83 -49.19 78.47 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -77.63 -6.68 54.64 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.194 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.65 59.77 8.77 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.491 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.5 ttt -146.97 147.25 30.54 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.4 m -68.47 145.29 54.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.027 0.918 . . . . 0.0 110.514 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.7 m -61.81 -36.63 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -57.59 -52.48 65.22 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.431 -0.793 . . . . 0.0 111.582 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.2 m -72.14 -19.76 61.72 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -73.03 -57.44 4.03 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.636 -0.665 . . . . 0.0 111.982 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.464 HD12 ' H ' ' A' ' 37' ' ' ILE . 4.5 mp -69.66 -26.64 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -58.11 -39.46 78.7 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.038 0.923 . . . . 0.0 109.538 168.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -73.68 -20.69 60.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.981 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.55 -34.0 41.39 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.043 -1.036 . . . . 0.0 111.673 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 m -78.47 2.23 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.48 170.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.71 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 1.9 mmt -113.88 -19.62 11.4 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.159 -0.963 . . . . 0.0 111.806 169.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -84.87 -22.92 29.19 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.884 171.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 68.2 m -87.59 -48.21 8.08 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -72.93 95.62 2.0 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.718 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 8.4 mmmt -156.64 19.05 0.33 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 118.621 -1.232 . . . . 0.0 113.832 -165.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.718 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 5.4 tmtt? 91.45 -12.83 0.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 1.314 ' HB2' ' NH2' ' A' ' 50' ' ' ARG . 2.2 mp0 -58.53 -37.13 75.0 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.63 -0.669 . . . . 0.0 110.267 169.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.23 36.65 0.05 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 119.615 -1.278 . . . . 0.0 114.089 172.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 1.314 ' NH2' ' HB2' ' A' ' 48' ' ' GLU . 0.2 OUTLIER -121.36 -93.04 0.53 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.038 0.919 . . . . 0.0 109.096 -176.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.8 tp -62.98 -40.17 87.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.5 -157.96 34.17 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.226 -0.987 . . . . 0.0 111.324 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.848 179.727 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -167.97 114.37 0.7 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.89 99.29 1.57 Allowed Glycine 0 N--CA 1.466 0.653 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 26.3 mmt -131.26 -42.98 1.06 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 75.0 m -154.48 -46.16 0.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.864 0.364 . . . . 0.0 110.087 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . 0.611 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 98.1 mttt -66.2 -35.67 81.07 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -176.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' MET . . . . . 0.473 ' HB2' ' HD3' ' B' ' 108' ' ' PRO . 64.4 mtt -72.63 -49.29 8.49 Favored Pre-proline 0 N--CA 1.472 0.651 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.473 ' HD3' ' HB2' ' B' ' 107' ' ' MET . 23.4 Cg_exo -67.47 98.08 0.46 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.381 2.054 . . . . 0.0 111.214 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 19.3 tt0 -99.1 147.97 24.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.936 0.874 . . . . 0.0 110.218 -174.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -133.58 108.91 8.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.756 -173.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -90.87 140.11 30.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.044 0.926 . . . . 0.0 111.956 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 55.7 mt -125.14 164.65 19.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.683 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -127.31 87.88 2.71 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.78 0.8 . . . . 0.0 109.563 -173.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' TRP . . . . . 0.439 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 47.5 m0 -120.0 146.07 41.29 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.972 -170.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.99 142.96 75.19 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 121.924 1.75 . . . . 0.0 110.922 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.892 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . 7.6 ttp180 -60.21 -32.0 70.69 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 119.911 -0.716 . . . . 0.0 112.639 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.04 -38.96 89.71 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.619 -0.676 . . . . 0.0 112.304 175.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 95.4 t -66.98 -42.64 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.789 -0.569 . . . . 0.0 111.184 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' B' ' 123' ' ' ARG . 57.5 tp -65.89 -39.93 91.09 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 176.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -66.57 -22.0 66.14 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 41.8 tp -73.33 -34.62 65.77 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.235 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.37 -28.61 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.738 -0.601 . . . . 0.0 110.723 168.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . 0.802 HH22 ' NZ ' ' A' ' 2' ' ' LYS . 94.4 mtt180 -74.92 -34.99 62.21 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.849 -0.532 . . . . 0.0 111.762 173.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -63.32 -54.04 43.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.447 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.431 HG21 ' HG3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -60.39 -37.58 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.43 -30.4 71.53 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.67 -47.19 55.89 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.863 -0.523 . . . . 0.0 111.907 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -56.61 -52.97 62.82 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 -80.24 -13.97 58.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.566 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.54 60.29 8.44 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.946 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 25.8 ttt -137.13 144.17 42.87 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.938 0.875 . . . . 0.0 109.239 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 66.7 m -70.76 141.44 51.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.863 0.84 . . . . 0.0 110.37 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 19.3 m -64.82 -35.59 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -59.55 -52.56 65.02 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.328 -0.858 . . . . 0.0 111.623 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 61.5 m -70.57 -18.41 62.91 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -73.16 -56.19 5.45 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.635 -0.665 . . . . 0.0 112.239 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' ILE . . . . . 0.411 HD12 ' H ' ' B' ' 137' ' ' ILE . 4.4 mp -69.8 -26.37 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -57.76 -36.44 72.12 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.849 0.833 . . . . 0.0 109.853 168.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -78.99 -21.82 46.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.135 176.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 82.9 mt -78.89 -29.55 44.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.892 1.223 . . . . 0.0 112.344 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 29.6 m -73.57 -29.07 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.994 171.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.93 -23.61 33.41 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.378 -0.826 . . . . 0.0 112.632 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -76.67 -29.71 56.48 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.21 -0.931 . . . . 0.0 110.947 170.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 36.4 t -75.11 -44.7 45.71 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.147 -0.345 . . . . 0.0 110.392 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.662 ' HD1' ' CB ' ' B' ' 150' ' ' ARG . 9.9 m-30 -79.14 102.09 8.28 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.894 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 0.0 OUTLIER -174.7 -56.58 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 118.185 -1.406 . . . . 0.0 110.9 -159.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.894 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 2.3 tmtp? 158.02 61.37 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -148.35 -48.66 0.16 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.284 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . 0.637 ' H ' ' HG3' ' B' ' 150' ' ' ARG . . . 163.19 89.45 0.07 OUTLIER Glycine 0 N--CA 1.467 0.738 0 N-CA-C 106.675 -2.57 . . . . 0.0 106.675 -174.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . 0.662 ' CB ' ' HD1' ' B' ' 145' ' ' PHE . 0.1 OUTLIER -159.27 -129.68 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 119.241 -0.984 . . . . 0.0 111.298 -164.014 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.424 ' H ' ' HB2' ' B' ' 150' ' ' ARG . 0.0 OUTLIER -47.76 -43.56 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.84 72.54 0.1 Allowed Glycine 0 N--CA 1.467 0.736 0 C-N-CA 119.374 -1.393 . . . . 0.0 111.526 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.589 -0.719 . . . . 0.0 109.862 179.93 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.894 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 66.5 mtt . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.894 ' CB ' ' O ' ' A' ' 1' ' ' MET . 63.3 tttp 120.6 105.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.241 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.67 -76.99 0.02 OUTLIER Glycine 0 N--CA 1.465 0.621 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.314 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.7 mtt -99.24 -67.87 0.83 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.662 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.466 ' HB2' HE21 ' A' ' 9' ' ' GLN . 33.1 t -92.31 -91.32 0.17 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -127.51 -64.37 0.99 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 169.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.1 mtt -86.01 148.91 49.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 165.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.936 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 52.2 Cg_exo -44.72 127.31 7.93 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.773 2.315 . . . . 0.0 116.437 -175.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.466 HE21 ' HB2' ' A' ' 5' ' ' SER . 27.5 tt0 -81.41 155.58 25.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.596 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -139.72 109.52 6.34 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -174.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -95.84 133.39 40.05 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.307 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.452 HD13 ' CZ2' ' A' ' 14' ' ' TRP . 51.8 mt -114.69 174.69 5.84 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.661 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -133.2 87.68 2.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.853 0.835 . . . . 0.0 109.441 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.452 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 47.5 m0 -117.49 142.95 31.22 Favored Pre-proline 0 N--CA 1.473 0.714 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.341 -172.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.14 142.02 67.75 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 121.831 1.687 . . . . 0.0 111.045 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.986 ' HB3' ' HG2' ' B' ' 108' ' ' PRO . 0.3 OUTLIER -59.18 -29.75 67.69 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -67.56 -40.21 84.92 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.58 -0.7 . . . . 0.0 111.822 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.64 -45.3 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.953 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.867 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 54.8 tp -67.1 -34.72 78.24 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 68.0 m-20 -71.88 -25.47 61.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.589 176.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 25.8 tp -80.0 -30.7 39.69 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.346 172.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.0 t -64.77 -32.99 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 166.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.867 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 32.2 mmm-85 -64.9 -38.37 90.74 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.838 0.351 . . . . 0.0 111.821 171.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -63.59 -53.25 54.55 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.176 -0.327 . . . . 0.0 110.885 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.407 HG13 HG21 ' B' ' 151' ' ' ILE . 71.0 t -55.84 -40.56 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 176.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.4 -31.92 71.85 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -72.2 -41.73 66.62 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 174.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.96 -49.65 76.6 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -76.3 -8.75 57.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.137 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.65 56.68 21.64 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.864 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.5 tpt -150.83 148.03 27.98 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.4 t -65.12 147.87 52.7 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.123 0.964 . . . . 0.0 111.459 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.1 m -63.6 -34.88 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -58.8 -50.51 73.68 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.649 -0.657 . . . . 0.0 111.483 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -72.57 -19.63 61.46 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -71.98 -58.36 3.51 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.66 -0.65 . . . . 0.0 111.82 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.84 -29.84 46.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -57.63 -37.06 72.68 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.018 170.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.417 HE21 ' HA ' ' A' ' 39' ' ' GLN . 2.6 tp60 -74.28 -27.83 60.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.739 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.7 mt -76.32 -26.45 55.8 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 119.015 -1.074 . . . . 0.0 112.301 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.5 t -84.16 -3.52 7.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.659 175.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.741 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 1.8 mmt -114.23 -12.93 12.4 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.05 -1.031 . . . . 0.0 111.674 168.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -86.2 -27.17 24.68 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.529 171.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.0 t -83.55 -51.18 7.54 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -72.45 97.28 2.05 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.94 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 7.4 mmmt -160.72 -57.19 0.05 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.183 -1.007 . . . . 0.0 108.994 -164.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.94 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER 157.9 22.85 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.6 173.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 1.236 ' HB2' ' NH2' ' A' ' 50' ' ' ARG . 42.4 mt-10 -83.19 -34.2 25.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 169.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.4 34.16 0.05 OUTLIER Glycine 0 CA--C 1.531 1.086 0 C-N-CA 119.707 -1.235 . . . . 0.0 114.263 174.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 1.236 ' NH2' ' HB2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -118.51 -91.56 0.55 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.137 0.969 . . . . 0.0 108.945 -177.36 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.77 -42.41 96.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' HA3' ' HD3' ' A' ' 47' ' ' LYS . . . -96.02 -137.18 9.14 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.97 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.151 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.991 ' O ' ' HB2' ' B' ' 102' ' ' LYS . 66.0 mtt . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.991 ' HB2' ' O ' ' B' ' 101' ' ' MET . 88.2 tttt 149.9 -79.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.893 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.54 89.43 2.11 Favored Glycine 0 N--CA 1.467 0.704 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.405 ' HB2' ' H ' ' B' ' 109' ' ' GLN . 67.1 mtt -91.27 -55.69 3.43 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.382 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 29.5 t -91.09 -109.01 0.09 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -110.56 -65.37 1.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 168.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' MET . . . . . . . . . . . . . 67.5 mtt -83.12 136.93 43.23 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 164.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.986 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 34.8 Cg_exo -41.46 124.85 2.53 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 123.044 2.496 . . . . 0.0 116.849 -174.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 28.2 tt0 -77.52 149.07 34.97 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.887 -177.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -133.47 110.65 10.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.631 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -90.42 141.93 28.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.047 0.927 . . . . 0.0 111.881 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.469 HD13 ' CZ2' ' B' ' 114' ' ' TRP . 50.5 mt -123.91 165.73 16.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.002 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -129.36 88.67 2.73 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.86 0.838 . . . . 0.0 109.575 -173.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' TRP . . . . . 0.469 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 48.9 m0 -121.58 147.48 47.96 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.91 -171.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.95 143.94 70.19 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 121.914 1.742 . . . . 0.0 111.083 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.936 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . 9.9 ttp180 -59.9 -33.34 71.72 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.44 -38.77 90.86 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.602 -0.686 . . . . 0.0 112.32 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.59 -42.1 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.82 -0.55 . . . . 0.0 111.069 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.835 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 57.5 tp -68.4 -33.21 73.82 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 176.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -69.36 -24.52 63.9 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.949 -0.469 . . . . 0.0 111.624 175.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 48.2 tp -78.44 -33.76 48.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.218 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.23 -35.08 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 O-C-N 121.633 -0.667 . . . . 0.0 109.738 169.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . 0.835 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 7.0 mmm180 -66.75 -37.48 84.71 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.732 0.301 . . . . 0.0 111.555 172.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -65.3 -56.5 12.36 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.15 -0.344 . . . . 0.0 111.136 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -57.69 -38.5 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.67 80.57 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.74 -42.51 77.45 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -59.64 -50.19 74.82 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -78.41 -12.73 60.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.588 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 63.93 62.28 5.37 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.85 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 59.7 tpp -139.59 144.34 37.71 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.933 0.873 . . . . 0.0 108.94 -176.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 66.4 m -70.84 140.53 51.18 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.893 0.854 . . . . 0.0 110.468 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 17.6 m -65.19 -35.72 76.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -59.34 -52.79 64.12 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.345 -0.847 . . . . 0.0 111.722 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 60.9 m -71.47 -17.77 62.34 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -72.57 -56.62 5.07 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.645 -0.659 . . . . 0.0 112.077 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' ILE . . . . . 0.421 HD12 ' H ' ' B' ' 137' ' ' ILE . 4.4 mp -69.94 -26.77 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -58.02 -37.37 74.19 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.106 0.955 . . . . 0.0 109.601 168.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -79.85 -16.27 55.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.416 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 87.0 mt -81.88 -35.72 28.96 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.066 1.303 . . . . 0.0 111.881 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.11 -19.84 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.438 170.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 0.499 ' O ' ' HB2' ' B' ' 146' ' ' LYS . 0.5 OUTLIER -95.78 -26.34 15.71 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.146 0.885 . . . . 0.0 112.979 177.056 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.94 -31.16 56.42 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.262 -0.899 . . . . 0.0 111.719 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 74.9 m -90.17 -63.3 1.3 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.912 ' HA ' ' CB ' ' B' ' 150' ' ' ARG . 0.3 OUTLIER -88.29 80.62 7.48 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.789 1.28 . . . . 0.0 108.266 176.469 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 1.104 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 36.9 ttpt -107.58 -42.62 4.72 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.537 -173.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 1.104 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 0.0 OUTLIER 126.84 55.79 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 122.809 1.29 . . . . 0.0 108.699 -176.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -156.32 -23.16 0.1 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.916 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 145.09 58.85 0.02 OUTLIER Glycine 0 N--CA 1.465 0.58 0 N-CA-C 106.102 -2.799 . . . . 0.0 106.102 -169.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . 0.912 ' CB ' ' HA ' ' B' ' 145' ' ' PHE . 0.0 OUTLIER -81.64 -117.95 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.8 -1.2 . . . . 0.0 110.365 -169.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.627 HG22 ' CG ' ' B' ' 150' ' ' ARG . 4.7 tp -43.91 -48.23 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 113.597 -1.638 . . . . 0.0 113.656 169.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.79 88.34 0.07 OUTLIER Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.258 -179.391 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.901 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 66.1 mtt . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.901 ' CB ' ' O ' ' A' ' 1' ' ' MET . 55.1 tptt 117.47 109.32 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.169 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.55 104.11 0.17 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.4 mtt -131.6 -42.8 1.03 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 1.099 ' CB ' ' HB3' ' B' ' 113' ' ' ARG . 68.9 m -137.63 -42.77 0.54 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.742 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -82.77 39.36 0.62 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.463 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 26.0 ttt -154.61 -65.82 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 7' ' ' MET . 71.4 Cg_endo -80.73 77.01 4.22 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.412 2.075 . . . . 0.0 111.092 176.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 42.3 mt-30 -93.9 142.17 27.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.924 0.869 . . . . 0.0 109.323 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -116.79 98.82 6.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.052 -173.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -85.21 138.4 32.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.034 0.921 . . . . 0.0 111.731 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.461 HD13 ' CZ2' ' A' ' 14' ' ' TRP . 28.8 mt -123.99 173.6 8.14 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.786 -174.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.829 ' HB3' ' HB3' ' B' ' 105' ' ' SER . 88.9 mtt180 -138.06 93.04 2.72 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.624 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.461 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 52.5 m0 -119.65 139.41 27.91 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.937 -173.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -48.02 139.79 19.87 Favored 'Trans proline' 0 CA--C 1.53 0.286 0 C-N-CA 122.109 1.873 . . . . 0.0 111.528 171.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -26.09 61.23 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -174.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.22 -44.18 80.18 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.348 -0.845 . . . . 0.0 111.546 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.86 -44.47 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.541 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.775 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 64.4 tp -67.4 -35.63 79.68 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -74.92 -18.16 60.45 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.931 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.7 tt -82.7 -31.06 28.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.288 169.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.6 t -65.1 -34.4 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.939 -1.101 . . . . 0.0 109.348 168.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.775 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 28.0 mmm-85 -68.31 -39.28 82.06 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.167 -0.333 . . . . 0.0 111.472 171.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.04 -57.47 7.67 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.126 -0.359 . . . . 0.0 111.56 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 p -52.68 -39.97 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.07 -36.24 83.35 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.45 -41.16 76.63 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -58.82 -50.25 74.68 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -79.44 -12.69 59.89 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.545 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.84 62.43 5.51 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.644 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -145.46 135.51 23.76 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -174.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.0 p -62.54 142.84 57.78 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.961 0.886 . . . . 0.0 112.772 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.6 m -67.98 -37.3 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -58.76 -50.98 71.91 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.367 -0.833 . . . . 0.0 111.634 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' A' ' 38' ' ' TYR . 62.2 m -70.99 -21.27 62.32 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -70.75 -58.48 3.59 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.487 -0.758 . . . . 0.0 112.318 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.465 HD12 ' H ' ' A' ' 37' ' ' ILE . 4.4 mp -67.6 -27.46 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.816 176.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.408 ' HB3' ' HA ' ' A' ' 35' ' ' SER . 42.7 t80 -57.21 -38.1 73.21 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.865 168.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -76.95 -18.11 58.46 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.767 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.4 mt -82.02 -33.26 30.13 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.787 1.176 . . . . 0.0 112.439 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.36 -25.62 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.044 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.43 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 1.3 mmt -77.69 -33.57 53.16 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.73 -0.606 . . . . 0.0 111.946 174.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.66 -28.55 64.88 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.392 -0.818 . . . . 0.0 111.363 172.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 66.7 m -76.35 -37.21 57.63 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.918 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.67 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 22.3 m-85 -81.65 78.95 8.33 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 172.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.67 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 14.5 mtpt 179.2 -23.56 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.374 -0.93 . . . . 0.0 113.127 -168.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 2.0 tmtt? -83.25 37.88 0.58 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 118.808 -1.157 . . . . 0.0 111.631 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -164.15 -23.2 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.633 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.07 69.6 1.38 Allowed Glycine 0 N--CA 1.468 0.777 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 -170.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -102.0 -70.33 0.75 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.558 1.171 . . . . 0.0 110.064 -168.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.451 ' H ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -72.07 -50.2 38.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.839 178.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 170.99 87.55 0.07 OUTLIER Glycine 0 N--CA 1.466 0.649 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.145 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.791 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.957 ' O ' ' HB2' ' B' ' 102' ' ' LYS . 15.9 tpt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.957 ' HB2' ' O ' ' B' ' 101' ' ' MET . 88.6 tttt 135.93 94.05 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.283 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.9 93.5 0.09 OUTLIER Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 67.0 mtt -128.35 -53.06 1.28 Allowed 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . 0.829 ' HB3' ' HB3' ' A' ' 13' ' ' ARG . 73.0 m -119.38 -48.51 2.41 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.591 177.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -54.29 -40.7 68.12 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' MET . . . . . 0.488 ' HB2' ' HD3' ' B' ' 108' ' ' PRO . 26.3 mmt -91.12 -48.18 0.35 Allowed Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 118.438 -0.792 . . . . 0.0 113.018 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' B' ' 107' ' ' MET . 32.7 Cg_exo -70.94 84.44 0.84 Allowed 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.441 2.094 . . . . 0.0 112.709 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 17.7 tt0 -102.23 149.78 23.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.957 0.884 . . . . 0.0 110.0 -176.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -140.59 102.04 4.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.815 -173.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -92.14 141.63 28.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.06 0.933 . . . . 0.0 111.313 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.456 HD13 ' CZ2' ' B' ' 114' ' ' TRP . 30.0 mt -114.24 179.96 3.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.556 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 1.099 ' HB3' ' CB ' ' A' ' 5' ' ' SER . 95.5 mtt180 -135.2 88.99 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.645 -177.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' TRP . . . . . 0.456 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 51.2 m0 -121.76 136.8 26.42 Favored Pre-proline 0 N--CA 1.473 0.704 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.098 -172.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.19 145.06 36.11 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 121.952 1.768 . . . . 0.0 111.382 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.83 -28.95 64.56 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -175.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.16 -41.77 85.43 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.462 -0.774 . . . . 0.0 111.925 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.22 -43.65 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.496 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' B' ' 123' ' ' ARG . 64.4 tp -62.81 -43.47 98.71 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' B' ' 124' ' ' LYS . 76.1 m-20 -69.17 -21.19 64.0 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 50.1 tp -75.29 -31.69 60.77 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.731 -0.606 . . . . 0.0 110.305 168.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.97 -27.15 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.668 -0.645 . . . . 0.0 110.702 168.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' B' ' 119' ' ' LEU . 89.6 mtt180 -77.44 -35.84 53.58 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.748 -0.595 . . . . 0.0 111.322 171.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' B' ' 120' ' ' ASP . 69.8 mmtt -63.06 -54.13 42.87 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.264 -0.273 . . . . 0.0 110.92 176.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.6 -39.13 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.84 -33.11 74.55 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.02 -40.92 71.47 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.85 -49.54 77.31 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -76.55 -14.74 59.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.457 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.3 59.14 9.9 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.949 -177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 57.7 tpp -142.29 151.45 42.02 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.96 0.886 . . . . 0.0 108.962 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 63.8 m -62.97 136.46 57.85 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.815 0.817 . . . . 0.0 110.811 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 4.3 p -70.43 -37.87 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.001 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -62.87 -41.88 99.55 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.434 -0.791 . . . . 0.0 112.335 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 54.4 m -72.52 -19.34 61.54 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -72.36 -54.92 8.04 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.832 -0.543 . . . . 0.0 112.051 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' ILE . . . . . 0.44 HD12 ' H ' ' B' ' 137' ' ' ILE . 4.2 mp -68.86 -28.83 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 175.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -57.92 -35.81 71.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.203 169.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -77.75 -22.18 50.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.123 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 72.3 mt -78.83 -35.39 44.11 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.593 1.088 . . . . 0.0 112.27 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 33.1 m -69.99 -27.88 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.966 170.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 1.6 mmt -81.02 -28.04 35.6 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.492 -0.755 . . . . 0.0 112.447 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.28 -29.91 61.86 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 119.626 -0.829 . . . . 0.0 111.169 171.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 66.9 m -75.01 -40.9 60.36 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.678 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.787 ' O ' ' HG3' ' B' ' 146' ' ' LYS . 19.3 m-30 -79.92 86.59 5.42 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 173.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.787 ' HG3' ' O ' ' B' ' 145' ' ' PHE . 13.4 mtpt 164.94 -35.43 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.581 -165.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' B' ' 147' ' ' LYS . 0.2 OUTLIER -79.45 62.45 3.78 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.773 1.273 . . . . 0.0 109.741 177.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' B' ' 147' ' ' LYS . 21.7 tt0 165.81 -38.06 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.684 -173.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.93 70.8 1.21 Allowed Glycine 0 N--CA 1.467 0.733 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 -171.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . 0.48 ' HB2' ' H ' ' B' ' 151' ' ' ILE . 47.1 mtt180 -104.33 -83.74 0.49 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.388 1.089 . . . . 0.0 108.925 -169.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.48 ' H ' ' HB2' ' B' ' 150' ' ' ARG . 7.3 tp -57.93 -39.0 69.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 113.878 -1.51 . . . . 0.0 113.208 173.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -154.92 101.98 0.21 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.148 -179.686 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.937 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 26.4 mmt . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.937 ' HB2' ' O ' ' A' ' 1' ' ' MET . 65.5 tttm 153.41 109.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.358 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -160.67 -70.78 0.02 OUTLIER Glycine 0 N--CA 1.466 0.655 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.378 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.415 ' HB2' ' H ' ' A' ' 9' ' ' GLN . 67.8 mtt -109.91 -61.37 1.66 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.89 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -90.17 -122.22 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.59 ' HG3' ' H ' ' A' ' 7' ' ' MET . 42.6 pttt -99.41 -57.23 2.2 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.59 ' H ' ' HG3' ' A' ' 6' ' ' LYS . 1.8 mpt? -93.52 139.09 22.76 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 165.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.719 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 46.9 Cg_exo -41.25 125.18 2.44 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.067 2.512 . . . . 0.0 116.561 -174.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' B' ' 112' ' ' LEU . 26.4 tt0 -77.57 153.71 33.06 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.683 -176.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -138.65 109.43 6.67 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -174.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -96.6 130.28 43.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.766 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.446 HD13 ' CZ2' ' A' ' 14' ' ' TRP . 38.5 mt -113.81 169.86 8.69 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.634 0.731 . . . . 0.0 110.056 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -130.38 91.26 3.07 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.695 0.76 . . . . 0.0 109.284 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.446 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 49.2 m0 -125.79 151.36 70.88 Favored Pre-proline 0 N--CA 1.475 0.79 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.509 -170.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.45 150.49 67.85 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.038 1.825 . . . . 0.0 111.819 168.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.699 ' HB3' ' HG2' ' B' ' 108' ' ' PRO . 4.0 ptm180 -59.06 -40.33 84.81 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -64.07 -31.32 72.47 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 177.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.74 -53.21 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.206 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.13 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 3.1 pp -81.2 -1.62 45.48 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -79.95 -28.09 39.71 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.786 -1.196 . . . . 0.0 110.0 167.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' B' ' 150' ' ' ARG . 50.6 tp -77.74 -35.09 52.2 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.841 -0.537 . . . . 0.0 111.908 174.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 19' ' ' LEU . 1.4 p -67.18 -30.59 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.337 -0.852 . . . . 0.0 110.247 169.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 1.13 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 5.9 mmm180 -66.05 -41.01 91.39 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.281 170.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -65.91 -57.36 8.04 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.133 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.83 -39.54 71.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.04 -35.79 82.28 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.15 -37.69 84.23 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 175.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.65 -46.8 88.22 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -76.89 -13.76 59.95 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.557 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.27 62.13 5.15 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.231 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.4 ttt -141.94 145.77 34.9 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.999 0.904 . . . . 0.0 109.653 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.8 m -69.98 142.6 52.81 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.756 0.789 . . . . 0.0 110.303 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -62.43 -39.12 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -58.26 -51.81 68.2 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.063 -1.023 . . . . 0.0 112.709 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 64.5 m -72.16 -22.97 61.22 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 175.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -71.38 -55.38 8.09 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.512 -0.743 . . . . 0.0 112.537 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mp -67.3 -26.66 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -56.72 -39.35 73.74 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.583 168.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -76.62 -20.4 56.77 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.2 mt -82.99 -35.26 26.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.282 1.401 . . . . 0.0 112.265 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 m -70.1 -26.95 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.871 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -87.79 -25.53 23.31 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -83.19 -25.86 31.39 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.13 174.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.8 t -92.85 -70.52 0.69 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.946 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -70.44 135.54 48.78 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 171.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.083 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 40.1 ttpt 177.56 -50.64 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.118 0.961 . . . . 0.0 109.929 -171.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.083 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 2.6 tmtp? 142.46 54.73 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -153.52 -36.74 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.457 -170.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 50' ' ' ARG . . . -176.64 -58.1 0.06 OUTLIER Glycine 0 N--CA 1.464 0.559 0 N-CA-C 107.582 -2.207 . . . . 0.0 107.582 -173.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.946 ' HG2' ' HA ' ' A' ' 45' ' ' PHE . 96.3 mtt180 72.52 -87.73 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 168.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.678 HG22 ' HB3' ' A' ' 50' ' ' ARG . 2.9 tp -145.48 -51.86 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 112.726 -2.034 . . . . 0.0 110.777 -159.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.7 100.04 0.16 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.527 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.802 179.045 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.907 ' O ' ' CB ' ' B' ' 102' ' ' LYS . 67.0 mtt . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.907 ' CB ' ' O ' ' B' ' 101' ' ' MET . 87.9 tttt 113.65 -76.32 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.047 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 158.5 84.83 0.05 OUTLIER Glycine 0 N--CA 1.466 0.684 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 66.9 mtt -92.75 -62.27 1.42 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.525 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 29.0 m -64.88 -55.66 18.05 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.083 0.944 . . . . 0.0 110.786 174.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -173.55 -49.95 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' MET . . . . . . . . . . . . . 67.7 mtt -106.81 156.17 37.74 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 167.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.699 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 41.5 Cg_exo -41.64 122.18 1.84 Allowed 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.969 2.446 . . . . 0.0 116.461 -177.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -81.86 152.72 26.73 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.043 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -136.75 110.68 8.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.522 0.677 . . . . 0.0 109.699 -172.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -92.73 140.59 29.37 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.96 0.886 . . . . 0.0 111.806 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.453 HD13 ' CZ2' ' B' ' 114' ' ' TRP . 58.6 mt -124.0 172.79 8.7 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.918 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -132.95 88.79 2.54 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.815 0.817 . . . . 0.0 109.342 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' TRP . . . . . 0.453 ' CZ2' HD13 ' B' ' 112' ' ' LEU . 48.4 m0 -118.22 141.8 30.11 Favored Pre-proline 0 N--CA 1.472 0.652 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.579 -172.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.52 143.88 65.46 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 121.899 1.732 . . . . 0.0 111.022 171.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.719 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . 7.8 ttp180 -58.7 -32.04 68.8 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.1 -40.85 95.13 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.542 -0.724 . . . . 0.0 112.27 176.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.63 -46.02 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.802 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.967 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 56.0 tp -65.13 -32.07 73.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -69.08 -32.46 71.92 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.179 176.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 42.6 tp -76.31 -32.01 58.5 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.682 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 79.8 t -64.99 -36.14 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.565 -0.709 . . . . 0.0 109.166 169.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . 0.967 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 24.6 mmm-85 -64.97 -38.93 92.58 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.817 172.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -62.5 -51.38 67.65 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.232 -0.292 . . . . 0.0 111.775 177.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 99.5 t -59.31 -38.55 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 120.404 -0.518 . . . . 0.0 112.163 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.36 72.39 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.68 -40.28 66.4 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.27 -49.45 77.58 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -78.44 -10.91 59.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.856 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.37 59.2 11.08 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.702 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' B' ' 132' ' ' SER . 0.0 OUTLIER -145.65 147.71 32.29 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -176.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.464 ' N ' ' SD ' ' B' ' 131' ' ' MET . 56.2 m -61.04 150.78 32.66 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.441 1.115 . . . . 0.0 112.317 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 17.7 m -67.81 -37.79 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -175.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -60.74 -47.84 84.47 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.477 -0.765 . . . . 0.0 112.559 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 64.6 m -70.72 -26.58 63.46 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -65.83 -59.78 3.53 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.755 -0.591 . . . . 0.0 112.293 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.88 -24.16 26.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.375 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -58.64 -38.31 77.83 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.411 168.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -76.63 -19.55 57.68 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.675 -0.81 . . . . 0.0 112.684 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 71.1 mt -82.81 -32.25 27.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.798 1.181 . . . . 0.0 112.536 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.84 -28.08 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 119.521 -0.871 . . . . 0.0 109.913 169.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . 1.028 ' O ' ' HG2' ' B' ' 146' ' ' LYS . 9.1 mmt -78.99 -33.33 45.12 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.612 -0.68 . . . . 0.0 112.131 174.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . 0.488 ' HA ' ' HG3' ' B' ' 146' ' ' LYS . 38.1 mt-10 -72.3 -22.9 61.13 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.294 -0.879 . . . . 0.0 112.152 174.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 68.5 m -85.21 -39.81 17.38 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.118 -0.364 . . . . 0.0 110.69 173.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 0.665 ' O ' ' HB2' ' B' ' 146' ' ' LYS . 12.4 m-30 -72.2 -99.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 172.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 1.028 ' HG2' ' O ' ' B' ' 142' ' ' MET . 3.0 mmmt 81.63 -134.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.484 -0.887 . . . . 0.0 109.584 166.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -109.8 45.87 1.06 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 122.889 1.328 . . . . 0.0 109.853 170.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 1.423 ' HB2' ' NH2' ' B' ' 150' ' ' ARG . 37.5 mm-40 -86.23 -29.69 22.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.825 167.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 148.0 40.22 0.04 OUTLIER Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.286 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . 1.423 ' NH2' ' HB2' ' B' ' 148' ' ' GLU . 0.1 OUTLIER -126.84 -93.46 0.47 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.572 0.701 . . . . 0.0 110.488 -172.171 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 10.6 tp -67.54 -39.34 82.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -172.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.8 -80.7 1.19 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.905 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.464 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.921 ' O ' ' HB2' ' A' ' 2' ' ' LYS . 28.0 ttt . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.921 ' HB2' ' O ' ' A' ' 1' ' ' MET . 88.5 tttt 139.29 103.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.125 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.57 42.08 6.24 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.905 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.6 mtt -144.12 -55.51 0.36 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.582 ' HB3' ' HB3' ' B' ' 113' ' ' ARG . 61.9 m -146.39 40.36 1.11 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.42 0.629 . . . . 0.0 110.109 172.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 38.1 ttpt -76.66 -31.78 57.53 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.587 ' H ' ' CD ' ' A' ' 8' ' ' PRO . 61.1 mtt -142.07 -42.53 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -177.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.587 ' CD ' ' H ' ' A' ' 7' ' ' MET . 70.1 Cg_exo -60.83 98.89 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.48 2.12 . . . . 0.0 114.622 -174.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -108.04 156.63 19.04 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.801 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -146.26 120.98 9.85 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -91.52 128.89 37.52 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.755 0.788 . . . . 0.0 110.785 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' B' ' 109' ' ' GLN . 28.7 mt -102.47 165.49 11.07 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.603 ' HD3' ' HA ' ' B' ' 106' ' ' LYS . 94.6 mtt180 -133.98 94.74 3.31 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.824 -175.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.41 ' CZ2' HD13 ' A' ' 12' ' ' LEU . 53.3 m0 -124.06 149.3 59.85 Favored Pre-proline 0 N--CA 1.474 0.736 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.142 -173.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.7 144.38 65.24 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 121.815 1.677 . . . . 0.0 111.181 170.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.58 -29.39 66.38 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.5 -40.83 80.72 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.52 -0.738 . . . . 0.0 111.798 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.06 -47.29 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.942 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 64.6 tp -59.79 -43.72 94.3 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -69.7 -24.24 63.55 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 120.097 -0.641 . . . . 0.0 112.076 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.6 tp -76.42 -33.58 58.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.035 170.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.38 -33.67 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.59 -0.694 . . . . 0.0 109.934 169.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 19' ' ' LEU . 21.9 mmt180 -66.41 -36.71 83.51 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.143 -0.348 . . . . 0.0 111.659 171.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -63.61 -56.28 17.05 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.026 -0.421 . . . . 0.0 110.769 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.5 t -56.32 -37.33 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.81 -34.97 79.11 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.54 -40.24 70.17 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 175.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.27 -48.39 81.63 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -76.46 -12.35 60.03 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.56 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.89 60.38 8.17 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.676 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.3 tpt -141.43 149.1 40.57 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 122.056 0.931 . . . . 0.0 108.879 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.4 t -64.38 141.77 58.65 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 122.104 0.954 . . . . 0.0 110.811 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -63.22 -37.9 80.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -63.08 -47.98 80.58 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.551 -0.718 . . . . 0.0 111.957 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.8 m -70.43 -26.03 63.48 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -67.19 -58.01 5.65 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.663 -0.648 . . . . 0.0 112.146 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -69.84 -25.44 28.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.249 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -57.05 -39.04 74.1 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.474 168.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -76.91 -22.73 52.94 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.732 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.5 mt -81.13 -36.05 30.79 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.056 1.298 . . . . 0.0 112.615 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.4 m -67.95 -30.31 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.139 169.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.69 ' CE ' ' HA ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -82.23 -16.97 47.69 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.018 -1.051 . . . . 0.0 113.707 178.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.17 -28.07 21.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.389 173.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 1.04 ' O ' ' HB3' ' A' ' 50' ' ' ARG . 33.1 t -93.6 -72.4 0.61 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.97 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 5.6 t80 -66.53 164.76 15.89 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 165.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.001 ' O ' ' CB ' ' A' ' 47' ' ' LYS . 25.5 ttpt 161.17 52.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 O-C-N 119.752 -1.843 . . . . 0.0 111.439 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.479 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 45.3 tptt 117.92 -16.74 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 117.769 -1.573 . . . . 0.0 110.536 -168.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 49.6 mt-10 79.76 7.87 1.69 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -105.28 36.82 4.15 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 169.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 1.479 ' NH2' ' HB3' ' A' ' 47' ' ' LYS . 1.3 mpp_? -127.36 -84.21 0.6 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -169.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.0 tp -63.26 -35.52 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.285 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.07 96.46 0.16 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.031 179.966 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -165.6 123.98 1.6 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 169.02 122.67 0.63 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 66.9 mtt -126.83 -38.01 2.08 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 61.7 m -157.91 -51.08 0.07 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' LYS . . . . . 0.603 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 98.3 mttt -65.71 -40.96 92.77 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' MET . . . . . 0.431 ' HB2' ' HD3' ' B' ' 108' ' ' PRO . 61.6 mtt -73.09 -48.18 7.77 Favored Pre-proline 0 N--CA 1.473 0.679 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -177.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' B' ' 107' ' ' MET . 31.3 Cg_exo -66.71 94.73 0.33 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.346 2.031 . . . . 0.0 111.503 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 79.9 mt-30 -100.17 160.87 13.99 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 122.648 1.213 . . . . 0.0 111.355 -176.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -137.5 101.49 4.51 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -90.64 125.39 35.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.53 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.83 176.55 7.95 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.741 176.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 5' ' ' SER . 99.8 mtt180 -131.91 113.57 13.61 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.504 0.669 . . . . 0.0 110.9 -171.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -123.53 154.65 66.37 Favored Pre-proline 0 N--CA 1.474 0.737 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.623 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.58 144.33 52.68 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 121.676 1.584 . . . . 0.0 110.443 170.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -59.99 -30.09 68.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.923 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.15 -40.4 94.3 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.577 -0.702 . . . . 0.0 112.003 174.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 82.3 t -66.51 -43.85 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.862 -0.524 . . . . 0.0 111.608 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 1.012 ' O ' ' HG2' ' B' ' 123' ' ' ARG . 65.4 tp -67.85 -37.13 81.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.0 -20.91 60.18 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.778 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 25.8 tp -85.46 -32.26 22.38 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.927 -0.483 . . . . 0.0 111.795 176.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' B' ' 119' ' ' LEU . 28.1 m -69.91 -25.99 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.07 167.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . 1.012 ' HG2' ' O ' ' B' ' 119' ' ' LEU . 27.6 mmm-85 -67.35 -42.68 83.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.983 170.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -65.27 -52.37 54.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.894 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.57 -40.33 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.75 -35.81 80.99 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.01 -38.78 86.59 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -61.36 -47.65 84.88 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.232 0.539 . . . . 0.0 112.454 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -75.72 -11.91 60.09 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.734 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' GLY . . . . . . . . . . . . . . . 65.35 61.83 5.38 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.856 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' MET . . . . . . . . . . . . . 57.4 tpp -141.94 144.1 33.58 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.945 0.879 . . . . 0.0 109.104 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 64.3 m -69.02 142.01 54.71 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.876 0.846 . . . . 0.0 110.183 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 18.2 m -64.88 -37.51 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -60.6 -48.85 79.96 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.286 -0.884 . . . . 0.0 112.377 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 60.9 m -71.21 -23.66 62.06 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 175.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -70.58 -55.06 9.71 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.648 -0.658 . . . . 0.0 112.208 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.03 -26.31 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.107 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -56.33 -39.8 73.4 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.502 168.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -74.81 -24.2 58.6 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.882 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 60.7 mt -82.34 -34.13 28.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.071 1.305 . . . . 0.0 112.537 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' VAL . . . . . . . . . . . . . 20.8 m -70.32 -26.67 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.832 171.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -86.22 -29.6 23.03 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.397 -0.815 . . . . 0.0 112.907 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.04 -27.95 48.89 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.195 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' SER . . . . . . . . . . . . . 37.2 t -91.84 -72.13 0.6 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . 1.156 ' HA ' ' CB ' ' B' ' 150' ' ' ARG . 0.1 OUTLIER -68.58 112.77 5.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 1.109 ' O ' ' HB2' ' B' ' 147' ' ' LYS . 37.8 ttpt -154.07 -43.17 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.838 0.828 . . . . 0.0 111.143 -171.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 1.109 ' HB2' ' O ' ' B' ' 146' ' ' LYS . 0.0 OUTLIER 132.35 53.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.877 1.322 . . . . 0.0 108.736 178.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -156.09 -21.18 0.1 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.891 -177.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 145.17 57.44 0.02 OUTLIER Glycine 0 N--CA 1.466 0.644 0 N-CA-C 106.132 -2.787 . . . . 0.0 106.132 -169.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' ARG . . . . . 1.156 ' CB ' ' HA ' ' B' ' 145' ' ' PHE . 0.0 OUTLIER -76.16 -40.78 51.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -170.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . 0.793 HG22 ' HG2' ' B' ' 150' ' ' ARG . 3.4 tp -156.63 -49.11 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -168.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -169.88 97.7 0.13 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 120.334 -0.546 . . . . 0.0 109.886 -179.917 . . . . . . . . 0 0 . 1 stop_ save_